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PREFACE 
 
The dissertation “The Relationships between Domain-Specific Cognitive Function, 
Functional Performance and Life Satisfaction in Persons with Chronic Obstructive Pulmonary 
Disease (COPD)” is a three-paper dissertation to partially fulfill the graduation requirements of 
the University of Michigan School of Doctor of Philosophy in Nursing. 
The inspiration for the subject came from the man that was my sailing mentor. After 
smoking two packs of cigarettes daily for the past 62 years, he developed COPD. With the 
progression of COPD, decisions to call tactics took longer and now so much strength has left his 
body he can no longer sail. He has become a power boater to continue to enjoy being on the 
water. I was curious if others with COPD had similar experiences in which there was a change in 
cognition and the loss of strength that led to lifestyle changes to maintain activities of enjoyment. 
My research questions were formulated together with my committee chair, Dr. Janet L. Larson. 
The research questions were answered through three papers; a systematic review and 
meta- analysis, a secondary data analysis and a pilot study using the National Institute of Health 
Cognitive Toolbox and PROMIS® to begin to explain the relationships between domain-specific 
cognition, functional performance and life satisfaction in persons with COPD. 
Julie Slack 
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ABSTRACT 
 
Chronic Obstructive Pulmonary Disease (COPD) is a major cause of disability. Not only 
does COPD cause breathing difficulties, there are extrapulmonary effects including cognition 
with domain-specific cognition as our primary focus. Evidence suggests that COPD has negative 
effects on domain-specific cognition which may be related to declines in functional performance 
and life satisfaction. This three-paper dissertation includes a) a meta-analysis summarizing the 
effect size of changes in domain-specific cognition, b) a secondary analysis of the HRS data set 
examining longitudinal changes in domain-specific cognition in persons with and without COPD 
and c) a pilot study examining feasibility and acceptability computerized adaptive testing CAT) 
in persons with COPD and describing a preliminary relationship between domain-specific 
cognition, functional performance and life satisfaction. In the meta-analysis, differences 
indicated that persons with COPD had poorer performance than persons without COPD. No 
difference was found between the groups in the domains of executive function measured with 
verbal fluency animal or language measured with Boston Naming. A small effect size was found 
in memory and learning measured with Digit Span Forward (-0.298, 95% CI [ -0.480 - -0.114], p 
< 0.001) and executive function measured with Digit Span Backward (-0.352, 95% CI [-0.105 – 
 - 2.80], p < 0.001). Moderate effect sizes were found in attention measured with Trailmaking 
Test A (TMT-A) (-0.516, 95% CI [ -0.747 – -0.286], p < 0.001), in memory and learning 
measured with Wechsler Memory Scale immediate recall (-0.6, 95% CI [-0.480 – -0.114], p < 
0.001) and delayed recall (-0.420, 95% CI [-0.610 – - 0.231], p < 0.001); in executive function  
 
xix  
Measured with Trailmaking Test B (TMT-B) (-0.571, 95% CI [- 0.769 - - 0.374], p < 0.001) and 
large effect sizes were found in executive function measured with verbal letter fluency (-0.746, 
95% CI [- 0.961 - - 0.530], p < 0.001) and processing speed measured with digit symbol (-0.923, 
95% CI [ -0.769 - -0.374], p < 0.001). In the secondary data analysis, persons with COPD had 
significantly poorer performance in executive function and memory and learning. Both groups 
had significant declines over time, with a steeper decline immediate recall in the non-COPD 
group. In cross-sectional analysis, persons with COPD, no significant relationships between the 
cognitive domains and life satisfaction to mediate. In the non-COPD group, there was a 
relationship between delayed recall and life satisfaction that was fully mediated by activities of 
functional performance. Hopelessness explained a significant portion of the variance in 
cognition in both groups. Semipartial in the COPD group, hopelessness uniquely contributed to 
immediate recall (7%) and delayed recall (9%) and explained very little in the non-COPD group 
(<1%). Finally, a pilot study examined feasibility and acceptability of computer adaptive testing 
(CAT) in COPD. On a scale of 0 - 5, the CAT had a 4.3 overall impression indicating 
acceptability. Only processing speed approached the level of significance with 47.5% of persons 
below norm. Findings suggest that persons with COPD have domain-specific cognitive deficits 
that are greater than those occurring in normal aging. 
Keywords: Domain-specific cognitive decline, COPD 
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CHAPTER I 
 
Background and Significance 
 
COPD is a major public health problem. Persons with COPD have a 10-fold higher risk 
of developing disability than members of the general population (Eisner et al., 2011). Based on 
data from the 2007-2012 National Health and Nutrition Examination Survey (NHANES), a 
nationally representative data set in the United States (U.S.), 14.7% of adults in the U.S. aged 
40 - 79 had measurable airflow obstruction; 9.4% had mild obstruction and 5.3% had moderate 
to severe obstruction (Tilert, Paulose-Ram, & Brody, 2015). In another nationally representative 
survey, the Health and Retirement Study (HRS), in persons over the age of 50 with COPD there 
is an 8.6% decreased likelihood of being employed, a 3.9% increase in the probability of 
collecting Social Security Disability Insurance and 1.7% increase in the use of Supplement 
Security Income (Snider et al., 2012). COPD is a public health burden as it leads to disability 
which interferes with the ability to work. 
Beyond the changes that occur in the pulmonary system, COPD has extrapulmonary 
effects which add to the risk of disability. One extrapulmonary effect is a change in muscles 
which includes a shift in fiber type, weakening of the quadriceps, and atrophy (Bone, Hepgul, 
Kon, & Maddocks, 2017). When the loss of skeletal muscle is associated with a decline in 
physical function it is known as sarcopenia which offers prognostic information in COPD 
independent of pulmonary function (Bone et al., 2017). The prevalence of sarcopenia 
occurring in persons with COPD has been reported as 14.5% (95% CI [11.8% to 17.4%]), 
(Jones et al., 2015). 
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Another extrapulmonary effect of COPD is a change in cognition. It is generally 
recognized that there is a high prevalence of cognitive decline. However, there are 
inconsistencies in the evidence related to the prevalence. Cognitive decline has been 
reported in 22% - 77% of patients with COPD (Ambrosino, Bruletti, Scala, Porta, & Vitacca, 
2002; Grant, Heaton, McSweeny, Adams, & Timms, 1982; Heaton, Grant, McSweeny, 
Adams, & Petty, 1983). The wide variation in the estimated prevalence of cognitive decline 
may be attributed to the selection of neuropsychological measures and inclusion criteria such 
disease severity. In most studies that used global measures of cognition, it was suggested 
from the findings that between groups there was no significant difference to a significant 
difference cognition prevalent in 5.5% of persons with COPD (Incalzi et al., 2002; Isoaho, 
Puolijoki, Huhti, Laippala, & Kivela, 1996; Stuss, Peterkin, Guzman, Guzman, & Troyer, 
1977, Thakur et al., 2010). In contrast, when using a neuropsychological battery, 48.5% - 
77% of persons with hypoxemic COPD had cognitive decline in all abilities but the 
magnitude was not equal across all domains of cognition (Cleutjens et al., 2017; Grant et al., 
1982; Incalzi et al., 1993). Several studies (Grant et al., 1982; Krop, Block, & Cohen, 1973; 
Prigatano, Parson, Lein, Wright & Hawryluk, 1983) found the prevalence of cognitive 
decline dramatically increases with worsening hypoxemia and hypercapnia. Independent of 
hypoxemia and disease severity, in the domain of processing speed, 57% of persons with 
acute exacerbation of COPD were in the impaired range and 20% were considered to have 
suffered pathological loss in processing speed (Dodd, Charlton, van den Broek, & Jones, 
2013). These results indicate that the selection of neuropsychological measures, disease 
severity and exacerbations may partially explain the variation in estimated prevalence of 
cognitive decline. 
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Persons with COPD have a higher prevalence and are at a greater risk for developing 
mild cognitive impairment (MCI) than in controls. Mild cognitive impairment refers to a 
complaint of defective memory, normal activities of daily living, normal general cognitive 
function, abnormal memory function for age and absence of dementia (Petersen et al., 1997). 
Mild cognitive impairment was present is 36% of persons with COPD compared to 12% in 
controls (Villeneuve et al., 2012). COPD was associated with a substantive risk of global 
cognitive decline compared to referent subjects (OR 2.43; 95% CI [1.043 - 6.64]) (Thakur et 
al., 2010). A dose response was also noted with the risk of developing cognitive decline such 
that persons with COPD duration of 5 years or longer at baseline had the greatest risk of both 
MCI (HR 1.58, 95% CI [1.04 - 2.40]) and non-amnesic-MCI (HR 2.58, 95% CI [1.32–5.06]) 
(Singh et al., 2014). These results support persons with COPD have a higher prevalence and 
a greater risk for developing MCI than controls. 
This dissertation includes a) a meta-analysis summarizing the effect size of domain- 
specific cognitive decline, b) a secondary analysis of the HRS data set to examine 
longitudinal changes in cognition, comparing people with and without COPD, and c) a pilot 
study examining feasibility and acceptability of the use of the National Institute of Health 
(NIH) toolbox in persons with COPD and describe a preliminary relationship between 
domain-specific cognition, functional performance and life satisfaction. This chapter 
describes the background for this work with an emphasis on the impact of COPD on domain- 
specific cognition. Brief descriptions of current biological theories of causes for changes in 
cognition that occurs in COPD are examined and a preliminary exploration of the 
relationship between domain-specific cognition, functional performance and life satisfaction 
are presented. 
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Cognitive function consists of the complex processes by which an individual 
perceives, registers, stores, retrieves, and uses information from the environment to adapt 
behavior to new situations (Dodd, Getov, & Jones, 2010). To provide more information about 
the nature of cognitive function, cognitive processes have been separated into discrete 
domains. According to Dodd et al., (2010, p.914), no universal classification or division of 
cognitive domains has been accepted. It is important to note that even though cognition is 
reported in specific domains, it is difficult to examine a domain in isolation as domains are 
part of the process of cognition and many occur at the same time. Presently, there is not a 
standard assessment tool to assess global cognition and there is no standard for the types or 
number of neuropsychological tests required for evaluation of cognitive domains. 
The prevalence and extent of domain-specific cognitive decline in COPD has poorly 
studied. In a systematic review to determine the prevalence of cognitive impairment in 
persons with COPD, a classification system of cognitive domains proposed by Lezak (2004 
as cited in Torres-Sanchez et al., 2015) which included the domains: perception, attention, 
memory and learning, executive function and language. Prevalence was of cognitive decline 
was found in all domains. However, extent of cognitive decline was not examined. Another 
frequently studied cognitive domain is processing speed. Processing speed is an underlying 
cognitive process that is associated with several cognitive processes. These six domains will 
be examined in this research. 
Cognitive Domains 
 
Perception 
 
Little is known about the effect of COPD on the cognitive domain of perception. 
 
Perception is the processes and activities in which one extracts stimuli and information from 
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the environment and acts upon it (Torres-Sanchez et al., 2015). To perceive, one must be 
able to attend to the stimuli. Thus, perception and attention, even though they are separate 
areas of cognition, are often tested together. Several studies have examined the cognitive 
domain of perception (Antonelli-Incalzi et al., 2008; Grant et al., 1982; Orth et al., 2008; 
Prigatano et al., 1983; Villeneuve et al., 2012). The results were mixed. The studies used a 
variety of measures making comparison between studies difficult. To understand the effect 
of COPD on perception, further research is needed. 
Attention 
 
Extensive research has been done of the relationship COPD and attention. Attention is 
a major contributor to cognitive performance as it is a process of selection and reduction of 
relevant aspects (Orth et al., 2008). Although several studies have examined the relationship 
between COPD and attention (Favalli, Miozzo, Cossi, & Marengoni, 2008; Grant et al., 
1982; Klein, Gauggel, Sachs, &Pohl, 2010; Liesker et al., 2004; Parekh, et al. 2005; Pereira 
et al., 2011; Vos, Folgering, & van Herwaarden et al., 1995), these studies have used different 
neuropsychological tests yielding mixed results. These majority of the findings suggest that 
persons with COPD may experience cognitive impairment in the domain of attention. 
Memory and Learning 
 
People with COPD had poorer performance on tests of memory and learning. One 
way to categorize memory and learning are short-term and long-term memory. Short-term 
memory is also called immediate recall. Long-term memory is also called delayed recall or 
learning. A multitude of tests have been used to compare memory in persons with COPD and 
controls. The results were mixed. On tests of short-term memory, when tested with digit 
span forward, no significant difference was found between the groups (Cleutjens et al., 2014; 
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Incalzi et al., 1993; Kozora, Filley, Julian, & Cullum, 1999; Ortapamuk & Naldoken, 2006; 
Pereira et al., 2011; Zhang et al., 2013). It has been found that persons with COPD had 
poorer cognitive function in both verbal immediate and delayed recall (Dodd et al., 2013; 
Favalli et al., 2008; Grant et al., 1982; Hjalmarsen et al., 1999; Incalzi et al., 1993; Incalzi et 
al., 1997; Kozora et al., 1999; Ortapamuk & Naldoken, 2006; Pereira et al., 2011; & Zhou et 
al., 2012). One explanation for these differences in results is a model of working memory 
that is fractioned into a central controlling system aided by two peripheral systems. The 
central executive system forms strategies to retrieve information for the two slave systems: 
the phonological loop (digit span forward) and the visuospatial sketch pad (speech-based 
material) (Strauss, Sherman & Spreen, 2005). These findings support that persons with 
COPD have more problems with speech-based material in the domain of memory and 
learning than controls. 
Executive Function 
 
COPD does not impact the processes that make up executive function equally. 
 
Executive function is the cognitive processes necessary for planning, organizing, focusing 
attention, problem solving, remembering instructions, and juggling multiple tasks 
successfully (Torres-Sanchez et al., 2015). Several neuropsychological tests have been used 
to test executive function. One test used to assess executive function is verbal fluency. The 
results of this test are mixed. Several studies reported significant difference (Dodd et al., 
2013; Incalzi et al., 1993; Prigatano et al., 1983; Zhou et al., 2012) while others found no 
significant differences on tests of language (Favalli et al., 2008: Grant et al., 1982; Kozora et 
al., 2005; Kozora, Emery, Zhang, & Make, 2010; Ortapamuk et al., 2006; Pereira et al., 
2011). One study reported performance of persons with COPD on verbal fluency test had 
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statistically significantly lower scores than controls, but the deficit did not reach the clinically 
impaired range (Kozora et al., 1999). One important factor that the study brought to attention 
is that although many studies have found statistically significant declines in domain-specific 
cognition, the clinical relevance of these declines remain unknown. 
Another test frequently used to assess executive function is TMT-B. Persons with COPD 
were found to have poorer performance than aged matched control (Bratek et al., 2015; Dal Ben 
& Bricolo, 2012; Favalli et al., 2008; Liesker et al., 2004; Park & Larson, 2015). In one study 
(Dal Negro, Bonadiman, Tognella, Bricolog, & Turco, 2014), the cognitive deterioration in 
executive function observed in respiratory patients aged 40-69 years was equivalent to the 
cognitive deterioration reported in healthy subject aged 70-79 years. Cognitive decline in the 
domain of executive function may begin in the early stages of COPD. Further research is needed 
to understand the relationship between executive function and its impact on performing daily 
activities. 
Language 
 
Language is impacted by COPD but may not be as affected as other cognitive 
domains. Results are inconsistent on test of language. When language was assessed using 
the aphasia screening test the results found no significance differences between those with 
COPD and controls (Grant et al., 1982). In contrast, Prigatano et al. (1983), found a 
significant difference between the two groups using same measure. When language ability 
was tested using the Boston Naming test, no significant difference was found between 
persons with COPD and controls (Kozora et al, 1999; Kozora et al. 2005; Kozora et al., 
2010). These studies provide some evidence that not all domains are affected to the same 
extent. 
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Processing Speed 
 
Persons with COPD have a slower processing speed than age matched controls. 
Processing speed is the ability to fluently perform relatively easy cognitive tasks and the 
flexibility to move rapidly from one task to another. Studies have consistently found that 
persons with COPD have slower overall processing speed regardless of the 
neuropsychological test used to assess processing speed (Grant et al., 1982; Klein et al, 2010; 
Liesker et al., 2004; Orth et al., 2008; Vos et al., 1995). The loss of cognitive flexibility is a 
consistent finding in persons with COPD and clinical implications need to be examined. 
Mechanisms of Cognitive Decline in COPD 
 
Multiple pathophysiological mechanisms have been examined as possible causes of 
cognitive decline in persons with COPD. Possible mechanisms include hypoxemia, hypercapnia, 
cerebral metabolic abnormalities, changes in cerebral perfusion, inflammatory processes, 
changes in brain structures and exacerbations. The impact that each of these mechanisms has on 
domain-specific cognition will be briefly discussed. 
Hypoxemia 
 
There is a strong negative association between hypoxemia and cognitive decline. In a 
study modeling impact of COPD on the brain, pathways linking disease severity with impaired 
cognitive performance were mediate through oxygen dependence (Borson et al. 2008). The rate 
of cognitive impairment increased from 27% in individuals with mild hypoxemia to 61% in 
individuals with severe hypoxemia (Grant et al., 1987). As hypoxemia increased persons with 
COPD scored progressively worse on the Halstead Battery Index (control 0.59(0.26), mildly 
hypoxic 0.65 (0.23), moderately hypoxic 0.73 (0.24), and severely hypoxic 0.77 (0.23)). Persons 
with moderate and severe hypoxia were statistically indistinguishable from each other. These 
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results support the negative relationship between hypoxemia and cognitive decline. Long-term 
oxygen therapy may prevent COPD hypoxemia-induced cognitive decline has been investigated. 
Persons with hypoxemic COPD that were prescribed and used long-term oxygen therapy had 
significantly less impairment in the domains of global cognition, executive function and attention 
compared to those that did not use oxygen or used it on an as needed basis (Dal Negro, 
Bonadiman, Bricolo, Tognella, & Turco, 2015, Karamanli, Ilik, Kayhan, & Pazarli, 2015). In 
domains of processing speed, ability to detect correct sequence of tones and serial memory, was 
not improved by providing short term oxygen therapy did not reverse information processing 
deficits in hypoxemic COPD (Wilson, Kaplan, Timms, & Dawson, 1985). These results provide 
support that hypoxemia-induced cognitive decline may be slowed or prevented with the use of 
long-term oxygen therapy but not short-term oxygen therapy. 
Hypercapnia 
 
The relationship between hypercapnia and cognitive decline in persons with COPD is not 
clear. Increased carbon dioxide in the blood can lead to an increase in free radical formation and 
oxygen dependent enzymes which can result in global neuronal injury (Cleutjens et al., 2014). In 
the Nocturnal Oxygen Therapy Trial (NOTT) found no correlations between any domains of 
cognitive function and hypercapnia (Grant et al., 1987). In contrast, the level of PaCO2 was 
negatively correlated with scores of executive functions (Parekh et al., 2005), verbal memory 
(Incalzi et al., 1997) and attention and processing speed (Incalzi et al., 1993). Further research is 
needed to understand the impact of hypercapnia on cognitive domains in COPD. 
Cerebral metabolites 
 
Cerebral metabolic abnormalities have been implicated as a possible cause for the 
change in cognition that occurs with COPD. In a preliminary study, cerebral metabolites (N- 
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acetyl aspartate, creatine, choline and myo-inositol) and the neuropsychological tests were 
significantly lower in persons with COPD (Shim et al., 2001). In examining relationships of 
these metabolites, only the decrease in choline in the parietal white matter was associated with 
the general memory quotient of the Wechsler memory scale (Shim et al., 2001). There is some 
evidence that select cerebral metabolites are associated with negative cognitive changes in the 
domain of memory and learning in persons with COPD. However, the clinical significance of 
cerebral metabolic changes and their role in cognitive impairment in COPD requires further 
investigation. 
Cerebral perfusion 
 
Change in cerebral perfusion patterns is another possible mechanism that may lead to 
cognitive impairment in persons with COPD. There is strong evidence that changes in patterns of 
cerebral perfusion in persons with COPD are associated with cognitive impairment. In a study 
comparing cerebral perfusion patterns in patients with COPD and normal age-related perfusion 
changes, there was a downward trend in cerebral perfusion in most regions of interest which had 
a direct negative effect on the performance of neuropsychological tests for verbal attainment, 
attention, and deductive reasoning (Antonelli-Incalzi et al., 2003) and verbal memory, attention 
and delayed recall (Ortapamuk & Naldoken, 2006).  These findings support that in COPD there 
is decrease in cerebral perfusion and subsequent domain-specific cognitive impairment. 
Chronic inflammation 
 
Since COPD is a disease of chronic inflammation, many studies have examined the 
relationship between COPD and circulating biomarkers of inflammation. There is weak 
evidence to support the role of chronic inflammation as a mechanism for cognitive decline in 
persons with COPD. In a pilot study, Borson et al. (2008) examined the relationship between 
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disease severity, cognitive measures, depression, anxiety, plasma measures of 
proinflammatory cytokine panel, and brain structures in persons with COPD. Statistically 
significant differences were found between controls and persons with COPD in global 
cognition, memory, mood and systemic inflammation marker TNFRI levels but not in brain 
structures (Borson et al., 2008). Another biomarker of inflammation that has been studied in 
persons with COPD is fibrinogen. Fibrinogen was associated with a significant faster four- 
year decline in general cognition independent of major vascular comorbidity (Rafnsson et al., 
2007). These findings suggest that some biomarkers of inflammation associated with COPD 
may play a role in the development of cognitive impairment. More research is needed to 
develop a full understanding of chronic inflammation and its biomarkers in domain-specific 
cognitive decline in person with COPD. 
Changes in brain structures 
 
There are changes in neurophysiological architecture of the brain in persons with COPD 
that may impact cognitive function. There is a strong association between COPD, hypoxemia as 
measured by arterial blood gases and changes in brain structures leading to cortical atrophy. 
Stuss et al. (1997) compared CT scans and neuropsychological tests of persons with mild and 
severe hypoxemic COPD. In the mildly hypoxemic group, the scan showed no cortical atrophy. 
In the severely hypoxemic group, cortical atrophy ranged from mild to severe and was associated 
with a decrease in performance on tests of memory and sustained attention (Stuss et al, 1997). 
Gray matter density was positively correlated with arterial blood PaO2 and negatively correlated 
with disease duration and poorer performance on two aspects of the MMSE; figure memory and 
visual reproduction (Zhang et al., 2013). In another study of gray matter, a reduction in white 
matter and a disturbance in functional activation of gray matter was found throughout the brain 
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with a subsequent negative change in global cognition (Dodd, Chung, van den Broek, Charlton, 
& Jones., 2012). Similarly, Borson et al. (2008) found a negative association with indicators of 
brain tissue damage (increased frontal choline), which in turn was associated with subcortical 
white matter attenuation.  These studies provide evidence there are changes in 
neuorphysiological architecture of the brain and associated declines on various tests of cognition. 
Exacerbations 
In COPD, an exacerbation is an acute onset of sustained worsening of the person’s 
symptoms of breathlessness, cough, increased sputum production and change in sputum that are 
beyond their normal day-to-day variation and poorer cognitive function has been associated with 
exacerbations. Dodd et al. (2013) compared patients with COPD exacerbations, patient with 
stable COPD, controls and normal values of age on multiple neuropsychological tests. The 
patients that experienced COPD exacerbation had poorer performance on all cognitive measures 
compared to stable COPD and controls. In processing speed, 57% were impaired and 20% had 
pathological deficits. Three months after exacerbation, a marginal recovery was found only in 
immediate recall and processing speed. Subsequently, COPD patients hospitalized for 
exacerbations are discharged home with unrecognized mild to severe cognitive impairment 
(Dodd et al., 2013). The findings have important implications in caring for persons during the 
recovery period after an exacerbation of COPD. 
Domain-Specific Cognition, Functional Performance and Life Satisfaction 
 
To depict the relationships between domain-specific cognition, functional performance, 
and life satisfaction a visual representation of Cognition, Functional Performance, and Life 
Satisfaction was created (see Figure 1 Visual Representation of Relationships among Domain- 
specific Cognition, Functional Performance and Life Satisfaction). This research was guided by 
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two frameworks: Revised Cleary & Wilson Model of Health-Related Quality of Life (Ferrans et 
al., 2005) and the Functional Status Framework (Leidy, 1994) (see Appendix A for more 
information see Figure A. 1 Revised Wilson and Cleary Model for Health-Related Quality to 
Life). The revised Wilson and Cleary Model for Health-Related Quality to Life illustrates the 
dynamic interactions between health, functioning, and life satisfaction (Ferrans et al., 2005). The 
Functional Status Framework defines functional performance as "those activities that people do 
in the normal course of their lives to meet basic needs and fulfill usual roles and maintain health 
and well-being" (Leidy, 1994, p. 198). Factors that may be related to functional performance 
include cognition, disease severity and symptoms, emotional states of anxiety and depression 
and sleep disruption (Leidy, 1994). Life satisfaction is subjective well-being related to how 
happy or satisfied someone is with important aspects of their life in the domains of health and 
functioning, psychological and spiritual, family, social and economic (Ferrans et al., 2005). This 
research will examine relationships among domain-specific cognition, functional performance 
and life satisfaction. Strong evidence suggests a difference in performance on measures of 
domain-specific cognition between persons with COPD and controls. There is evidence that 
domain-specific cognition and functional performance are impacted by the related factors of 
disease severity, symptoms of disease, emotional state and sleep disturbance. In respect to the 
impact of the psychosocial variables on domain-specific cognition little is known. Also, 
according to this model, cognition influences directly influence life satisfaction or is mediated 
by functional performance. 
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Figure 1: Visual Representation of Relationships among Domain-Specific Cognition, Functional 
Performance and Life Satisfaction 
 
Disease Severity, Cognition, and Functional Performance Disease Severity 
Disease Severity 
The Global Initiative for Chronic Obstructive Lung Disease (GOLD COPD) staging 
system incorporates two staging systems. COPD is staged by using forced expiratory volume in 
one minute (FEV1) % predicted. The FEV1 is reported as the percentage of predicted normal 
value for age, sex height, and ethnicity. The stages are ranked 1-4 with 4 representing the 
poorest pulmonary function (for more information see Appendix B: Table 10 B. 1 GOLD 
COPD Staging System). 
The GOLD COLD staging systems has a combined assessment which adds risks of 
exacerbation and symptoms to the classification system. Exacerbations are assessed by 
examining the numbers of exacerbations per year and determining whether the exacerbation 
led to hospitalization. Degrees of symptoms are determined by using the COPD Assessment 
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Test (for more information see Appendix C; COPD Assessment Test) and the modified 
Medical Research Council (mMRC) dyspnea scale (for more information see Appendix D; 
mMRC dyspnea scale). The results are then calculated using the combined assessment tool 
(for more information see Appendix E: Table 11 E. 1: Combined Assessment Tool of 
COPD). 
Disease severity has been linked to a decline in both cognition and functional 
performance, but little is known about the relationship between the effect of cognitive decline 
on functional performance in persons with COPD. Disease severity is negatively correlated 
with cognition but is not equal across all domains. Persons with COPD scored significantly 
worse than healthy controls on three cognitive measures: attention, mental flexibility and 
cognition in routine operations (addition and subtraction) and those with lower FEV1 < 50% 
score significantly worse that those with higher FEV1 on measures of attention (Liesker et al., 
2004). Development of functional limitation has also been associated with measures of 
disease severity. For every one-liter decrement in FEV1 or with every 5% decrease in oxygen 
saturation there was an increased risk of developing functional limitation (Eisner et al., 
2011). These results suggest that as COPD progresses, cognition declines and there is a 
decrease in functional performance with increased disease severity. 
There is some evidence to suggest that there is an association between cognitive 
decline and a decrease in functional performance in persons with COPD. Several studies 
found that persons with COPD that had lower scores on tests of global cognitive functioning 
also had greater prevalence of functional deficits in IADLs, ADLs and scores on the physical 
self-maintenance scale (Antonelli-Incalzi et al., 2008; Feng, Lim, Collinson, Ng, 2012; 
Ozge, Ozge, & Unal, 2006). In a prospective clinical study, in patients with COPD, persons 
with global cognitive decline also had declines in functional performance; 64.8% showed 
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global cognitive deficits with 22.2 % of those having difficulties in IADLs and 20.3% having 
difficulties in ADLs (Ozge, Ozge, & Unal, 2006). Antonelli-Incalzi et al. (2008) found as 
cognitive decline increased persons had a greater prevalence in dependence on ADLs and 
IADLs. In studying cognitive impairment and decreasing functional performance, moderate 
to severe airway obstruction was positively associated with cognitive IADLs disabilities 
(using the telephone, taking medications, and managing money) (Feng et al., 2012). In a 
two-year longitudinal study, the risk of developing disability or dependency in one or more 
ADLs for persons with COPD and MCI was greater than having COPD or MCI alone 
(Martinez, Richardson, Han & Cigolle, 2014). These results demonstrate that disease 
severity has a negative impact on both cognitive and functional performance. Additionally, 
there is greater risk of functional dependency if a person with COPD develops MCI but what 
remains unknown is if certain domains of cognition have a greater impact on developing the 
risk for decline in functional performance. Further research is needed to provide a better 
understanding of these relationships. 
Symptoms 
 
Dyspnea. Dyspnea is the subjective experience of breathlessness.  Dyspnea is a 
“common and often progressively debilitating symptom in advanced chronic disease that is 
associated with fear, anxiety, activity limitations, and profound suffering” (Mularski et al., 2013). 
It is the most frequently reported respiratory symptom in COPD (Miravitlles, Anzueto, Legnani, 
Forstmeier, Fargel, 2007; Calverley, 2008). Due to its simplicity, ease of use and established 
validation, the most commonly used measure of dyspnea is the mMRC Dyspnea Scale (Okutan, 
Tas, Demirer & Kartaloglu, 2013). Dyspnea is the usual reason for seeking medical attention, 
chief contributor to disability, limiting factor for exercise, precipitates hospitalization and it has a 
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negative impact on functional performance, health-related quality of life and it is independent 
marker for premature death (Leidy et al., 2014; Okutan et al., 2013; Rabe et al., 2007; Ries, 
2006; Viegi et al., 2007). These studies support that dyspnea impacts both functional 
performance and life satisfaction. 
Fatigue. Fatigue is a major problem for persons with COPD. Fatigue is a “subjective, 
unpleasant symptom which incorporates total body feelings ranging from tiredness to exhaustion 
creating an unrelenting overall condition which interferes with the individuals’ ability to function 
to their normal capacity” (Ream & Richardson, 1996). In persons with COPD, fatigue is the 
most common reported non-respiratory symptom and is worse in the afternoon (Antoniu, 
Petrescu, Stanescu, Anisie, & Boiculese, 2015; Antoniu & Ungureanu, 2015; Kapella, Larson, 
Patel, Covey, & Berry, 2006; Stridsman , Lindberg & Skar, 2014). In persons with COPD, 
fatigue is associated with poorer general health, anxious and depressed moods, decreased sleep 
quality, impaired concentration, decline in functional performance, decrease in daily hobbies and 
pastime activities, lower level of social functioning, limited relationships with family and 
friends, lack of motivation, less enjoyment in personal life and feelings of helplessness (Antoniu 
& Ungureanu, 2015; Antoniu, et al., 2015; Breslin et al. 1998; Kapella et al., 2006; Stridsman et 
al., 2014). These results support that the fatigue impacts domain-specific cognition, functional 
performance and life satisfaction. 
Emotional State 
 
Depression. There is a high prevalence of depression in persons with COPD. The 
prevalence of depression in persons with COPD ranges from 10% - 57% (Pumar et al., 2014). 
Depression in persons with COPD is associated with increased symptom burden which impacts 
functional performance. Persons with COPD and depression walked a shorter distance in the 6- 
18  
min walk test, showed less physical activity, increased difficulty in performing daily activities, 
poorer physical and social functioning and a worse quality of life (Borges-Santos et al., 2015; 
Pumar et al., 2014; Rivera et al., 2016). It is important to consider the many clinical implications 
of depression. 
Anxiety. There is a higher rate of anxiety in persons with COPD than controls. The 
prevalence rate of anxiety ranges between 7% - 50% (Pumar et al., 2014). Anxiety is a subjective 
state defined as an unpleasant emotional arousal, characterized by feelings of tension and 
apprehension and heightened autonomic nervous system (Giardino et al., 2010). The most 
common anxiety disorders in persons with COPD are generalized anxiety and panic attacks 
which occur in approximately one-third of persons with COPD. In persons with COPD, a ten- 
point increase in anxiety score was significantly associated with a mean decrease in the 6-minute 
walk distance of nine meters and a one Watt decrease in peak exercise workload indicating a 
decrease in functional capacity, and a two-point increase in St. George Respiratory Questionnaire 
and Shortness of Breath Questionnaire indicating a decrease in quality of life and increase in 
shortness of breath (Giardino et al., 2010). It has been documented that anxiety impacts 
functional performance and quality of life, but further research needed to determine how it 
impacts domain-specific cognition in a person with COPD. 
Sleep 
 
Sleep disturbances are common in persons with COPD and are negatively associated 
with cognition. In persons with COPD, the prevalence of self-reported sleep disturbance is 
24% (Omachi et al., 2012). The impact of self-reported sleep disturbance on the domains of 
cognition has mixed results. Disturbed sleep was associated with worse learning and 
episodic memory scores but not with tests of executive function (Omachi et al., 2012). In 
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contrast, subjective sleep quality was associated with slower reaction time and poorer 
executive function but not memory (Biddle et al., 2017). The mixed results from the impact 
of subjective sleep disturbances on cognition indicate further research needs to be done to 
understand the relationship between sleep and cognitive decline in persons with COPD. 
Psychosocial factors 
Need for cognition. One’s perception of the need for cognition may impact behaviors 
that in turn domain-specific cognition. The need for cognition is “the tendency for an individual 
to engage in and enjoy thinking” (Cacioppo, Petty, & Kao, 1984). Engaging in cognitive 
activities may enhance cognitive capacity. No studies were found that examined the need for 
cognition in the person with COPD. 
Sense of Mastery. The sense of mastery has been associated with better cognitive 
performance. It has been defined as the extent that one believes that they have the power to 
control life chances including outcomes (Clench-Aas, Nes, & Aaro, 2017). Individuals with a 
higher sense of mastery trust that they can adapt their behaviors in each circumstance to achieve 
their goal while those with a low sense of mastery feel powerless. The sense of mastery is not 
considered a stable element of personality, but a personal resource that constitutes a crucial 
coping skill that is important to daily functioning, health and well-being. It evolves and changes 
over the lifespan in response to experiences and circumstances (Clench-Aas et al., 2017). Higher 
levels of mastery have been associated with better health, more health promoting behaviors, 
better performance on tests of memory and cognitive function (Colcombe & Kramer, 2003). Old 
age, low socioeconomic status, and poor health are inversely associated with feelings of mastery 
(Schieman & Turner, 1998). Additionally, the experiences of growing old and losing personal 
resources may be more burdensome and likely to erode sense of mastery (Schieman & Turner, 
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1998). No studies were found that examined the relationship between sense of mastery and 
COPD. 
Hopelessness. A person’s level of hopelessness can be determined by defining 
hopelessness in terms of a system of negative expectances concerning himself and his future life 
(Beck & Weissman, 1974). A lack of hope, or “giving up,” is generally believed to have a 
negative impact on physical health and psychological well-being; more negative emotions, are 
more vulnerable to depression, and have higher levels of anxiety (Satici & Uysal, 2017). 
No studies were found that examined the relationship between hopelessness and COPD. 
 
Satisfaction with Aging. Satisfaction with aging is a psychosocial predictor of 
disabilities. According to Levy, Slade and Kasl (2002) satisfaction with aging is defined as one’s 
self-perception of aging or an individual’s beliefs about their own aging.  Attitudes towards 
aging develop over one’s lifetime. They are derived from encounters with the elderly and 
societal attitudes towards aging. When these attitudes are internalized, they become part of one’s 
self and the expectations for the trajectory of one’s own aging process. When one reaches late 
adulthood the positive or negative expectations that are internalized regarding aging are likely to 
be experienced impacting both cognitive and physical functioning (Levy et al., 2002).  No 
studies were found that examined the relationship between satisfaction with aging and COPD. 
Functional performance in persons with COPD 
 
COPD is characterized by gradual deterioration in functional performance. Higher rates 
of disability in instrumental activities of daily living, activities of daily living and mobility 
disabilities were found in persons with COPD compared to the general population (Rodriguez- 
Rodriguez et al., 2013). Strategies used to compensate for the reduction in functional 
performance included planning, pacing and prioritizing for activities of daily living and various 
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disease management activities (Cicutto, Brooks, & Henderson, 2004). Further research of the 
relationship between changes in domain-specific cognition and functional performance is needed 
to determine which ADLs and IADLs are most impacted by the decline in cognition. 
Life Satisfaction 
 
COPD is characterized by gradual deterioration in functional performance. Higher 
rates of disability in instrumental activities of daily living, activities of daily living and 
mobility disabilities were found in persons with COPD compared to the general population 
(Rodriguez-Rodriguez et al., 2013). Strategies used to compensate for the reduction in 
functional performance included planning, pacing and prioritizing for activities of daily 
living and various disease management activities (Cicutto, Brooks, & Henderson, 2004). 
Further research of the relationship between changes in domain-specific cognition and 
functional performance is needed to determine which ADLs and IADLs are most impacted 
by the decline in cognition. Life satisfaction is one of the most important indicators of quality 
of life (Ferrans & Powers, 1985). “Overall quality of life is the subjective well-being related 
to how happy or satisfied someone is with life as a whole” (Ferrans et al, 2005). It can be 
measured with a uniscale consisting of one question that states “Please rate your overall 
quality of life” or multiple-item scales assessing life satisfaction or happiness (Ferrans, 
2007). Very few studies have examined life satisfaction in COPD, most of the studies focus 
on relationship between health-related quality of life and COPD.  In comparisons of scores 
on life satisfaction, persons with COPD on long term oxygen therapy had significantly lower 
life satisfaction levels (Sturesson  & Branholm, 2000).  Comparing life satisfaction in 
persons with COPD to those with coronary artery disease, both groups reported moderate 
satisfaction with life, however, the group with coronary artery disease was significantly more 
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satisfied with life that persons with COPD (Brown, Rawlinson, & Hilles, 1981). These 
findings support there is a variance in life satisfaction scores in persons with COPD. Further 
research is needed to develop an understanding of the impact of domain-specific cognitive 
decline on life satisfaction persons with COPD. 
Specific Aims 
 
This dissertation will be completed by writing three papers that address the following 
 
aims: 
 
Aim 1. Describe the state of the science in regard to patterns of decline in 
domain-specific cognitive impairment in persons with COPD. 
It is hypothesized that the findings will support that cognitive impairment does not 
occur equally across all domains in persons with COPD and differs from cognitive changes 
that occur in normal aging. 
Aim 2. Describe the relationship between disease severity and change in domain- 
specific cognitive function, functional performance and life satisfaction in persons with 
COPD. 
It is hypothesized with greater the disease severity there will be poorer performance 
on tests of domain-specific cognition and functional performance and subsequently lower 
scores on life satisfaction 
Sub-aim 1: Determine if the relationship between cognition and life satisfaction 
is mediated by functional performance. 
It is hypothesized that the relationship between domain-specific cognition and life 
satisfaction is mediated by functional performance. 
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Sub-aim 2: Explore the relationship between the psychosocial variables of need 
for cognition, sense of mastery, satisfaction with aging and hopeless and their impact on 
cognition in persons with COPD. 
It is hypothesized that each psychosocial variable will impact cognition. 
 
Aim 3. Examine the feasibility and acceptability of the computer assisted testing using 
the NIH Toolbox Cognitive Battery and selected assessment tools from PROMIS® to 
describe a preliminary estimate of the strength of the relationship among domain- 
specific cognition, functional performance and life satisfaction in persons with mild to 
severe COPD. 
The working hypothesis is that assessments delivered via tablet will be a feasible and 
well accepted by persons with COPD. The second hypothesis is that functional performance 
with be a mediating factor between domain-specific cognition and life satisfaction 
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CHAPTER II 
 
Domain-Specific Cognitive Changes in Persons with COPD: A Systematic Review and 
Meta-Analysis 
 
COPD is a major cause of disability and is the third leading cause of death in 2014 
(CDC, 2016). It is estimated that 15 million people or 6.4% of the U.S. population have been 
diagnosed with COPD and more than 50% of persons with low pulmonary function were not 
aware that they have COPD indicating that the number of persons with COPD may be even 
higher (CDC, 2016). Not only does COPD limit airflow and cause breathing difficulties, it has 
been associated with extrapulmonary effects including cognitive decline. There is compelling 
evidence that persons with COPD have a higher prevalence of cognitive decline when 
compared to general population. Cognitive decline has been reported in 22% - 77% of patients 
with COPD (Ambrosino, Bruletti, Scala, Porta, & Vitacca, 2002; Grant, Heaton, McSweeny, 
Adams & Timms, 1982; Heaton, Grant, McSweeney, Adams, & Petty, 1983; Incalzi et al., 2002) 
while 10 – 20.3% of general population has been reported to have cognitive decline (Langa & 
Levine, 2014; Luck et al., 2016). There is also strong evidence that persons with COPD have a 
greater risk of developing cognitive decline compared to the age matched controls decline 
(Hung, Wisnivesky, Siu, & Ross, 2009; Singh et al., 2014; Thakur, 2010). There are 
inconsistencies in the evidence related to the prevalence and risk of cognitive decline in persons 
with COPD. The wide variation in the estimated prevalence and risk of cognitive decline may 
be attributed to selection of neuropsychological measures and inclusion criteria such disease 
severity. When global measures of cognition were used, the results were little (5.5%) to no 
significant difference in cognitive decline between persons with COPD and control groups 
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(Incalzi et al., 2002; Isoaho, Puolijoki, Huhti, Laippala, & Kivela, 1996; Stuss, Peterkin, 
Guzman, Guzman, & Troyer, 1977, Thakur et al., 2010). In contrast, using a neuropsychological 
battery showed a longer prevalence of cognitive decline in persons with COPD. In hypoxemic 
COPD, 48.5% - 77% of persons had cognitive decline in all abilities it was not equal across all 
domains of cognition (Cleutjens et al., 2017; Grant et al., 1982; Incalzi et al., 1993). These 
results indicate that the selection of neuropsychological measures and disease severity may 
explain a portion of the variation in the estimated prevalence and risk of cognitive decline. Most 
of these studies support a negative association between COPD and performance in cognitive 
domains but the domains measured often vary between studies. The variation in the selection of 
the domains included in studies may be explained by a variety of classification systems. There 
is a lack of a universal classification for cognitive domains in research (Dodd, Getov & Jones, 
2010). To develop a better understanding of the effect of COPD on cognitive domains, in a 
systematic review, Torres- Sanchez et al. (2015) classified the cognitive domains as proposed by 
Lezak (2004 as cited in Torres-Sanchez et al. 2015) which included the domains: perception, 
attention, memory and learning, executive function and language. There were 34 different 
neuropsychological tests used to evaluate the six cognitive domains (p. 188). Yet, cognitive 
decline was prevalent in all domains on at least one test. The use of both a variety of cognitive 
domain classification systems and the neuropsychological tests leads to a variation in 
prevalence and risk of cognitive decline across studies. Because of the importance of cognition 
in daily life and the proliferation of research examining the relationship between COPD and 
domain-specific cognition, we sought to advance the science by conducting a systematic review 
to determine what is known about the extent of domain-specific cognitive decline in persons 
with stable COPD. In addition to the domain classification used by Torres-Sanchez et al. 
(2105), we added the domain of processing speed. Processing speed is a process that underlies 
35  
many of the other cognitive processes and is frequently found in literature. To our knowledge, 
this is the first meta-analysis of this literature. The aim of the systematic review was to 
synthesize the state of current knowledge regarding the extent of domain-specific cognitive 
decline in relationship to the various stages of COPD. The aim of this meta-analysis review was 
to address two questions: 1) what are the effect sizes of any decline in the cognitive domains of 
perception, attention, memory and learning, executive function and language in persons with 
COPD? 2) Is age or disease severity a moderating factor? 
Methods 
 
Data sources and search strategy 
 
We utilized standard systematic review methodology following the handbook from the 
Cochrane Collaboration (Higgins & Green, 2008). The manuscript follows the PRISMA 
statement for reporting systematic reviews and meta-analysis (Liberti et al., 2009). The guidance 
of a professional librarian was sought. A systematic approach was used to complete the search 
using the following search strings (comprising terms related to COPD, cognition and domain- 
specific cognition): chronic obstructive airway disease (COAD) “COAD, COPD, emphysema or 
chronic bronchitis”; AND “cognition”, “cognitive function”, “executive function”, ”perception”, 
“attention”, “memory”, “working memory”, “visual memory”, “verbal memory”, “reaction 
time”, “processing speed”, “language”, “visuospatial”, “cognitive dysfunction”, “cognitive 
deficit”, and “cognitive domains” (for more information see Appendix F: Search Terms). The 
search was limited to humans and English language. The following databases were 
systematically searched: PubMed, CINAHL, Scopus, Psych Info, Web of Science, and 
Sociological Abstracts. Ancestry searches were performed on authors from all eligible studies 
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seeking any previous work. Hand search was completed on all bibliographies from selected 
studies. The bibliographic details of all retrieved studies were stored in a Ref Word-COS file. 
Duplicate records that were retrieved from various data bases were removed 
Study selection  
Three reviewers (JS, GN & JA) conducted of independent title and abstract screening of 
2295 studies retrieved from the database searches using specific inclusion criteria guidelines 
(for more information see Appendix G:  Table 12 G. 1:  Study Selection Tool). Two 
independent reviewers evaluated the retrieved studies and determined inclusion or exclusion 
based on predefined selection criteria. In the advent of non-agreement, JL a fourth reviewer 
made the determination for inclusion. We included studies in the systematic review if they 
fulfilled the following criteria: 
1. Studies of persons with COPD included one of cognitive domains of interest. 
 
2. Studies in which the research design was descriptive, experimental, quasi- 
experimental. 
3. Participants: major focus of the article was persons with COPD/chronic 
bronchitis/emphysema defined by any of the following measures: FEV1 or 
FEV1/FVC, arterial blood gases, diffusion capacity, lung volumes or self-report of 
diagnosis. 
4. A healthy control group or age referents normal were reported for the 
neuropsychological test measured. 
5. Domain-specific cognition: the article had to include at least one of the following 
domains: perception; attention; memory and learning; executive function, language or 
processing speed. 
6. No date restriction was imposed. 
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7. Studies were limited to English language and humans. 
 
Studies that reported the Mini-Mental Status Exam (MMSE) as the sole assessment tool for 
cognition and used the components of the MMSE as cognitive domains were excluded from 
systematic review and meta-analysis. The MMSE is a useful screening tool for 
differentiating individuals with serious neurocognitive impairments from healthy controls, 
but it has ceiling effects, poor test-retest reliability, is insensitive to subtle brain morphology 
and individual items demonstrate limited construct validity (Spencer et al., 2013). 
Additionally, the MMSE is insensitive to impairment in attention and executive function 
which are two of the main deficits associated with COPD (Villeneuve et al., 2012). Eighty- 
seven studies deemed potentially eligible by at least one reviewer were retrieved. From the 
87 studies, 27 studies were selected to be included in the systematic review. Studies were 
selected from the systematic review to be included in the meta-analysis if the data for at least 
one cognition domain was reported with mean and standard deviation. A total of 14 studies 
were included in the meta-analysis. In each domain, three studies using the same measure of 
cognition were required to perform the meta-analysis. The flow diagram for the search is 
depicted in Figure 2 (see Figure 2 Flow Diagram of Systematic Search). 
Data extraction and quality assessment. 
 
The results of the data extraction were summarized in structured tables, one for each 
cognitive domain. A meta-analysis was performed for each cognitive domain that reported 
findings from at least three studies using comparable measurements. The data was analyzed 
using Comprehensive Meta-Analysis Software Version 3. The fixed effect model was used to 
estimate the effect size in the various cognitive domains. The data are presented with 
standardized mean differences (SMD); less than 0.39 was considered small effect, 0.4 - 0.7 a 
38  
Literature search: 
Databases: PubMed, CINAHL, 
Scopus, Psych Info, Web of 
Science and Sociological 
Abstracts. 
Ancestry Author & Hand 
Bibliography Searches 
Limits: English 
 
 
 
Search Results Combined 
(n =4975) 
 
 
 
After removal of duplicates 
Studies screen on basis of title and 
abstract (n =2295) 
 
2,680 studies were excluded 
for not being related to the 
main objective, COPD not 
primary lung disease or not 
available in English, 
 
 
 
 
 
 
Manuscript review and 
application of inclusion criteria 
(n = 87) 
 
 
 
Included in systematic review (n 
= 27) 
Total Studies Excluded: (n = 60) 
MMSE as measure of cognition 
(n= 18) 
Intervention studies (n=9) 
Practice Guidelines (n=1) 
No healthy control or report of 
Mean/SD =18) 
Review studies (n=8) 
Communications to Editors (n=4) 
Cognitive bias (n = 1) 
Driving Performance (n =1) 
 
 
 
Included in meta-analysis 
(n = 14) 
Studies excluded: (n=12) 
Domain/Test used did not meet criteria (n = 
4) 
Multiple age groups (n=2) 
No Mean/SD reported (n=6) 
 
 
 
Figure 2 Flow Diagram of Systematic Search 
39  
moderate effect and more that 0.7 a large effect (Higgins & Green, 2008). To assess for 
publication bias funnel plot or Egger’s regression test was used as appropriate. However, due to 
the small number of articles that were included in each analysis, a funnel plot or Egger’s 
regression test could not be performed. To test for heterogeneity the I2 was performed for 
quantifying the ratio of heterogeneity to total variation in observed effects. The thresholds that 
were used for the interpretation of I2 were: 0-40% might not be important. To be consistent in 
describing the information obtained from each included study, a tool was developed based on 
Effective Practice and Organization of Care from the Cochrane Collection (EPOC, 2013) (for 
more information see Appendix H: Table 13 H. 1:  Data Extraction Tool). Quality of the 
research was assessed using the appropriate Scottish Intelligence Guideline Network (SIGN) 
methodology checklist (Sign Checklist, 2004) (for more information see Appendix I SIGN 
checklist). Using the checklist, studies were ranked as high quality (++), acceptable (+) or 
unacceptable (0). No articles reviewed were deemed of an unacceptable quality. All studies 
included in this review were of acceptable to high quality. 
Results 
 
Perception 
 
Results yielded 2 studies that examined perception (for more information see Appendix J: 
Table J. 14 Perception Studies). Three different instruments were used in assessing perception. 
The results from these studies were mixed. There was insufficient data from the studies to 
perform analysis for effect size. 
Attention 
The search yielded 16 studies that examined attention (for more information see 
Appendix K: Table 15 K. 1 Attention Studies). Eight different measurements were 
used in assessing attention. The results were mixed. Although finding from two of the 
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tests, Stroop Test and Digit Vigilance Test, were each used in two studies with no 
significant difference found between groups. The Seashore Rhythm Test was used in 
three studies with mixed results. However, a meta-analysis could not be performed as 
one study (Grant, et al. 1982) did not report mean and standard deviation. Of these 
eight measurements, only the TMT A met the criteria to be included in the meta-
analysis. Ten studies used the TMT A. The results were mixed. Of these, five studies 
were excluded from the meta-analysis: one (Bratek, et al., 2013) reported the mean 
time to complete the assessment but did not report the standard deviation or the 
significance; two studies (Favalli, et al., 2008; Liesker, et al. 2004) reported the results 
as median and range and two studies (Dal Ben & Bricolo, 2012; Dal Negro et al., 2014) 
reported results in decades of age resulting in multiple age brackets and no summary 
report for the groups. In addition, Dal Ben & Bricolo (2012) when assessing cognition 
with TMT-A, reported cognitive performance was significantly impaired in persons 
with COPD in all ages of life yet the means scores for age groups 40 - 49 and 50 - 59 
indicated that persons with COPD performed better than healthy controls as evidenced 
by lower reported mean time in seconds to complete the task. 
A meta-analysis was performed which included five studies that measured attention 
using the TMT A. The sample size was 209 COPD and 146 controls. The results showed that 
persons with COPD had higher score or poorer performance than the controls. There was a 
moderate summary effect size was found, -0.516, 95% CI [-0.747 – - 0.286], z = -4.395, 
p = 0.00. Test for heterogeneity I2 = 40.467, (see Figure 3: Forest Plot: Attention - TMT-A). 
 
Memory and Learning 
The search results yielded 19 studies that examined memory and learning (for more 
information see Appendix L:  Table 16 L. 1:  Memory and Learning Studies). Thirteen 
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different measurements were used in assessing memory and learning. The results of the 
studies were mixed for either immediate or delayed recall. 
Wechsler Memory Scale III- logical memory test was used in two studies with results 
indicating persons with COPD having significantly poorer memory. Three studies used 
Raven’s Colored Progressive Matrices. The results were mixed. A meta-analysis could not 
Attention: Trailmaking Test A 
Study name Statistics for each study Std diff in means and 95%CI 
Std diff Standard Lower   Upper 
in means error Variance  limit limit   Z-Value  p-Value 
Bratek 2015 -0.475 0.316 0.100   -1.094  0.145   -1.501 0.133 
Hjalmarsen 1999 -1.192 0.485 0.236   -2.144 -0.241   -2.457 0.014 
Kozora 2005 -0.877 0.291 0.085   -1.448 -0.306   -3.009 0.003 
Kozora 2010 -0.564 0.194 0.038   -0.945 -0.183   -2.900 0.004 
Prigatano 1983 -0.118 0.224 0.050   -0.556  0.321   -0.527 0.598 
-0.516 0.117 0.014   -0.747 -0.286   -4.395 0.000 
 
-4.00 -2.00 0.00 2.00 4.00 
 
 
COPD Controls 
 
 
Meta-Analysis 
 
Figure 3 Forest Plot: Attention-TMT-A 
be performed on attention measured by Raven’s Colored Progressive Matrices as one study 
(Favalli et al, 2008) reported results in median and range. Five studies used the Wechsler 
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Memory Scale Revised. The test has seven subsets each requiring the participant to 
recall and to retell certain details. In reporting the results of the test, the descriptive labels 
were not consistent across studies making alignment for meta-analysis difficult. Three of the 
five studies reported a significant difference. Three studies used Rey Auditory Verbal Learning, 
but the descriptive labels were not consistent across studies making alignment for meta-analysis 
difficult. All three studies reported a significant difference between groups. Two measurements 
met the criteria to be included in the meta-analysis: Digit Span Forward and Wechsler Memory 
Scale. Nine studies used span forward to assess short term memory span. Two of these studies 
were excluded from the meta-analysis: one used verbal span forward (Incalzi et al., 1993) and 
the other did not report results in mean and standard deviation (Cleutjens et al., 2014). Six 
studies used the Wechsler Memory Scale for assessing immediate and delayed recall. Two of 
these studies were excluded from the meta-analysis: immediate and delayed recall. Two of these 
studies were excluded from the meta-analysis: one was excluded as the results were reported in 
percentage loss (Grant et al., 1982) and one reported visual memory not verbal memory (Zhang 
et al., 2013). 
In the digit span forward test for memory and learning, sample size COPD 254 and 
controls 232, persons with COPD had lower scores than controls; small summary effect size - 
0.297, 95% CI [ -0.480 - - 0.114], z = - 3.187, p = 0.001 and I2 = 33.755, (see Figure 4: Forest 
Plot: Memory and Learning - Digit Span Forward). Persons with COPD had lower scores 
compared to controls on measures of immediate and delayed recall than controls. The sample 
was COPD 364 and controls 249. The moderate summary effect size for immediate recall 
was - 0.603, 95% CI [-0.794 – -0.412], z = -6.174, p = 0.00, I2 = 57.5, (see Figure 5: Forest 
Plot: Memory and Learning - Immediate Recall). In delayed recall, there was a moderate 
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summary effect size for delayed recall: - 0.420, 95% CI [ -0.610 - -0.231, z = -4.344, p = 
0.00, I2 = 61.05 (see Figure 6: Forest Plot: Memory and Learning - Delayed Recall). 
Memory & Learning: Digit Span Forward 
Study name  Statistics for each study Std diff in means and 
95%CI Std diff   Standard  Lower Upper 
in means error Variance   limit limit   Z-Value p-Value 
Incalzi 1993 -0.667 0.256 0.066   -1.169  -0.164   -2.601 0.009 
Incalzi 1997 -0.333 0.251 0.063   -0.826   0.159   -1.327 0.184 
Kozora 1999 0.410 0.255 0.065  -0.089   0.909 1.610 0.107 
Kozora 2005 -0.360 0.282 0.079   -0.912   0.192   -1.278 0.201 
Kozora 2010 -0.389 0.193 0.037   -0.767  -0.012   -2.022 0.043 
Ortapamuk 2006 -0.136 0.448 0.200   -1.013   0.742   -0.304 0.761 
Pereira 2011 -0.315 0.293 0.086   -0.889   0.260   -1.074 0.283 
Zhang 2013 -0.466 0.287 0.082   -1.027   0.096   -1.624 0.104 
-0.297 0.093 0.009   -0.480  -0.114   -3.187 0.001 
-4.00 -2.00 0.00 2.00 4.00 
 
COPD Control 
 
 
 
Figure 4: Forest Plot: Memory & Learning - Digit Span Forward 
 
Memory & Learning: Immediate Recall 
 
Study name Statistics for each study Std diff in means and 95%CI 
Std diff Standard Lower    Upper 
in means error Variance   limit limit   Z-Value  p-Value 
Incalzi 1997 -0.970 0.260 0.068   -1.480 -0.461   -3.731 0.000 
Dodd 2013 -0.729 0.238 0.057   -1.196 -0.263   -3.064 0.002 
Kozora 1999 -0.980 0.265 0.070   -1.499 -0.462   -3.706 0.000 
Ortapamuk 2006 -1.102 0.509 0.259   -2.099 -0.105   -2.167 0.030 
Zhou 2012 -0.327 0.136 0.018   -0.593 -0.061   -2.408 0.016 
-0.603 0.098 0.010   -0.794 -0.412   -6.174 0.000 
 
-4.00 -2.00 0.00 2.00 4.00 
 
 
COPD Control 
 
 
Figure 5:  Forest Plot: Memory and Learning Word List Immediate Recall 
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Memory & Learning: Delayed Recall 
 
Study name Statistics for each study Std diff in means and 95%CI 
Std diff   Standard Lower    Upper 
in means error Variance   limit limit  Z-Value p-Value 
Incalzi 1997 -0.903 0.261 0.068   -1.415 -0.391   -3.455 0.001 
Dodd 2013 -0.244 0.232 0.054   -0.698  0.210   -1.054 0.292 
Kozora 1999 -0.556 0.255 0.065   -1.055 -0.057   -2.182 0.029 
Ortapamuk 2006 -1.535 0.539 0.290   -2.591 -0.479   -2.848 0.004 
Zhou 2012 -0.243 0.135 0.018   -0.508  0.023   -1.793 0.073 
-0.420 0.097 0.009   -0.610 -0.231   -4.344 0.000 
-4.00 -2.00 0.00 2.00 4.00 
 
 
COPD Control 
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Figure 6 Forest Plot: Memory and Learning - Delayed Recall Word List 
Executive Function 
 
The search yielded 22 studies which examined executive function (for more 
information see Appendix M: Table 17 M. 1:  Executive Function Studies). Eight different 
instruments were used to measure executive function. Regardless of the instrument used, the 
results were mixed. One study reported fluid intelligence with no significant difference noted 
between the groups (Cleutjens et al., 2014). Corse-Block Reverse Spatial Span (Incalzi et al., 
1993) and Standard Progressive Matrices (Klein et al., 2010) were each used in one study 
with persons with COPD having lower scores than controls. Copying Design was used in two 
studies with mixed results (Incalzi et al. 1993, Ortapamuk & Naldoken, 2006). WAIS 
Similarities was used in three studies but could not be included in the meta-analysis due to 
methods of reporting. One study indicated there was no difference between groups and the 
other two studies did not report the significance level (Hjalmarsen et al, 1999; Kozora et al., 
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2005: Kozora et al., 2010). The results of studies of executive function are mixed even within 
the same cognitive test was used. 
Four measures of executive function were included in enough studies to be included 
in the meta-analysis: verbal fluency letter, verbal fluency animal, digit span backward and 
TMT B. Nine studies measured verbal fluency letters and/or animals to assess executive 
function. One study was excluded from meta-analysis as it used a test of verbal fluency 
called Delis-Kaplan which differed from the other studies (Dodd, et al., 2013). Eight studies 
assessed executive function with verbal fluency letters. Two studies were excluded: one 
study reported medians and ranges (Favalli et al, 2008) and in another study (Kozora et al., 
2002) the verbal fluency letter was part of a controlled oral word association test. Five 
studies assessed executive function with verbal fluency animals. One study (Favalli et al, 
2008) was excluded as it reported medians and ranges. 
The sample size for letter fluency was COPD 185 and controls 142 and for animal 
fluency COPD 253 and controls 239. Person with COPD had lower scores on both letter 
fluency and animal fluency than controls. There was a large summary effect size for letter 
fluency was - 0.746. 95% CI [-0.961 - -0.530], z = -6.784, p = 0.00.  Test for heterogeneity I2 
= 0, (see Figure 7 Forest Plot: Executive Function - Letter Fluency).  There was no 
significant difference between persons with COPD and controls on verbal fluency animal test 
- 0.136, 95% CI [-0.368 - -0.097], z = -1.144, p = 2.53. Test for heterogeneity I2 = 51.938, 
 
(see Figure 8 Forest Plot: Executive Function – Verbal Fluency Animal). 
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Executive Function Verbal Fluency Letter 
 
Study name Statistics for each study Std diff in means and 95%CI 
Std diff   Standard Lower   Upper 
in means error Variance   limit limit  Z-Value p-Value 
Incalzi 1993 -0.757 0.258 0.067   -1.263  -0.251   -2.931 0.003 
Kozora 1999 -0.797 0.262 0.069   -1.310  -0.284   -3.044 0.002 
Kozora 2005 -0.724 0.288 0.083   -1.288  -0.160   -2.516 0.012 
Kozora 2010 -0.645 0.196 0.038   -1.029  -0.262   -3.298 0.001 
Ortapamuk 2006 -0.112 0.448 0.200   -0.989   0.765   -0.250 0.803 
Pereira 2011 -1.261 0.317 0.100   -1.881  -0.640   -3.982 0.000 
-0.746 0.110 0.012   -0.961  -0.530   -6.784 0.000 
-4.00 -2.00 0.00 2.00 4.00 
 
COPD Controls 
 
 
Meta-Analysis 
Figure 7 Forest Plot: Executive Function - Verbal Fluency Letter 
 
 
Executive Function Verbal Fluency Animal 
 
Study name Statistics for each study Std diff in means and 95%CI 
Std diff Standard Lower Upper 
in means error Variance limit limit   Z-Value  p-Value 
Incalzi 1993 -0.703 0.257 0.066  -1.207  -0.199 -2.736 0.006 
Kozora 1999 0.064 0.252 0.064  -0.431   0.558 0.252 0.801 
Kozora 2005 0.000 0.280 0.078  -0.548   0.548 0.000 1.000 
Kozora 2010 0.000 0.191 0.036  -0.374   0.374 0.000 1.000 
-0.136 0.119 0.014  -0.368   0.097 -1.144 0.253 
 
-4.00 -2.00 0.00 2.00 4.00 
 
 
COPD Controls 
 
 
Figure 8 Forest Plot: Executive Function- Verbal Fluency Animal 
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Five studies used digit span backwards. The sample size was COPD 143 and controls 
122. There was a small summary effect – 0.352, 95% CI [-0.106 - - 2.80], p = 0.005, I2 = 
60. Persons with COPD performed lower than controls (see Figure 9: Forest Plot: 
Executive Function - Digit Span Backward). 
Executive Function: Digit Span Backward 
 
Study name Statistics for each study Std diff in means and 95%CI 
Std diff  Standard Lower   Upper 
in means error Variance  limit limit  Z-Value p-Value 
Incalzi 1993 -0.933 0.263 0.069   -1.448  -0.419   -3.555 0.000 
Incalzi 1997 -0.546 0.254 0.064   -1.043  -0.048   -2.150 0.032 
Kozora 1999 0.143 0.252 0.064  -0.352   0.637 0.566 0.571 
Ortapamuk 2006 -0.208 0.448 0.201   -1.087  0.671   -0.464 0.643 
Zhang 2013 -0.117 0.283 0.080   -0.672  0.438   -0.413 0.680 
-0.352 0.126 0.016   -0.599  -0.106   -2.800 0.005 
-4.00 -2.00 0.00 2.00 4.00 
 
COPD Controls 
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Figure 9 Forest Plot: Executive Function -  Digit Span Backward 
 
Fourteen studies used TMT B. Seven were excluded: five because mean and 
standard deviation were not reported (Bratek, et al., 2013; Favalli, et al., 2008; Grant et al, 
1982; Liesker, et al., 2004; Shim et al., 2001); two reported by age group categories (Dal Ben 
& Bricolo, 2012; Dal Negro, et al., 2014). From the seven studies included in the meta- 
analysis, the sample size was 180 COPD and 198 controls. Persons with COPD had lower 
scores than controls on the TMT B, (see Figure 10: Forest Plot: Executive Function –  
TMT-B). There was a moderate effect -0.572, 95% CI [-0.769 – -0.374], z = - 5.674, p = 0, 
 I2 = 36.45. 
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Executive Function: Trailmaking B 
 
Study name  Statistics for each study Std diff in means and 
95%CI Std diff   Standard  Lower Upper 
in means error Variance   limit limit  Z-Value p-Value 
Bratek 2015 -1.072 0.333 0.111   -1.725   -0.419    -3.219 0.001 
Hjalmarsen 1999 -1.445 0.502 0.252   -2.429   -0.460    -2.877 0.004 
Kozora 1999 -0.305 0.253 0.064    -0.802   0.192    -1.203 0.229 
Kozora 2002 -0.206 0.287 0.083    -0.769   0.357    -0.717 0.473 
Kozora 2005 -0.748 0.288 0.083   -1.313   -0.183    -2.594 0.009 
Kozora 2010 -0.668 0.196 0.038   -1.052   -0.284    -3.409 0.001 
Prigatano 1983 -0.369 0.225 0.051    -0.809   0.072    -1.639 0.101 
-0.572 0.101 0.010   -0.769   -0.374    -5.674 0.000 
-4.00 -2.00 0.00 2.00 4.00 
 
COPD Control 
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       Figure 10 Forest Plot: Executive Function - TMT-B 
 
Language 
 
 
Five studies compared language abilities between persons with COPD and healthy 
controls (for more information see Appendix N:  Table 18 N. 1:  Language Studies). Two 
different measurements were used. Two studies used the Aphasia Screening Test with mixed 
results (Grant et al., 1982; Prigatano et al., 1983). Three studies used the Boston Naming and 
were included in the meta-analysis. There was no significant difference from person with COPD 
and controls. Summary estimate was -0.239, CI 95% [- 0.502 – 0.025], z = - 1/777, p = 0.076,  
I2 = 0 (see Figure 11: Forest Plot Language - Boston Naming). 
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Language: Boston  Naming 
 
Study name Statistics for each study Std diff in means and95%CI 
Stddiff  Standard Lower Upper 
in means error Variance   limit limit Z-Value p-Value 
Kozora 1999 0.000 0.252 0.064  -0.494  0.494 0.000 1.000 
Kozora 2005 -0.366 0.282 0.079 -0.919  0.186  -1.300 0.194 
Kozora 2010 -0.318 0.192 0.037 -0.694  0.059  -1.655 0.098 
-0.239 0.134 0.018 -0.502  0.025  -1.777 0.076 
 
-4.00 -2.00 0.00 2.00 4.00 
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Figure 11: Forest Plot: Language - Boston Naming
 
Processing Speed 
 
 
The search yielded nine studies that examined processing speed in persons with COPD 
compared to controls (for more information see Appendix O:  Table 19 O. 1:  Processing Speed 
Studies). Five different measurements were used in assessing processing speed. Of these 
measurements, six studies used digit symbol. The sample size was 214 COPD and 167 controls 
Persons with COPD had lower scores on digit symbol than controls. There was a large effect size 
-0.923, 95% CI [-1.148 - -0.698], z = - 8.043, p = 0.00 with I2 = 0 (see Figure 12: Forest 
Plot:  Processing Speed - Digit Symbol). 
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Processing Speed: Digit Symbol 
 
Study name Statistics for each study Std diff in means and 95%CI  
Std diff   Standard Lower   Upper 
in means error Variance   limit limit  Z-Value p-Value 
Borzon 2008 -0.400 0.476 0.227   -1.333   0.533   -0.840 0.401 
Dodd 2013 -1.100 0.247 0.061   -1.584  -0.616   -4.457 0.000 
Kozora 2005 -1.200 0.301 0.091   -1.790  -0.610   -3.985 0.000 
Kozora 2010 -0.902 0.200 0.040   -1.294  -0.509   -4.505 0.000 
Priganto 1993 -0.759 0.229 0.052   -1.208  -0.311   -3.320 0.001 
-0.923 0.115 0.013   -1.148  -0.698   -8.043 0.000 
-4.00 -2.00 0.00 2.00 4.00 
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Figure 12: Forest Plot: Processing Speed - Digit Symbol 
Discussion 
 
We found that changes in cognition do not occur equally across all cognitive domains. 
 
Additionally, the findings were inconsistent. The more frequently a cognitive domain was 
studied, the greater the number of measurements used, the greater the inconsistencies in the 
findings. We found that in all domains if the effect size was significant, it was also negative 
indicating persons with COPD had poorer performance in the cognitive domain of interest. In 
summary 1) attention (TMT-A) had a moderate effect 2) memory and learning had a moderate 
effect in immediate and delayed recall (Wechsler Memory Scale) and a small effect in short-term 
memory span (Digit Span Forward) 3) executive function had a large effect (verbal fluency 
letter), moderate effect (TMT B), small effect (digit span backwards) and not significant (verbal 
fluency animal) 4) language effect was not significant (Boston naming) and 5) processing speed 
had a large effect (digit symbol). These findings show there is a decline in cognitive domains of 
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attention, memory and learning, executive function and processing speed but based on effect 
size, the decline is not equal. There is also variation within domains when assessed with more 
than one measurement.  The greatest inconsistency in effect size was in executive function.  In 
the test of verbal fluency, a relatively large difference between frequency of letter and category 
animal are not uncommon with 10% of sample have a letter fluency to animal score difference of 
18 or more words (Strauss, Sherman & Spreen, 2006). To perform the semantic fluency tasks, it 
requires four retrieval components 1) activation automatically spreading from the cue, 2) self- 
monitoring of output to prevent repetition and error, 3) suppression of previously retrieved 
response and 4) generation of cues to access new names. Words that start with a letter compared 
to words that are in a certain category are potentially stored different. Thus, in animal fluency, a 
person may have to switch categories more frequently decreasing the number of words named 
(Strauss et al, 2006). One explanation for the inconsistency is that within each cognition domain 
several processes occur. The term executive function is an umbrella term that includes a wide 
range of cognitive and behavioral processes such as reasoning, problem-solving, planning, ability 
to sustain attention, utilization of feedback, multitasking, cognitive flexibility and the ability to 
deal with novelty (Chan, Shum, Toulopoulou & Chen, 2008), There is also an emotional 
component to executive function which relates to the experience of reward and punishment, 
regulations of one’s social behavior and decision making involving emotional and personal 
interpretation (Chan, 2008). It is possible that some processes within the domain demonstrate a 
larger decline than others. Deficits in executive function can interfere with a person’s daily life. 
Understanding the relationship between the decline of a component of executive function and its 
impact on daily life is important for patient education. Additionally, the domain of executive 
function may need to be examined within a context-specific situation of living with COPD. For 
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example, a person with COPD has fluctuating symptoms and must frequently problem-solve to 
determine when to take additional prescribed medication such as a rescue inhaler or decide when 
it is time to seek medical treatment. Given the wide range of processes included in executive 
function, to understand the impact of decline that occurs in COPD, it may be beneficial to exam 
only a certain component of executive function such as problem solving. The decrease in 
cognitive function can impact the severity of COPD by interfering with optimal self- 
management. According to Emery, Finkel & Penderson (2012) the relationship between COPD 
and decreased cognitive function is a directional relationship, a decrease in pulmonary function 
leads to subsequent decrease in cognitive function but there is no evidence that a decline in 
cognition can lead to a decline in pulmonary function. It is posited that a decline in cognitive 
function decreases a person’s ability to perform the necessary patient-initiated treatments for 
managing their COPD. This in turn can lead to further decline in pulmonary function. 
Cognitive decline in COPD can increase the risk of having a further decline in pulmonary 
function. When using dry powder inhalers, in subjects with an MMSE score between 10 -24, the 
higher the score on the MMSE or the better the cognitive function, the better the performance in 
self-administering dry powdered inhalers (Fraser, Patel, Norkus & Whittington, 2012) but those 
with a MMSE score less than were rarely able to develop the ability to learn to use a metered 
dose inhaler (Allen, Warwick-Sanders & Baxter, 2009). In another study of proper inhaler use 
found in persons with COPD that were competent in the acquisition and short-term retention of 
inhaler on a test for frontal executive function the EXIT25, had a score of < 15(Allen, Jain, 
Ragab, & Malik, 2003). These studies support the finding that declines in cognitive domains 
interfere with the ability to acquire the skills needed to monitor and administer airway 
medications. COPD and the comorbidity of cognitive decline may lead to an increase in health 
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care utilization and mortality, but evidence is mixed. Individuals with both COPD and cognitive 
decline had a 48% higher rate of all cause hospitalizations and a rate of death nearly three times 
as high as the risks for COPD or cognitive decline alone (Chang, Chen, McAvay, & Tinetti, 
2012). In contrast, other studies have found no association between executive function, 
frequency of hospitalization and survival in persons with COPD (Dodd et al., 2015; Fix, 
Daughton, Kass, Bell & Golden, 1985). Further researcher is needed to examine the relationship 
among COPD, cognitive decline and utilization of healthcare. As these relationships are better 
understood, interventions could be tailored to decrease hospital re-admissions in the COPD 
population. There were several limitations in this study. While the search was extensive, within 
each domain there were a small number of studies to be analyzed. One factor that limited the 
studies included in the analysis of each domain was the variety of neuropsychological tests 
used. We also had too few studies to exam the mediator effects of disease severity and age. 
Additionally, power could not be assessed do to the small number of studies and the lack of a 
clear-cut point for a specific score on the neuropsychological tests that would indicate a 
functional decline would be noted. There was evidence of decline in all cognitive domains 
except language. The largest effect size was found in the domains of executive function and 
processing speed. Further research needs to be done to connect the significant findings in 
cognitive decline with changes in the functional performance. As a better understanding occurs 
between domain-specific cognitive decline and their relationship to functional performance, 
strategies can be developed to optimize cognitive performance and compensate for losses. 
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CHAPTER III 
 
The Relationship between Length of Time with COPD and Changes in Domain-Specific 
Cognition, Functional Performance, and Life Satisfaction: The Health and Retirement 
Study 
Cognitive function is important to successful aging. Cognitive function consists of the 
complex processes by which an individual perceives, registers, stores, retrieves and uses 
information from the environment to adapt behavior to new situations (Dodd, Getov, & Jones, 
2010). To provide more information about the nature of cognitive function, cognitive processes 
have been separated into discrete domains. COPD has a negative impact on domain-specific 
cognition. Although there are inconsistencies in findings, there is strong evidence that person 
with COPD have lower scores in most domains cognition. Compared to those without COPD, 
persons with COPD were found to have significantly poorer performance in the domains of 
attention (Grant, Heaton, McSweeny, Adams, Timms., 1982) short-term memory (Cleutjens et 
al., 2014; Favalli et al., 2008; Fioravanti, Nacca, Amati, Buckley & Bisetti, 1995; Incalzi et al., 
1997), long-term memory (Cleutjens et al., 2014; Favalli et al., 2008; Incalzi et al., 1997), 
executive function (Dal Negro et al., 2014, Favalli, et al., 2008), language (Favalli, et al., 2008) 
and processing speed (Cleutjens et al, 2014). These results suggest that all domains of cognition 
may be affected by COPD. As COPD progresses in severity, so does the decline in cognition. 
Several studies found that persons with higher disease severity had greater cognitive decline 
(Crisan et al., 2014; Dal Negro, Bonadiman Tongnella, Bricolo, & Truco, 2014; Fioravanti et al., 
1995; Incalzi et al., 2002; Singh et al., 2014). Other studies found no relationship between 
62  
markers of disease severity and cognitive decline (Grant et al., 1982; Thakur et al., 2010). 
Several studies found the prevalence of cognitive decline dramatically increases with worsening 
hypoxemia and hypercapnia (Grant et al., 1982; Krop, Block, & Choen, 1973; Prigatano, Parson, 
Lein, Wright & Hawryluk, 1983). In persons with hypoxemic COPD, 48.5% - 77% had cognitive 
decline in all abilities but the magnitude was not equal across all domains of cognition (Cleutjens 
et al., 2017; Grant et al., 1982; Incalzi et al., 1993). Independent of hypoxemia and disease 
severity, in persons with acute exacerbation of COPD, 57% were in the impaired range and 20% 
were considered to have suffered pathological loss in processing speed (Dodd, Charlton, van den 
Broek, & Jones, 2013). These results suggest that there is a strong relationship between disease 
severity and declines in domain-specific cognition. The preponderance of these studies was cross 
sectional, providing little information regarding the change in cognition that occurs over time 
with advancing disease. A few studies have examined differences in global cognition over time. 
In a 15-month study incident MCI and MCI subtypes, persons with COPD had a higher rate of 
developing MCI than did controls (Singh, 2014). A study from the HRS data base found when 
comparing baseline and two to six years later in persons with and without COPD, persons with 
COPD had a significantly greater decline than persons without COPD (1 point to 0.7 points 
respectively) (Hung, Wisneivesky, Siu, & Ross, 2009). In a 3-year longitudinal study, there was 
no difference in global cognition but persons with COPD had greater declines in immediate and 
delayed memory, language (word fluency) and attention (digit symbol) (Zhou et al., 2012), Thus, 
longitudinal data regarding cognitive decline is very limited but the evidence suggests that there 
is a different trajectory in the development of cognitive decline in the presence of COPD. There 
is a strong body of evidence describing a decrease in functional performance and a small body of 
evidence that supports the notion that a decline in cognition contributes to functional decline. 
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The annual rate of decline in functional performance is approximately 3% (Kapella, Larson, 
Covey & Alex, 2011). Two studies examined the capacity or capability to perform activities at 
baseline and two years later. At baseline 26% of persons with COPD had disability or a decrease 
in capacity or capability to perform activities and 10.5% developed functional disability over the 
course of the study (Eisner et al., 2011). In other study, there was a difference of prevalent 
disability (dependency in at least one ADL) between persons with COPD and those without 
(12.8% and 5.2% respectively) and over two years 9.2% of those with COPD developed a 
disability above baseline compared to 4% in those without COPD (Martinez, Richardson, Han & 
Cigolle, 2014). In addition, persons with coexisting COPD and MCI had a greater risk 
developing disability (OR, 2.7) compared to COPD alone (OR, 1.9) or MCI alone (OR 2.0) 
(Martinez et al., 2014). These studies support that not only does functional performance decline 
with COPD; the decline is greater in the presence of cognitive decline. To depict the 
relationships between domain-specific cognition, functional performance, and life satisfaction 
for this portion of the study a modified visual representation of Cognition, Functional 
Performance, and Life Satisfaction was created (see Figure 13 Visual Representation of 
Cognition, Functional Performance, and Life Satisfaction Modified for Longitudinal Study). 
Two frameworks guided this work; Revised Wilson & Cleary Model of Health-Related Quality 
of Life (Ferrans et al., 2005) (see Appendix A for more information on Revised Wilson & Cleary 
Model of Health-Related Quality of Life) and Functional Status Framework (Leidy, 1994). The 
revised Wilson & Cleary Model of Health-Related Quality of Life illustrates the dynamic 
interactions between health, functioning, and life satisfaction (Ferrans et al., 2005). The 
Functional Status Framework defines functional performance as "those activities that people do 
in the normal course of their lives to meet basic needs and fulfill usual roles and maintain health 
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Figure 13 Visual Representation of Cognition, Functional Performance and Life Satisfaction Modified for 
Longitudinal Study 
 
and well-being" (Leidy, 1994, p. 197.). Life satisfaction is subjective well-being related to how 
happy or satisfied someone is with various aspects of their lives (Ferrans et al., 2005). 
Psychosocial factors could influence cognition. For purpose of this work we will 
focus on perception of the need for cognition, sense of mastery, hopelessness, and 
satisfaction with aging. The need for cognition is "the tendency for an individual to engage in 
and enjoy thinking" (Cacioppo, Petty & Kao, 1984). It impacts behaviors that in turn affect 
behaviors that have an impact on cognitive performance. 
The sense of mastery is the belief that one has the skills and abilities to achieve a 
goal. One of the best predictors of success in goal attainment is an individual belief that they 
have control in their lives (Daniel, Brown, Dhurrkey, Cargo, & O’Dea, 2006). Higher levels 
of mastery are associated with better health, more health-promoting behaviors, increased 
memory and cognitive function (Colcombe & Kramer, 2003; Lachman & Andreoletti, 2006). 
Lower levels of mastery have been associated with perceived stress and subjective memory 
complaints (Daniel et al., 2006; Lee & Kim, 2014). The sense of mastery is a potentially 
modifiable variable that has been associated with memory, cognitive function, and health. 
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Hopelessness is a negative perspective concerning the future. A sense of 
hopelessness has been identified as a predictor of future poor health and social functioning 
(Pompili et al., 2013). The presence of feelings of hopelessness, when measured in midlife, 
is a predictor of cognitive impairment an average of 21 years later (Håkansson, Soininen, 
Winblad, & Kivipelto, 2015). Thus, exploration of the relationship between hopelessness and 
domain-specific cognition could add to the understanding of cognitive decline in persons 
with COPD. 
Satisfaction with aging is one's self-perception of aging or an individual's beliefs 
about their aging (Levy, Slade & Kasl, 2002). Satisfaction with aging is a social 
psychological predictor of disabilities. Attitudes towards aging develop over one's lifetime. 
A person’s attitude toward aging is derived from encounters with older people and current 
societal attitudes towards aging. When these attitudes are internalized, they become part of 
one's self and the expectations for the trajectory of one’s aging process. When one reaches 
late adulthood, the positive or negative expectations are likely to be experienced impacting 
both cognitive and physical functioning (Levy et al., 2002). Thus, determining the strength of 
the relationship between satisfaction with aging and domain-specific cognitive function in 
persons with COPD is of interest. 
The decline in domain-specific cognition and functional performance in presence of 
COPD has been well established. However, there is very limited information regarding 
change in domain-specific cognition over time and the impact that this change has on 
functional performance and life satisfaction. To our knowledge, there is only one study that 
has longitudinally examined domain-specific cognition in COPD and had a duration of three 
years with the mean age of the participants of 80 years old (Zhou et al., 2012). Our aim is to 
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expand the knowledge related to longitudinal effects on domain-specific cognition in persons 
with COPD. The primary aim of this research was to describe the relationship cognition over 
time for people with COPD and a non-COPD group. The secondary aims were determining 
if functional performance mediates the relationship between domain-specific cognition and 
life satisfaction and exploring the relationship between the psychosocial variables and 
cognitive function. The working hypotheses are: (1) there is a positive relationship between 
the length of time with COPD and decline in domain-specific cognition in persons with 
COPD (2) functional performance mediates the relationship between cognitive function and 
life satisfaction and (3) the psychosocial variables; need for cognition, sense of mastery, 
hopelessness and satisfaction with aging impact domain-specific cognition. 
Methods 
 
Data Source 
 
We used data from the HRS, a population-based nationally representative, biennial 
longitudinal health survey initiated in 1992. The HRS is a public use data set that is 
produced and distributed by the University of Michigan with funding from the Nations 
Institute on Aging (grant number NIA U01AG009740). The HRS is managed jointly through 
a cooperative agreement between the National Institute on Aging (NIA) and the Institute for 
Social Research (ISR) at the University of Michigan (HRS). The HRS was approved by the 
Health Science Institutional Review Board at the University of Michigan. Two data sets 
were used from the HRS; the HRS 2014 Final Release wave 12 and the RAND HRS Data, 
Version P. The RAND HRS data is produced by the RAND Center for the Study of Aging, 
Santa Monica CA with funding from the NIA and the Social Security Administration, 
(August 2016). 
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For this study, cross-sectional data was drawn from the HRS 2014 data set. The 2014 
data set was also used to identify person with COPD. After identification of having COPD, a 
backward process was used to identify the first interview in which the participant self- 
reported the diagnosis of COPD. This interview was labeled zero for baseline and each 
subsequent interview was consecutively by twos to correlate with the biennial data collection 
times. For the non-COPD group, the first interview was labeled zero for baseline complete 
longitudinal data analysis, the two databases were merged to provided data from 1992-2014. 
Due to differences in cognitive measures data, years 1992 and 1994 were excluded from 
analysis. Participants are residents of the United States over the age of 50. 
Inclusion criteria/ Exclusion criteria 
 
Two groups were established: COPD and non-COPD. For both groups, data were 
included in this study if the participants were alive at the time of the 2014 interview, 
completed the survey without a proxy, and between the ages of 65-89 which corresponds 
with the HRS data collection for cognitive function. To be included in the COPD group, the 
participant must self-report that a doctor told them that they had a chronic lung disease such 
as chronic bronchitis or emphysema, not including asthma. The first year of self-reported 
COPD had to be identifiable. To be included in the non-COPD group, the participant must 
currently be a non-smoker. Data from both groups were excluded if the participant was 
residing in a nursing home, self-reported a history of stroke, Alzheimer's disease, dementia, 
or taking medication prescribed by their primary care provider for Alzheimer's disease, 
dementia or memory problem. 
Persons with COPD were identified in 2014 and followed backwards into the study to 
determine first self-report of COPD. This was labeled baseline and then each subsequent 
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year was labeled consecutively. For the non-COPD group identified in 2014, their first 
interview was labeled baseline and each subsequent year labeled consequently. The final 
sample size at baseline was 3070 non-COPD and 380 with COPD. The groups were 
followed for seven-time periods or 12 years. 
Measurements of Domain-specific Cognition. 
 
The HRS includes a variety of measures to assess domain-specific cognition. The 
domains tested are attention/executive function, immediate and delayed memory, knowledge, 
language and orientation, abstract reasoning, fluid reasoning, and vocabulary. (for more 
information see Appendix P:  Table 20 P .1 Selected HRS Measures). Cognitive measures have 
changed over the course of the study. The cognitive domains and their measures that have 
remained consistent across time are executive function measured by serial sevens subtractions, 
and memory and learning as measured by immediate and delayed recall. 
Attention/Executive function. The HRS uses serial seven subtractions were used to 
assess attention/executive function. In serial seven subtractions, the participant is asked to 
subtract seven from 100 and continue subtracting seven from each following answer for a total of 
five times. American Psychiatric Association Diagnostic and Statistical Manual, 5th edition 
(DSM-5) defines inattention as the reduced ability to direct, focus, sustain and shift attention. 
Serial seven subtractions has a sensitivity of 97.7%, 95% CI [78.1 - 99.9], specificity 13.7% 95% 
 
CI [8.9 – 19.8], positive predictive value 13.2%, 95% CI [8.4 – 19.3%] and negative predictive 
value 95.8, 95% CI [78.9 - 99.9%] (Voyer et al., 2006). It should be noted that serial sevens are 
strongly associated with arithmetic ability and results should be used with caution (Karzmark, 
2000). In the HRS data set, serial seven subtractions have the highest quantity of missing data 
with appropriately 10% refusing to subtract sevens and those who refused had lower 
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performance on the other cognitive test (Herzog & Wallace, 1997). Thus, the rate of decline may 
be greater than depicted in this study. 
Memory and Learning. In the HRS, memory and learning are assessed by word list 
recall, immediate and delayed. To avoid practice effect, the HRS contains four different word 
lists (Lachman & Andreoletti, 2006). For immediate word recall, the participant was read a list 
of ten nouns and asked to recall as many as possible in any order immediately. Delayed recall is, 
after approximately five minutes, the participant was asked to remember the same nouns given in 
immediate recall. Both immediate and delayed recall are scored as the count of the number of 
correct responses, 0-10. Word list recall has a test-retest reliability of 0.70 -0.79 (Strauss et al., 
2006). 
Measurements of Related Factors 
 
Disease Severity. The HRS does not identify the severity of COPD. The length of time 
a person had COPD was used as a proxy for disease severity. Time one for COPD was created 
by identifying the first self-report of COPD. Time one for the non-COPD group was the first 
year in the study. In both groups, after defining time one, all subsequent interviews were 
sequentially numbered. 
Depression. Depression was measured with the Center for Epidemiology Studies 
Depression Scale (CES-D). The CES-D is 20-item scale measuring symptoms of depression in 
nine different groups as defined by the DSM-V including sadness or dysphoria, loss of interest or 
anhedonia, appetite, sleep, thinking/concentration, guilt or worthlessness, tired or fatigue, 
movement or agitation and suicidal ideations. The scores are summed across all 20 items with 
higher scores indicating greater depressive symptoms. The CES-D has high internal consistency 
across studies with Cronbach’s alpha coefficient ranging from 0.85 – 0.90 (Radloff, 1977). The 
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CES-D is sensitive for detection of depressive symptoms and change in symptoms over time 
(Weissman, Sholomskas, Pottenger, Prusoff & Locke, 1977). 
Anxiety. On the HRS survey, anxiety is a single-item of self-report responding to a 
history of ever having had an anxiety disorder 
Sleep. The HRS has four items which were used to quantify difficulties with sleep. The 
items included trouble falling asleep, difficulty staying asleep, waking up too early and not being 
able to go back to sleep and restless sleep. Responses are on a four-point Likert scale: most of 
the time, sometimes, rarely or never. The items were re-coded into dichotomous variables of any 
difficulty or no difficulty. A composite score, sleep disturbance score was created from these 
variables. 
Measurements of Potential Related Factors 
 
The Psychosocial and Lifestyle Questionnaire, a leave behind self-assessment survey, is 
administered to half of the persons in the HRS study biennially. It includes the variables 
perception of the need for cognition, sense of mastery, hopelessness, satisfaction with aging and 
the life satisfaction Scale. Only the cross-sectional data from the year 2014 was included in the 
analysis. Of the persons eligible to complete the leave behind the survey, the response rate for 
2014 was 77.8% (Smith, Ryan, Sonega & Weir, 2017). 
Need for Cognition. The HRS need for cognition scale is composed of six items. Six 
items selected for the "Need for Cognition" scale were based on research from the CogUSA 
project (Smith et al., 2017). Need for cognition contains two dimensions: cognitive enjoyment 
and cognitive effort (for more information see Appendix P:  Table 20 P. 1 Selected HRS 
Measures). Content validity for 2014 survey cognitive enjoyment Cronbach’s α =0.83 and the 
cognitive effort Cronbach’s α = 0.80 (Smith et al., 2017). 
71  
Sense of Mastery. The HRS sense of mastery scale is composed of five items. The five 
items on the scale are answered using a 6-point Likert Scale. An index is created by averaging 
the 5 items (for more information see Appendix P: Table 20 P.1 Selected HRS Measures). The 
reliability for the sense of mastery scale was reported as Cronbach's α 2014 survey = 0.91 
(Smith et al., 2017). 
Hopelessness. The HRS hopelessness scale consists of two items from Everson et al. 
(1997) and two items form Beck et al. (1974) (as cited in Smith, 2017) (for more information see 
Appendix P:  Table 20 P. 1 Selected HRS Measures). A hopelessness index is created by 
averaging the scores across all items. The reliability is reported with Cronbach's α 2014 survey = 
0.88 (Smith et al., 2017). 
Satisfaction with aging. HRS Satisfaction with aging assesses eight areas that provide 
positive and negative experiences of aging (HRS) (for more information see Appendix P:  
Table 20 P. 1 Selected HRS Measures). The reliability of aging satisfaction is reported for is 
2014 survey is Cronbach's α = .82, for positive aging satisfaction Cronbach's α = .77 and 
negative aging satisfaction, Cronbach's α = .77 (Smith et al., 2017). 
Measurements of Functional Performance 
  Activities.  The following four items from the HRS were used to measure functional 
performance activities: mobility, large muscles, gross motor skills, fine motor skills (for more 
information see Appendix P:  Table 20 P. 1 Selected HRS Measures). These activities were 
chosen to be included in the HRS as they were found to be the activities needed to perform 
ADLs and IADLs (HRS). Mobility includes five activities measuring ability walk and climb 
stairs for various distances. Large muscle skills include sitting for two hours, ability to get out 
of chair, kneel and stoop and push or pull large objects. Gross motor skill has overlap with 
mobility on ability to walk but only refers the distance of one block and adds transferring out of 
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bed and bathing. Fine motor skills include picking up a dime, dressing and eating. The items 
were re-coded into dichotomous items: any difficult with activity with the score of “1” and no 
difficulty with an activity score of “0”. A total functional performance score was created by 
adding the scores across the activities. The reliability of the physical functioning measures was 
Cronbach's 0.92 (Fonda & Herzog, 2004).  
Measurement of Life Satisfaction 
On the HRS, life satisfaction is reported as a score on a Likert scale. The respondent is 
asked to rate how satisfied they are with life ranked on a five-point Likert scale anchored with 
completely satisfied and not at all satisfied (for more information see Appendix P: Table 20 P. 1 
Selected HRS Measures). 
Analyses 
 
Statistical analysis was performed using STATA 15.0 (STATA Corp, 2017). The 
statistical analysis used includes baseline comparisons between groups using chi-square for 
count variables and independent sample t tests for continuous variable. Prior to performing 
t-tests, Levene’s test for unequal variance were performed. All reported p-values are two- 
sided, and results are considered statistically significant at p < 0.05. 
Separate mixed-effects Poisson models were used to describe the relationship 
between the number of years since self-reported diagnosis of COPD and the change in 
cognitive function over time compared to non-COPD group. The Poisson models compared 
the longitudinal changes in domain-specific cognition (one per outcome e.g. executive 
function) by group (COPD, non-COPD). We centered the time variable on the subjects’ first 
self-report of COPD for COPD subjects and the first interview for non-COPD group. Each 
model was fully factorialized, and included a fixed main effect parameter comparing COPD 
versus non-COPD, fixed effects parameters comparing person’s first reported outcome to 
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each subsequent observation, and importantly, the simple interaction effects comparing the 
change in domain-specific cognition outcome among COPD participants relative to non- 
COPD We included a-priori contrasts evaluating the omnibus effects of time (i.e. change 
overall) and the omnibus interaction effects (group differences over all time points), and we 
interpret the simple effects parameters only then the omnibus effects are significant. Each 
model included a random Y-intercept term to accommodate the longitudinal (i.e. repeated 
measures) experimental design. Our initial evaluations of these models revealed significant 
variability difference in outcomes by group, likely attributable to large differences in sample 
size. We incorporated robust standard error adjustments in our statistical model to 
accommodate these differences. By time eight, the sample size had decreased to less than 60 
persons having COPD, the variability of means and width of confidence intervals increased. 
Data analysis was limited to seven events of time. 
Regression analysis was used to investigate the hypothesis that functional 
performance mediates the relationship between cognition and life satisfaction. Separate 
mediation models examining domain-specific cognition (one per outcome e.g. executive 
function), functional performance by group (COPD, non-COPD) with life satisfaction were 
performed using Baron & Kenny’s (1986) four step test for mediation. Three simple 
regressions were performed to determine if zero-order relationships existed among the 
variables. If there was no significance in one or more of these relationships it was concluded 
that mediation is not likely possible. Multiple regression was then performed. If causal 
relationship was no longer significant, then full mediation was supported. If the causal 
relationship was still significant but the regression coefficient declined, the findings 
supported partial mediation. 
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Multiple linear regression models were run to explore the impact of the psychosocial 
variables (perception of need for cognition, the sense of master, hopelessness and satisfaction 
with aging) on domain-specific cognition. One linear regression was run for each cognitive 
domain with the psychosocial variables as the predictor variables. We used semipartial 
correlations to explain the direction of the relationship and squared semiparital correlations to 
explain the unique contribution of each psychosocial variable on domain-specific cognitive 
measures. 
Results 
 
The sample size at baseline was 380 persons with COPD and 3070 non-COPD. There 
was no significant difference between groups (COPD and non-COPD) in age, gender or years 
of education. There were significant differences between the two groups on measures of 
sleep disturbance, marital status, and educational degrees. Characteristics of the sample 
population are presented in Table 1 (for more information see Table 1 Characteristics of 
Sample Population from the 2014 HRS Data Set). The sample size for the COPD Group 
decreased across the time of the study (for more information see Appendix Q: Table 21 Q. 1 
Sample Size Based on Assessment Point). 
Domains of cognition were compared between the two groups at baseline and 12 years 
later at the end of the study (time seven). There was a significant difference between groups in 
the cognitive domains of attention/executive function, and memory and learning. The 
differences remained significant from baseline to end of study except for immediate recall 
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Table 1:  Characteristics of Sample Population from the 2014 HRS Data Set 
 
 COPD 
N = 380 (11%) 
Non-COPD 
N = 3070 (89%) 
 
 Mean (SD) Min/Max Mean (SD) Min/Max t-test, 
p-value 
Age 75.89 (4.42) (65 - 
89) 
76.06 (4.41) (65 -89) p = 0.47 
Number of Years 
in School 
12.20 (2.75) (0 - 17) 12.8 (3.05) (0 - 17) p < 0.001 
Sleep disturbance 2.21 (1.4) 1.94 (1.7) p < 0.01 
 Percentage (N) Percentage (N) χ2, 
p - value 
Gender Female 
Male 
66.5 (253) 
33.4 (127) 
62.1(1907) 
37.8(1163) 
p = 0.09 
Comorbidities 0 71.8 (273) 
1 23.7 (90) 
2 16 (21) 
3 <0.001% (1) 
0 85.8 (2637) 
1 13.4 (86) 
2 19 (21) 
3 <0.001% (1) 
p <0.001 
Marital status 
Married 
Separate/Divorce 
Widowed 
Never married 
 
47.1 (179) 
17.1 (65) 
32.2 (123) 
3.4 (13) 
 
60.7 (1866) 
9.1 (304) 
26.4 (814) 
2.8 (68) 
p <0.001 
Education 
GED/left high 
school 
High School 
Some College 
Grad School 
 
 
26 (99) 
46.3 (176) 
13.6 (52) 
13.9 (53) 
 
 
19.1 (589) 
42.4 (1303) 
13.8 (424) 
24.6 (754) (24.6%) 
 
 
 
p < 0.001 
Smoking status 
Current Non-smokers 
Current smokers 
 
320 (84.25) 
60 (15.7%) 
 
0 
 
 
 
The results are presented in Table 2 (for more information see Table 2:  Cognitive Outcome 
Variables at Baseline and 12 years later from the HRS Data Set). 
Change in cognition with the length of time with COPD. 
 
Attention/Executive Function. Slopes declined significantly in both groups but the 
omnibus interaction between groups was not statistically significant χ2 (6) = 4.85, p = 0.56. The 
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Table 2: Cognitive Outcome Variables at Baseline and 12 years later from the HRS Data Set 
 
 COPD 
N = 380* 
Non-COPD 
N = 3070* 
 
 Mean (SD) Min/Max Mean (SD)…Min/Max t-score 
p-value 
Serial Sevens: Baseline 3.5 (1.4) (1 – 5) 3.8 (1.4) (0 – 5) p <0.001 
Serial Sevens: Year 12 3.1 (1.6) (0 – 5) 3.7 (1.5) (0 – 5) p <0.001 
Immediate Recall 
Baseline 
5.4 (1.4) (1 – 8) 6.3(1.5) (0 – 10) p <0.001 
Immediate Recall 
Year 12 
5.4 (1.5) (2 – 10) 5.6(1.5) (0 – 10) p = 0.12 
Delayed Recall 
Baseline 
4.5 (1.7) (0 – 7) 5.3 (1.9) (0 – 10) p <0.001 
Delayed Recall 
Year 12 
4.2 (1.7) (0 – 10) 4.7 (1.8) (0 – 10) p <0.01 
*Year 12: COPD N = 95 Non-COPD N = 3070 
 
plot of means with 95% confidence intervals (CI) reveals rather parallel lines. (see Figure 14: 
Attention/Executive Function: Change in Mean over Time). 
Memory & Learning. Slopes declined significantly in both groups. The 
omnibus interaction for immediate recall between the two groups was statistically 
significant (χ2 (6) = 18.86, p = 0.004). The non-COPD group had a steeper decline 
than did the persons with COPD (see Figure 15 Memory and Learning: 
Immediate Recall Change in Means Over Time). Delayed recall, another measure 
of memory and learning, the slopes declined significantly in both groups but the 
omnibus interaction between groups was not significant (χ2 (6) = 9.25, p = 0.016) 
(see Figure 16 Memory and Learning, Delayed Recall: Change in Mean Over 
Time). 
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                Figure 14 Attention/Executive Function: Change in Mean over Time 
 
 
    Figure 15 Memory and Learning, Immediate Recall Word List: Change in Mean over Time 
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   Figure 16: Memory and Learning Delayed Recall Word List: Change in Mean over Time 
 
Impact of Domain Specific Cognition on Functional Performance 
In a cross-sectional study, using 2014 wave of the HRS, the persons with COPD 
performed significantly worse on all measurements of functional performance; mobility, large 
muscle groups, gross motor skills and fine motor skills (for more information see Table 3: 
Comparison of Functional Performance Between Groups using Cross-sectional data in the 2014 
Wave of the HRS Data Set).  
Functional Performance as Mediator Between Domain-Specific Cognition (delayed recall) 
and Life Satisfaction 
On the 5-point Likert scale of life satisfaction, there was no significant difference 
between the groups χ2 (4) = 6.23, p = 0.182. In persons with COPD, there were no zero-order 
relationships between domains of cognition and life satisfaction: executive function (β = -0.038, 
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t (1) = -1.33 p = 0.185), memory and learning; immediate recall (β = -0.032, t (1) = -1.03 p = 
0.303), delayed recall (β = -0.011, t (1) = -0.48 p = 0.06). Thus, there was no relationship to 
mediate. In the non- COPD group, a zero-order relationship was found between one measure in 
the domain of learning and memory. Delayed recall was a significant  
Table 3: Comparison of Functional Performance Between Groups using Cross-Sectional data in 
2014 Wave of HRS Data Set 
 
 COPD 
N =380 
Non-COPD 
N = 3070 
 
 Mean(SD) Min/Max Mean(SD) Min/Max t - score 
p-value 
Mobility 1.5 (1.5) 0 - 5 0.41 (0.86) 0 – 5 p < 0.001 
Large Muscle 1.7 (1.4) 0 - 4 .79 (1.14) 0 - 4 p < 0.001 
Gross Motor Skills 0.62 (1) 0 – 5 0.12 (0.48) 0 - 3 p < 0.001 
Fine Motor Skills .20 (0.5) 0 - 3 0.05 (0.27) 1 - 5 p < 0.001 
Higher Score indicates worse functional performance 
 
predictor of life satisfaction (β = -0.018, t (1) = -2.40 p = 0.017), delayed recall was a significant 
predictor of functional performance (β = -0.317, t (1) = -10.31 p < 0.01). Delayed recall was no 
longer a significant predictor of life satisfaction after controlling for the mediator, functional 
performance, (β = -0.004, t (2) = -0.6, p = 0.95). These findings are consistent with full 
mediation. Approximately 3% of the variance in life satisfaction was accounted for by the 
predictors (R2 = .03) (see Figure 17: Model Testing Relationship of  Domain-Specific Cognition 
(Delayed Recall) and Life Satisfaction is Mediated by Functional performance in the non-
COPD group). 
Psychosocial Variables Impact on Domain-specific Cognition 
 
There was no difference between the two groups in the perception of the need for 
cognition. The COPD group had statistically higher levels of hopelessness. The non-COPD 
group had a statistically higher sense of mastery, and satisfaction with aging (for more 
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information see Table 4: Cross- sectional Comparison of Differences in Psychosocial Variables 
by Groups in 2014 Wave of HRS Data set). 
 
 
 
 
Table 4: Cross-sectional Comparison of Differences is Psychosocial Variables by Groups in 
2014 Wave of the HRS Data Set 
 
 COPD 
Mean (SD 
 
Min/Max 
Non-COPD 
Mean (SD) 
 
Min/Max 
p value 
Need for N = 158  N = 1369  p = 0.33 
cognition 15.2 (3.0) (5.1 – 23.8) 15.0 (3.1) (5.1 - 25.8)  
Sense of N = 161  N = 1433  p < 0.001 
Mastery 18.9 (4.5) (4.2 – 25.4) 20.2(4.2) (4.2 – 25.2)  
Hopelessness N = 159  N = 1413  p = 0.02 
 8.2 (4.09) (3.2 – 19.5) 7.38 (4.07) (3.3 – 19.5)  
Satisfaction N =162  N = 1409  p < 0.001 
with Aging 25.4 (7.2) (7.1 - 42.8) 28.6 (6.9) (7.1 – 42.8)  
Number of respondents varies because of missing data. This portion of the HRS is from 
Psychosocial Leave Behind Survey that returned by mail 
 
In the COPD group, the regression model for predictive values of the psychosocial 
β= -0.037 
Life 
Satisfaction 
β= 0.483* 
 
Figure 17 Model Testing Relationship of Domain-Specific 
Cognition (delayed recall) and Life Satisfaction is Mediated by 
Functional Performance in the non-COPD Group. Standardized 
regression coefficients and 
*p<0.05. 
Functional  
Performance 
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variables on attention/executive function was not significant (F (4,138) = 14.09, p = .226). 
The psychosocial variables explained 11% of the variance in immediate recall and 12% of 
the variance in delayed recall. In the non-COPD group, the psychological variables 
explained 3% of the variance in executive function, 4% of the variance in immediate recall 
and 4% of the variance in delayed recall (for more information see Appendix R: Table 22 
R. 1 Regression of Psychosocial Variables on Domains of Cognition Cross-sectional Study 
from 2014 Wave of HRS Data Set). 
The sense of mastery did not have a significant correlation with any of the domains of 
cognition in either group while hopelessness was significantly correlated with all domains in 
both groups (for more information see Table 5: Cross-sectional Comparison of Squared 
Semipartial Correlations between Cognition and Psychosocial Variables by groups in 2014 
Wave of the HRS Data Set). In the COPD group, hopelessness was the only significant 
semipartial correlation. In the cognitive domain of memory and learning, immediate recall, the 
unique contribution of hopelessness was 7% and the unique contribution of delayed recall was 
9% variance in the regression of psychosocial variables on cognition. In the non-COPD group, 
the need for cognition and satisfaction with aging was predicator of variance in every cognitive 
domain. Need for cognition unique contribution to variance was less than 1% in executive 
function, 7% in immediate recall and 3% in delayed recall. Satisfaction with aging explained 
8% of variance in executive function, less than 1% in immediate and delayed recall. 
Discussion 
 
In this longitudinal study found that at baseline, the COPD group had significantly lower 
scores in executive function and learning and memory compared to the non-COPD group. When 
examining rate of change, there was no significant difference was found between the rate of 
change between the two groups in the domains of attention/executive function and delayed 
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recall. There was a significant difference in the rate of change in group having a sharper decline.
 In examining the relationships between cognitive domains, functional performance and 
life satisfaction, in the COPD group, no zero-order relationships were established. We found  
Table 5: Cross-sectional Comparison of Squared Semiparital Correlations between Cognition 
and Psychosocial Variable by Groups in 2014 Wave of the HRS Data Set 
 
 1. Need for 
Cognition 
2. Sense of 
Mastery 
3. Hopelessness 4. 
Satisfaction 
with Aging 
COPD 
Executive ry(1.2,3,4)2 ry(2.1,3,4)2 ry(3.1,2,4)2 ry(4.1,2,3)2 
Function 0.006 0.005 0.0080 0.0006 
 p = 0.35 p = 0.39 p = 0.28 p = 0.77 
Memory ry(1.2,3,4)2 ry(2.1,3,4)2 ry(3.1,2,4)2 ry(4.1,2,3)2 
Immediate 0.0112 0.0018 0.0701 0.0064 
recall P = 0.18 p = 0.60 p = 0.001 p = 0.31 
Memory ry(1.2,3,4)2 ry(2.1,3,4)2 ry(3.1,2,4)2 ry(4.1,2,3)2 
Delayed 0.0062 0.0004 0.0903 0.0060 
Recall p = 0.32 p = 0.81 p = 0.0002 p = 0.3309 
Non-COPD 
Executive ry(1.2,3,4)2 ry(2.1,3,4)2 ry(3.1,2,4)2 ry(4.1,2,3)2 
Function 0.0064 0.0011 0.0113 0.002 
 p = 0.003 p = 0.23 p = 0.0001 p = 0.08 
Memory ry(1.2,3,4)2 ry(2.1,3,4)2 ry(3.1,2,4)2 ry(4.1,2,3)2 
Immediate 0.0024 0.0016 0.0187 0.0052 
recall p = .07 p = 0.14 p = 0.00 p = 0.0081 
Memory ry(1.2,3,4)2 ry(2.1,3,4)2 ry(3.1,2,4)2 ry(4.1,2,3)2 
Delayed 0.0035 0.0007 0.0181 0.0037 
Recall p = 0.03 p = 0.33 p = 0.00 p = 0.02 
ry(4.1,2,3)2 – indicates the correlation between cognitive variable and independent variable 
with the effects of the other variables removed from the first listed independent variable 
alone -squared semipartial regression. 
 
in the non-COPD group, functional performance mediated the relationship between delayed 
recall and life satisfaction. Finally, the psychosocial variables, hopelessness was significant 
in both measures of memory in the COPD group and was significant across all domains in 
the non-COPD group. The need for cognition and satisfaction with aging, although they 
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explained only a small portion of the variance, were statistically significant for the non- 
COPD group only. 
To our knowledge, this is the first longitudinal study that examined the change in 
domain-specific cognitive function over 12 years, comparing COPD and aged -matched non- 
COPD groups. The baseline findings showed that the COPD group performed lower on all 
measures of cognitive function compared to the non-COPD group. This finding is consistent 
with previous studies in which persons with COPD had lower scores across all domains of 
cognition at all ages (Dal Ben & Bricolo, 2012; Dal Negro et al, 2014). In addition, it 
supports findings that cognitive changes in COPD occur earlier in life than those in the non- 
COPD group. Current asymptomatic smokers, person with COPD or COPD requiring long 
term oxygen therapy were significantly impaired on tests of cognition (Clock Drawing, Trail 
Making Test A and B) in all ages of life with persons aged 40 – 59 having the most 
significant impairment (Dal Ben & Bricolo, 2012). In another study, the extent and 
prevalence of cognitive declines was greater in COPD subjects followed by chronic non- 
obstructive bronchitis and then asymptomatic smokers (Dal Negro et al., 2014). These 
finding indicate that the cognitive impairment may begin at the early stages of COPD. Many 
persons with COPD go undiagnosed until respiratory symptoms become problematic. In 
examining first time admissions for COPD exacerbations, it was found that 34% had 
undiagnosed COPD as defined by no self-report of COPD diagnosis and not on any 
medications to treat COPD (Balcells et al., 2015). These findings provide strong support for 
the notion that cognitive changes can occur prior to the diagnosis of COPD. 
One plausible explanation for persons with COPD developing cognitive decline 
earlier in life than those without is based on theories of aging. Two prevalent theories of 
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aging are the programmed theory and the damage or error theory (Jin, 2012). In programmed 
theory, it implies that there is a timetable based on genetic expression that leads to 
deterioration over time. In the damage or error theory, the emphasis is on environmental 
assault that induces cumulative damage at various levels (Jin, 2012). Based on these 
theories, both groups would show decline based on the programmed theory of aging. 
However, persons with COPD would potentially have an earlier decline due to the 
cumulative assault that smoking has caused in the body. 
Between the two groups, the only cognitive domain that had a significantly different 
rate of change over time was immediate recall. In immediate recall there was a significantly 
sharper decline for the non-COPD group. This may be explained by critical ages in life 
course of the brain. One critical age period for brain volume shrinkage occurs between the 
ages of 60-90 (Fjell et al., 2013). In cross-sectional analysis, the regions with the steepest 
estimated decline are the cerebral white matter and the hippocampus (Fjell et al., 2013). The 
shrinking volumes of cerebral white matter and hippocampus may relate to the age-related 
memory changes as white matter in the cerebral cortex is involved in the speed of processing 
information and the activation of the hippocampus for memory formation (Yanker, Lu & 
Loerch, 2008). The reason the sharp decline was not seen during the same time period in 
persons with COPD is that inflammation can accelerate the aging brain (p.57). We were able 
to partially support our hypothesis that there is a positive relationship between the length of 
time with COPD and declines in domain-specific cognition in persons with COPD. 
Cognition has been identified as a predictor of life satisfaction. In a 3-year 
longitudinal study of the oldest old, persons aged 78 - 98-year-old, the cognitive domains of 
spatial abilities and processing speed predicted life satisfaction (Enkvist, Ekstrom, & 
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Elmstahl, 2013). In contrast, at baseline, we found no significant relationship between 
domain-specific cognition and life satisfaction in persons with COPD and only a weak 
relationship between delayed recall and life satisfaction in the non-COPD group. Life 
satisfaction levels have been found to stay consistent from late teens to early 70’s and then 
decline steeply until the end of life (Baird, Lucas & Donnellan, 2010). A plausible 
explanation for the lack of a relationship between cognitive function and life satisfaction is 
the compensation of expectations and adjustment of personal goal to maintain a steady level 
of life satisfaction. As a person experiences age-related changes, they use strategies such as 
selection, optimization and compensation to maintain a level of life satisfaction (Baltes, 
1997). Thus, we could not support our hypothesis the relationship between domain-specific 
and life satisfaction is mediated by functional performance. 
Beyond age and disease, we examined four psychosocial variables that may impact 
domain-specific cognition; need for cognition, the sense of mastery, hopelessness and 
satisfaction with aging. Of these variables, hopelessness was a consistent significant 
predictor variable in both groups and in all domains of cognition except executive functions 
in persons with COPD. Although it was a significant predicator, the amount of variance that 
was predicted was different across groups. Two factors could explain the impact of 
hopelessness on cognitive function. The first is the stereotype embodiment theory. The 
stereotype embodiment theory, posits that age stereotypes are internalized across the lifespan 
and can influence functioning in old age when they become self-relevant (Levy, 2009). The 
process of internalizing stereotypes has two stages. In the first stage, a person develops 
expectations and trajectories of the aging process from external sources such as society and 
media, but it holds no relevance to them. The second stage occurs when the person 
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encounters elderly individuals in everyday life. From these two stages, negativity can be 
developed towards the aging process. Then, when the person reaches old age, this 
internalized stereotype can become a self-fulfilling prophecy (Levy, 2009). The hopelessness 
scale may have captured a portion of internalized stereotype and the fact that one knows that 
they cannot change the fact certain facts. Those with COPD know that the disease is not 
curable and in the non-COPD group they are aging and there is nothing that can be done 
about either. 
The second factor that could explain the impact of hopelessness on cognition is 
depression. Depression is highly prevalent comorbidity in persons with COPD with 
estimated rates at approximately 40% compared to healthy elderly population that has 
estimated rate of 8 -16% (Fritzsche, et al., 2013). Depression influences cognition creating a 
bias that could have an impact on hopelessness. In depression, dysfunctional cognition and 
cognitive bias include recalling depression-specific stimuli better than positive or neutral 
stimuli, attention bias was found for depression-specific words and sad faces, and a limited 
ability to shift the focus of attention away from these stimuli (Fritzsche, et al., 2013). The 
focus on negative aspects could have an additive negative effect one’s internalized 
stereotype. 
Two other factors that explained a portion of the variance in cognition in the non- 
COPD group only were the need for cognition and satisfaction with aging. One plausible 
explanation for the difference in the need for cognition is education. Although there was not 
a significant difference in the years of education, there was a significant difference in degrees 
attained: 13.9% of COPD completed grad school compared to 24.6% in the non-COPD 
group. It is posited that the fact that persons attended college, they would have the tendency 
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for engaging in and enjoy thinking. A potential explanation for satisfaction with aging and 
its impact on cognition could also be related to having positive stereotypes regarding 
expectations of cognitive aging. 
Results partially supported our hypotheses that the rate of change in domain-specific 
cognition is different between the two groups. Persons with COPD had significantly lower 
scores at baseline and at each time there was a further significant decline. Persons in the non-
COPD group started with higher scores at baseline and had the sharpest decline in immediate 
recall. The results are consistent with findings from other studies. Studies suggest that 
cognitive changes occur earlier in life for persons with COPD and even before onset of 
COPD, the changes were seen in asymptomatic smokers (Dal Ben & Bricolo, 2014; Dal 
Negro et al., 2014). Future research on domain-specific cognition needs to incorporate 
younger persons with COPD. 
In relationship between cognition and life satisfaction, no significant relationships 
were found in the COPD group. In the non-COPD group only one weak relationship was 
found. A weak relationship was found between delayed recall and life satisfaction, but it was 
fully mediated by functional performance. Further research is needed to better understand the 
relationship in persons with COPD. 
Finally, we add to the body of literature a psychosocial aspect that explains some of 
the variance in cognition. The sense of hopelessness was a predictor of variance in all 
domains of cognition except executive future in the non-COPD. Hopelessness was a strong 
predictor of the variance in immediate and delayed recalls in the COPD group and a weak 
predicator of variance all domains in the non-COPD group. Additionally, the need for 
cognition and satisfaction with aging were weak predictors of cognition in the non-COPD 
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group. Further research is needed in examining the impact of hopelessness on cognition in 
persons with COPD. 
Strengths of the study was a population-based nationally representative, biennial 
longitudinal health survey began in 1992. We had a large sample size and were able to 
follow persons for 14 years. Limitations to this study are the cognitive assessments used and 
not a state of the art cognitive battery but were the cognitive tests that were available in the 
data base for a secondary analysis and are reasonable given the mode administration. Also 
present in the study was survivor effect. By selecting persons that were alive in 2014 and 
then searching back in time for first report, but we may have missed data from those that did 
not survive to the first data point. 
In this study, persons with COPD had poorer performance in all cognitive domains at 
baseline. Although both groups had a significant decline in all domains of cognition, the non- 
COPD groups had the sharpest decline occurring in the domain of immediate memory. The 
relationships between domains of cognition and life satisfaction and social participation and life 
satisfaction were weak and only present in the non-COPD group. The relationship between 
delayed recall and life satisfaction was fully mediated by functional performance. Each cognitive 
domain partially mediated the relationship between social participation and life satisfaction. 
Hopelessness was a significant predicator of memory and learning across both groups while need 
for cognition and satisfaction with aging was a weak predictor of cognition in all domains in the 
non-COPD group. Further research needs to examine the dynamic interactions between 
domain-specific cognition, functional performance, and life satisfaction.
89  
BIBLIOGRAPHY 
 
Baird, B., Lucas, R., & Donnellan, M. (2010). Life Satisfaction Across the Lifespan: Findings 
from Two Nationally Representative Panel Studies. Soc Indic Res, 99(2), 183-203. 
http://dx.doi.org/doi:10.1007/s11205-010-9584-9 
 
Balcalls, E., Gimeno-Santos, E., de Batlle, J., Ramon, M., Rodriguez, E., Benet, M., . . . Group., 
P.-C. s. (2015). Characterization and prognosis of undiagnosed chronic obstructive 
pulmonary disease patients at their first hospitalization. BMC Pulmonary Medicine, 
15(4). 
 
Baltes, P. B. (1997). On the Incomplete Architecture of Human Ontogeny Selection, 
Optimization, and Compensation as Foundation of Developmental Theory. American 
Psychologist, 52(4), 366-380. 
 
Bandura, A. (1977). Self-efficacy: toward a unifying theory of behavioral change. Psychol Rev, 
84(2), 191-215. 
 
Baron, R., & Kenny, D. (1986). The moderator–mediator variable distinction in social 
psychological research: Conceptual, strategic, and statistical considerations. Journal of 
Personality and Social Psychology, 51(6), 1173-1182. 
http://dx.doi.org/10.1037/0022-3514.51.6.1173 
 
Cacioppo, J., Petty, R., & Kao, C. (1984). The efficient assessment of need for cognition. J Pers 
Assess, 48(3), 306-307. http://doi.dox.org/10.1207/s15327752jpa4803_13 
 
Cleutjens, F. A., Spruit, M. A., Ponds, R. W., Dijkstra, J. B., Franssen, F. M., Wouters, E. F., &  
Janssen, D. J. (2014). Cognitive functioning in obstructive lung disease: results from the 
 United Kingdom biobank. J Am Med Dir Assoc, 15(3), 214-219.  
http://dx.doi.org/10.1016/j.jamda.2013.12.007 
 
Cleutjens, F. A., Franssen, F. M., Spruit, M. A., Vanfleteren, L., Gijsen, C., Dijkstra, J. B., . . .  
Janssen, D. J. (2017). Domain-specific cognitive impairment in patients with COPD and 
 control subjects. International Journal of Chronic Obstructive Pulmonary Disease, 12,  
1-11. http://dx.doi.org./10.2147/COPD.S119633 
 
Colcombe, S., & Kramer, A. (2003). Fitness Effects on the Cognitive Function of Older Adults. 
Psychological Science, 14(2), 125-130.
90  
Crisan, A. F., Oancea, C., Timar, B., Fira-Mladinescu, O., Crisan, A., & Tudorache, V. (2014). 
Cognitive impairment in chronic obstructive pulmonary disease. PLoS ONE, 9(7), 
e102468. http://dx.doi.org/10.1371/journal.pone.0102468 
 
Dal Ben, S., & Bricolo, F. P. (2012). The Psychological and Cognitive Profile. In R. W. Dal 
Negro & R. Hodder (Eds.), Long-Term Oxygen Therapy: new insight and perspectives 
Milan, Italia: Springer. 
 
Dal Negro, R. W., Bonadiman, L., Tognella, S., Bricolo, F. P., & Turco, P. (2014). Extent and 
prevalence of cognitive dysfunction in chronic obstructive pulmonary disease, chronic 
non-obstructive bronchitis, and in asymptomatic smokers, compared to normal reference 
values. Int J Chron Obstruct Pulmon Dis, 9, 675-683. 
http://dx.doi.org10.2147/COPD.S63485 
 
Daniel, M., Brown, A., Dhurrkay, J., Cargo, M., & O'Dea, K. (2006). Mastery, perceived 
stress and health-related behaviour in northeast Arnhem Land: a cross-sectional study.  
International Journal for Equity in Health, 5(10).  
  http://dx.doi.org10.1186/1475-9276-5-10 
 
Dodd, J. W., Getov, S. V., & Jones, P. W. (2010). Cognitive function in COPD. Eur Respir J, 
35, 913- 922. http://dx.doi.org/10.1183/09031936.00125109 
 
Dodd, J. W., Charlton, R., van den Broek, M., & Jones, P. W. (2013). Cognitive Dysfunction in 
Patients Hospitalized with Acute Exacerbation of COPD. CHEST, 144(1), 119-127. 
 
Eisner, M., Iribarren, C., Blanc, P., Yelin, E., Ackerson, L., Byl, N., . . . Katz, P. (2011). 
Development of disability in chronic obstructive pulmonary disease: beyond lung 
function. . Thorax, 66, 108-114. http://dx.doi.org10.1136/thx.2010.137661 
 
Enkvist, A., Ekstrom, H., & Elmstahl, S. (2013). Associations between cognitive abilities and 
life satisfaction in the oldest-old. Results from the longitudinal population study Good 
Aging in Skane. Clinical Interventions in Aging, 8, 845-853. 
http://dx.doi.org/10.2147/CIA.545382 
 
Favalli, A., Miozzo, A., Cossi, S., & Marengoni, A. (2008). Differences in neuropsychological 
profile between healthy and COPD older persons. Int J Geriatr Psychiatry, 23(2), 220-
221. http://dx.doi.org/10.1002/gps.1847 
 
Ferrans, C., Zerwic, J., Wilbur, J., & Larson, J. (2005). Conceptual Model of Health-Related 
Quality of Life. Journal of Nursing Scholarship, 37(4), 336-342. 
 
 
 
 
91  
Fioravanti, M., Nacca, D., Amati, S., Buckley, A., & Bisetti, A. (1995). Chronic Obstructive 
Pulmonary Disease and Associated Patterns of Memory Decline. Dementia, 6, 39-48. 
Fjell, A., Westlye, L., Grydeland, H., Amlien, I., Espeseth, T., Reinvang, I., . . . 
Initiative., t. A. D. N. (2013). Critical ages in the life course of the adult brain: nonlinear 
subcortical aging. Neurobiology of Aging, 34, 2239-2247. 
http://dx.doi.org/10.1016/j.neurobiolaging.2013.04.006 
 
Fritzche, A., Watz, H., Magnusen, H., Tuinmann, G., Lowe, B., & von Leupoldt, A. (2013). 
Cognitive biases in patients with chronic obstructive pulmonary disease and depression 
– a pilot study. British Journal of Health Psychology, 18, 827-843. 
http://dx.doi.org/10.1111/bjhp.12025 
 
Grant, I., Heaton, R., McSweeny, J., Adams, K., & Timms, R. (1982). Neuropsychologic 
Findings in Hypoxemic Chronic Obstructive Pulmonary Disease. Arh Intern Med, 142, 
1470-1476. 
 
Håkansson, K., Soininen , H., Winblad, B., & Kivipelto, M. (2015). Feelings of Hopelessness in 
Midlife and Cognitive Health in Later Life: A Prospective Population-Based Cohort 
Study. PLoS ONE. doi:DOI:10.1371/journal.pone.0140261 
  
Hung, W., Wisnivesky, J., Siu A., & Ross, J. (2009). Cognitive Decline among Patients with 
Chronic Obstructive Pulmonary Disease. American Journal of Respiratory Critical Care 
Medicine, 180, 134-137. http://dx.doi.org10.1164/rccm.200902-0276OC 
 
Herzog, R., & Wallace, R. (1997). Measures of Cognitive Functioning in the AHEAD Study. 
The Journals of Gerontology, 52B (Special Issue), 37-48. 
 
Hung, W., Wisnivesky, J., Siu A., & Ross, J. (2009). Cognitive Decline among Patients with 
Chronic Obstructive Pulmonary Disease. American Journal of Respiratory Critical Care 
Medicine, 180, 134-137. http://dx.doi.org/10.1164/rccm.200902-0276OC 
 
Incalzi, R. A., Gemma, A., Marra, C., Muzzolon, R., Capparella, O., & Carbonin, P. (1993). 
Chronic Obstructive Pulmonary Disease: An Original Model of Cognitive Decline. Am 
Re Respir Dis, 148, 418-424. 
 
Incalzi, R. A., Gemma, A., Marra, C., Capparella, O., Fuso, L., & Carbonin, P. (1997). Verbal 
Memory Impairment in COPD: Its Mechanisms and Clinical Relevance. CHEST, 112, 
1506-1513. 
 
Incalzi, R. A., Bellia, V., Maggi. S., Imperiale, C., Capparella, O., Catalano, R., Carbonin, P., 
Rengo, F., & the Sa.R.A. (Salute Respiratoria nell'Anziano) Study Group. (2002). Mild 
to moderate chronic airways disease does not carry an excess risk of cognitive 
dysfunction. Aging Clin Exp Res, 14(5), 395-401. 
 
Jin, K. (2010). Modern Biological Theories of Aging. Aging and Disease, 1(2), 72-74. 
 
92  
Kanno, S., Saito, M., Hayashi, A., Uchiyama, M., Hiraoka, K., Nishio, Y., . . . Mori, E. (2012). 
Counting- backward test for executive function in idiopathic normal pressure 
hydrocephalus. Acta Neurologica Scandinavica, 126, 279-286. 
http://dx.doi.org/10.111/j.1600-0404.2012.01644.x 
 
Kapella, M., Larson, J., Covey, M., & Alex, C. (2011). Functional Performance in Chronic 
Obstructive Pulmonary Disease Declines with Time. Med Sci Sports Exerc, 43(2), 2118-
2224. http://dx.doi.org//10.1249/MSS.0b013e3181eb6024 
 
Karzmark, P. (2000). Validity of Serial Sevens. International journal of Geriatric Psychiatry, 
15, 677- 679. 
 
Katz, P., Gregorich, S., Eisner, M., Julian, L., Chen, H., Yelin, E., & Blanc, P. (2010). 
Disability in Valued Life Activities among Individuals with COPD ad Other Respiratory 
Conditions. J Cardiopulm Rehabil Prev, 30(2), 126-136. 
http://dx.doi.org/10.1097/HCR.0b013e3181be7e59 
 
Krop, H., Block, J., & Cohen, E. (1973). Neuropsychologic Effects of Continuous Oxygen 
Therapy in Chronic Obstructive Pulmonary Disease*. CHEST, 64(3), 318-322. 
 
Lachman, M., & Andreoletti, C. (2006). Strategy use mediates the relationship between control 
beliefs and memory performance for middle-aged and older adults. J Gerontol B 
Psychol Sci Soc Sci, 61(2), P88-94. 
 
Lee, W., & Kim, S. (2014). Effects of Achievement Goals on Challenge Seeking and Feedback 
Processing: Behavioral and fMRI Evidence. PloS Medicine, 9(9). 
http://dx.doi.org/10.1371/journal.pone.0107254 
 
Leidy, N. (1994). Functional status and the forward progress of merry-go-rounds: toward a 
coherent analytical framework. Nur Res, 43(4), 196-202 
 
Levy, B., Slade, M., & Kasl, S. (2002). Longitudinal Benefit of Positive Self-Perceptions of 
Aging on Functional Health. Psychological Science, 57B(5), 409-417. 
 
Levy, B., & Leifheit-Limson, E. (2009). The Stereotype-Matching Effect: Greater Influence on 
Functioning When Age Stereotypes Correspond to Outcomes. Psychology and Aging, 
24(1), 230- 233. http://dx.doi.org/10.1037/a0014563 
 
Martinez, C., Richardson, C., Han, M., & Cigolle, C. (2014). Chronic Obstructive Pulmonary 
Disease, Cognitive Impairment and Development of Disability: The Health Retirement 
Study. Annals ATS, 11(9), 1362-1370. 
http://dx.doi.org/10.1513/AnnalsATS.20145-187OC 
 
 
 
 
93  
Pavot, W., Diener, E., Colvin, R., & Sandvik, E. (1991). Further Validation of the Satisfaction 
with Life Scale: Evidence for the Cross-Method Convergence of Well-Being Measures. 
Journal of Personality Assessment, 57(1), 149-161. 
 
Pompili, M., Innamorati, M., Gonda, Z., Serafini, G., Sarno, S., Erbuto, D., . . . Girardi, P.  
(2013).Affective temperaments and hopelessness as predictors of health and social 
functioning in mood disorder patients: A prospective follow-up study. . Journal of 
Affective Disorders, 150(216-222). http://dx.doi.org/10.1016/j.jad.2013.03.026 
 
Prigatano, G. P., Parsons, O., Levin, D., Wright, E., & Hawryluk, G. (1983). 
Neuropsychological Test Performance in Mildly Hypoxic Patients with Chronic 
Obstructive Pulmonary Disease. Journal of Consulting and Clinical Psychology, 51(1), 
108-116. 
 
Radloff, L. (1977). The CES-D Scale: A Self-Report Depression Scale for Research in the 
General Population. Applied Psychological Measures, 1(3), 385-401. 
 
Singh, B., Mielke, M., Parsaik, A., Cha, R., Roberts, R., Scanion, P., . . . Peterson, R. (2014). A 
Prospective Study of Chronic Obstructive Pulmonary Disease and the Risk for Mild 
Cognitive Impairment. JAMA Neurol, 71(5), 581-588. 
http://dx.doi.org./10.001/jamaneurol.2014.94 
 
Smith, J., Ryan, L., Fisher, G., Sonnega, A., & Weir, D. (2017). Psychosocial and Lifestyle 
Questionnaire 2006 - 2016: Documentation Report. Retrieved 
https://hrs.isr.umich.edu/sites/default/files/biblio/HRS%202006- 
2016%20SAQ%20Documentation_07.06.17.pdf 
 
STATA: StataCorp. 2017. Stata Statistical Software: Release 15. College Station, TX:  
StataCorp LLC 
 
Strauss, E., Sherman, E., & Spreen, O. (2006). A Compendium of Neuropsychological Tests: 
ADMINISTRATION, NORMS and COMMENTARY. New York, New York.: Oxford 
University Press. 
 
Thakur, N., Blanc,P., Julian L., Yelin, E., Katz, P, Sidney, S., Iribarren, C., & Eisner, M. 
(2010). COPD and cognitive impairment: the role of hypoxemia and oxygen therapy. 
International Journal of Chronic Obstructive Pulmonary Disease, 5, 263-269. 
 
Voyer, P., Champoux, N., Desrosiers, J., Landreville, P., Monette, J., Savoie, M., . . . Bedard, 
(2006). Assessment of inattention in the context of delirium screening: one size does 
 not fit all! International Psychogeriatrics, 28(8), 1293-1301.  
http://dx.doi.org/10.1017S10416110216000533 
 
Weissman, M., Sholomskas, D., Pottenger, M., Prusoff, B., & Locke, B. (1977). Assessing 
Depressive Symptoms in Five Psychiatric Populations: A Validation Study. American 
Journal of Epidemiology, 106(3), 203-214. 
94  
Yanker, B., Lu, T., & Loerch, P. (2008). The Aging Brain. Annu Rev Pathol Mech Dis, 3,  
41-46. http://dx.doi.org/10.1146/annurev.pathmechdis.2.010506.092044 
95  
 
 
 
 
 
CHAPTER IV 
 
Assessing Domain-specific Cognition in Persons with Mild to Severe COPD: Feasibility and 
Acceptability of Computerized Adaptive Testing 
COPD is one of the major causes of disability among middle-aged adults in the U.S. 
Persons with COPD have a 10-fold higher risk of developing disability than members of the 
general population (Eisner et al., 2011). Beyond the impact on the pulmonary system, COPD 
has extrapulmonary effects which influence the quality of life. Extrapulmonary features of 
COPD include weight loss, decrease in muscle mass, decrease in strength and endurance, 
osteoporosis, heart failure, anxiety, depression and cognitive impairment (Cleutjens, Janssen, 
Ponds, Dijkstra, & Wouters, 2014). The focus of this research was domain-specific 
cognition, functional performance and life satisfaction. 
There is strong evidence that persons with COPD have increased risk and higher 
prevalence of cognitive decline both in global measures and domain-specific measures of 
cognition. Studies have shown that persons with COPD are at an increased risk and have a 
higher incidence of global cognitive decline (Hung, Wisnivesky, Siu, & Ross, 2009; 
Martinez, Richardson, Han, & Cigolle et al., 2014; Ozge, Ozge, & Unal, 2006; Singh et al., 
2014; Thakur et al., 2010). Persons with COPD also have significantly poorer performance in 
the domain-specific cognition.  Significant differences were found in the domains of 
attention (Grant, Heaton, McSweeny, Adams, & Timms, 1982), short-term memory 
(Cleutjens et al., 2014; Favali et al., 2008; Fioravanti, Nacca, Amati, Buckley & Bisetti, 
1995; Incalzi et al., 1999), long-term memory (Cleutjens et al., 2014, Favalli et al., 2008; 
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Incalzi et al., 1997), language (Favalli, et al., 2008) and processing speed (Cleutjens et al., 
2014). These results suggest that both global and domain-specific cognition are 
compromised in persons with COPD. 
There is a small body of evidence that supports view that a decline in cognition 
contributes to functional decline. Using measures of global cognition many studies have 
found an association between cognitive decline and decreased functional performance in 
persons with COPD (Antonelli-Incalzi et al., 2008; Feng, Lim, Collinson, & Ng, 2012; Ozge 
et al., 2006).  In a two-year longitudinal study, cognitive impairment had an additive effect 
on disability that occurs in person with COPD (Martinez et al., 2014). Antonelli-Incalzi et al. 
(2008) observed cognitively lower function persons with COPD had higher prevalence in 
dependence in ADLs and IADLs. Cognitive decline and decreased functional performance 
have been associated with a decline in life satisfaction (Blinderman, Homel, Billings, 
Tennstedt, & Portenoy, 2009). In addition to the basic activities needed for survival, declines 
also occur in valued life activities.  Valued life activities are those activities that are 
important to the individual. As a person experiences loss in functional performance, 
preserving energy for activities needed for survival, there a greater reduction in valued life 
activities (Katz et al., 2010). The performance of the valued activities is closely more closely 
linked to life satisfaction than are activities of survival (Katz et al., 2010). Even though there 
is a link between cognitive decline, functional performance and life satisfaction, the evidence 
supporting the link is weak. Further research that examines the relationship levels of 
functional performance and life satisfaction is needed. 
The purpose of this research was to examine the relationships between domain- 
specific cognition and other related factors, functional performance, and life satisfaction. To 
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depict the relationships for this study a second modified visual representation of the 
interactions between Cognition, Functional Performance, and Life Satisfaction was created 
(see Figure 18: Second Modified Visual Representation of Relationships Among Cognition, 
Functional Performance, and Life Satisfaction with inclusion of PROMIS and NIHTB-CB 
variables). This work was guided by two frameworks: Revised Cleary & Wilson Model of 
Health-Related Quality of Life (Ferrans et al., 2005) (see Appendix A for more information 
on Revised Cleary & Wilson Model of Health-Related Quality of Life) and Functional Status 
Framework (Leidy, 1994). The revised Cleary & Wilson Model of Health-Related Quality of 
Life illustrates the dynamic interactions between health, functioning, and life satisfaction 
(Ferrans et al., 2005). The Functional Status Framework defines functional performance as 
"those activities that people do in the normal course of their lives to meet basic needs and 
fulfill usual roles and maintain health and well- being" (Leidy, 1994, p. 197.). It also 
describes characteristics of the individual that may influence functional performance 
including cognition, emotional states of anxiety and depression, and sleep disturbances 
(Leidy, 1994). Life satisfaction is subjective well-being related to how happy or satisfied 
someone is with various aspects of their lives (Ferrans et al., 2005). 
Several factors have made it difficult to describe the pattern of domain-specific 
cognitive decline. One issue is the lack of an accepted universal classification of cognitive 
domains (Dodd et al., 2010, p.914). In a review of 16 articles, Torres-Sanchez et al. (2015) 
found that 39 neuropsychological tests were used to assess seven cognition domains. 
Presently, there is no standard assessment tool to evaluate global cognition, and there is no 
standard for the types or number of neuropsychological tests required for evaluation of 
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domains of cognition. The use of different tools to assess the same cognitive function has 
made it difficult to compare data across studies. 
 
 
Figure 18: Second Modified Visual Representation of Relationship among Cognition, Functional 
Performance and Life Satisfaction with inclusion of PROMIS and NIHTB-CB Variables 
It is important to assess cognition using a standard battery. There are many studies 
that have collected data on aspects of cognitive decline in persons with COPD. However, 
little uniformity was found in assessing the various domains of cognitive function (Torrez- 
Sanchez et al., 2015). Noting that the lack of standardized measures made it difficult to 
compare and interpret findings across studies and populations, NIH awarded contracts to 
develop standardized tests meet the need of enhancing comparison of results across studies 
and to be used in data collection in large cohort studies (Talan, 2012). Two batteries of 
instruments were created; patient reported outcome measurement information system 
(PROMIS®) and the National Institute of Health (NIH) Toolbox® (NIHTB). PROMIS® 
assesses many patient-reported outcomes including pain, fatigue, emotional distress, physical 
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functioning and social role participation (Cella et al., 2010). The NIHTB divides tests into 
four aspects of neural function called cognition, sensation, motor, and emotion. The NIHTB 
cognition battery (NIHTB-CB) is further divided into cognitive domains and currently 
consists of seven test instruments to measure abilities within the five major domains (Heaton 
et al., 2014). The need for a "state-of-the-art" instrument which was brief, less than 30 
minutes led to the use of the digital platform. 
To our knowledge, the NIHTB-CB has not been used to measure cognitive function 
in persons with COPD. The primary aim of this research is to determine the feasibility and 
acceptability of using computer adaptive testing tools from the NIHTB-CB for assessment of 
domain-specific cognition in persons with COPD. A secondary aim is to describe a 
preliminary estimate of the strength of the relationship among domain-specific cognition, 
functional performance and life satisfaction in persons with mild to severe COPD. 
Methods 
 
Nineteen participants were recruited from pulmonary clinics at the University of 
Michigan Health System and by referral. Inclusion criteria were over the age of 55, 
documented FEV1, ability to walk and to take computerized tests. Exclusion criteria include 
impairment, taking Aricept or Namenda, taking any medications that would alter cognition or 
history of a stroke. 
To our knowledge, the NIHTB-CB has not been used to measure cognitive function 
in persons with COPD. The primary aim of this research is to determine the feasibility and 
acceptability of using computer adaptive testing tools from the NIHTB-CB for assessment of 
domain-specific cognition in persons with COPD. A secondary aim is to describe a 
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preliminary estimate of the strength of the relationship among domain-specific cognition, 
functional performance and life satisfaction in persons with mild to severe COPD. 
PROMIS® CAT and NIHTB-CB Measurements 
PROMIS® is available via paper questionnaire, interactive voice response or 
computer adaptive testing (CAT). According to Bjorner et al. (2014), there were no 
statistically or clinically significant differences in scores or psychometric properties between 
the three methods of administration. The basis of PROMIS® CAT is item response theory 
(HealthMeasures, 2017). Each assessment lasts approximately one minute. The person 
receives items until they reach a specified level of measurement precision or a specific 
number of items, usually 4 - 12. In a study of persons with multiple sclerosis, persons took 
the PROMIS® CAT surveys in 4.08 minutes while the estimated completion time with paper 
and pencil test was estimated at 15.6 minutes (Senders, Hanes, Bourdette, & Shinto, 2015). 
NIHTB-CB is a set of brief psychometrically sound instruments to assess motor, 
emotional, sensory and cognitive function in the person aged 3 – 85 (NIHTB, 2015). Survey 
data from 102 cognitive experts was used to select NIHTB-CB domains. The cognitive 
experts endorsed Executive Function (95%), Episodic Memory (93%), Language (55%), 
Processing Speed (52%) and Attention (50%) and 57% indicated that a "Global Score" would 
be desirable (Weintraub et al., 2014). 
Measurements selected from PROMIS® are based on related factors of cognition 
from the visual representation. All seven instruments from the NIHTB-CB assessing the five 
domains of cognition were included in this study (for more information see Table 6: List of 
Variables and Measures used from PROMIS® CAT and NIHTB-CB). 
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Table 6 List of Variables and the Measures used from PROMIS CAT Test and NIHTB-CB 
 
Variable PROMIS® CAT test NIHTB-CB 
Disease Severity NA NA 
Dyspnea NA NA 
Fatigue Fatigue  
Sleep Sleep Disturbance  
Emotional State Anxiety 
Depression 
 
Cognition 
Attention 
 
 
Executive Function 
 
 
Episodic Memory 
Language 
 
Processing Speed 
Working Memory 
 NIH Toolbox Flanker 
Inhibitory Control 
and Attention Test 
 
NIH Toolbox 
Dimension Change 
Card Sort Test 
 
NIH Toolbox Picture 
Sequence Memory 
Test 
 
NIH Toolbox Picture 
Vocabulary and 
NIH Toolbox Oral 
Reading Recognition 
Test 
 
NIH Toolbox Pattern 
Comparison. 
 
NIH Toolbox Oral 
Reading Recognition 
Test 
Functional Performance Physical Function 
Mobility 
Ability to Participate 
Social 
 
Life Satisfaction  General Life 
Satisfaction 
Survey 
The select of this content does not necessarily represent an endorsement by the US Federal 
Government or PROMIS®. See www.nihPROMIS® .org for additional information on the 
PROMIS® Initiative. 
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Domain-specific Cognition 
 
The NIHTB-CB has been normed and validated across the lifespan in subjects ages 
3-85. Convergent and discriminant validity measures have been performed on all NIH 
toolbox measures (for more information see Appendix S: Table 23 S. 1 Convergent and 
Discriminant Validity of the NIHTB-CB Persons Aged 8 - 85 and Appendix T: Table 24 
Reliability of NIHTB-CB). 
Attention and Executive Function. NIH Toolbox Flanker Inhibitory Control and 
Attention Test and NIH Toolbox Dimension Change Card Sort Test were used to assess 
executive function. In the Flanker test, the participant must focus on a given stimuli while 
inhibiting attention to stimuli flanking it.  The participant is presented with a series of five 
arrows and must select the direction of the middle arrow. The test takes approximately four 
minutes to administer. Convergent validity r = - 0.48, p < 0.001, discriminant validity r = 0.15, p 
< 0.001 and reliability r = 0.85. The Dimensional Change Card Sort Test measures flexibility 
and attention. The participant is given two pictures with two dimensions, shape and color. The 
participant must select the appropriate dimension based on a word displayed in the center of the 
screen. The test takes about four minutes to administer. Convergent validity r = - 0.51, p < 
0.001, discriminant validity r = 0.14, p < 0.05 and reliability r = 0.88. 
Episodic memory. NIH Toolbox Picture Sequence Memory Test assessed episodic 
memory. As a sequence of pictures appears in the center of the screen, a recording describes it. 
The computer places the picture in a fixed order around the border of the screen. Once all the 
pictures are in place, they return to the center of the screen. The participant must return the 
pictures to their proper place. The test takes about ten minutes to administer. Convergent 
validity r = 0.69, p < 0.001, discriminant validity r = -0.08, p < 0.05 and reliability r = 0.77 
(Weintraub et al., 2014). 
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Language. Language was measured with the NIH Toolbox Picture Vocabulary. The 
Picture Vocabulary Test measures receptive vocabulary. The participant is read a word and has 
four pictures on the screen and must select the picture that best matches the word provided. The 
test takes about five minutes to administer. Convergent validity r = 0.78, p < 0.001, discriminant 
validity r = -0.08, p < 0.05 and reliability r = 0.81 (Weintraub et al., 2014). The NIH Toolbox 
Oral Reading Recognition Test is a single word reading task that has been used to estimate the 
quality of education. The test takes about four minutes to administer. Convergent validity 
 r = 0.93, p < 0.001, discriminant validity r = -0.19, p < 0.001 and reliability r = 0.77 (Weintraub 
et al., 2014). 
Processing Speed. Processing Speed was assessed using the NIH Toolbox Pattern 
Comparison. The participant is asked to compare two pictures presented side by side to 
determine if they are the same or different. They are given 85 seconds to respond to as many 
pairs of pictures as possible. The test takes about three minutes to administer. Convergent 
validity r = 0.49, p < 0.001, discriminant validity r = 0.12, p < 0.05 and reliability r = 0.72 
(Weintraub et al., 2014). 
Working memory. Working memory was assessed using the NIH Toolbox Oral Reading 
Recognition Test. The participant is presented with visual and verbal lists.  The participant is 
then asked to sort and recall the list.  For example, the participant is given three animals and 
must state them back in order of smallest to largest. The test takes about seven minutes to 
administer. Convergent validity r = 0.58, p < 0.001, discriminant validity r = 0.30, p < 0.001 and 
reliability r = 0.77(Weintraub et al., 2014).
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Composite Scores of Crystallized, Fluid and Cognitive Function 
 
Fluid Cognition Composite Score. This composite score includes all the tests noted 
above that reflect fluid ability: Flanker, Dimensional Change Card Sort, Picture Sequence 
Memory, List Sorting and Pattern Comparison. Fluid abilities are used to problem solve, 
respond quickly to stimuli, and encode new episode memories. Fluid abilities are essential in 
adapting to new situations in everyday life. They are more sensitive to neurobiological integrity 
including changes with aging or systemic disorders that alter brain function (Toolbox Scoring). 
Crystallized Cognition Composite Score. The composite score is the average of the 
scores from the Picture vocabulary and Reading Tests. Crystallized abilities are presumed to be 
more dependent on experience and less on biological influences. Experience heavily influences 
crystallized cognition composite score as it represents an accumulated store of verbal 
knowledge and skills and thus are heavily influenced by education (Toolbox Scoring). 
Cognitive Function Composite Score. The Cognitive Function Composite is the 
average of the Fluid and Crystallized composites. Interpretation is like a "full-scale score." It 
provides a highly reliable overall snapshot of general cognitive functioning (Toolbox Scoring). 
The test-retest reliability of the composite scores were acceptable; crystallized r = .85, fluid  
r = .76 and total cognition r = .88 (Akshoomoff et al., 2013). Convergent validity of the 
composite scores for age 8-85 were crystallized r =.90 (df =85), fluid r = .70 (df = 85) and total 
r = .88 (df =113); all p values were < .0001 (Akshoomoff et al, 2013, p.15). 
Related factors 
Disease severity. Disease severity was determined by using the GOLD COPD staging 
system (for more information see Appendix B: Table 10 B.1  GOLD COPD staging system) 
which includes predicted FEV1% based on age, gender, height, weight, the impact of the 
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disease on well-being and daily life The GOLD COLD staging systems has a combined assessment 
which adds risks of exacerbation and symptoms to the classification system.  Exacerbations are 
assessed by examining the numbers of exacerbations per year and determining whether the 
exacerbation led to hospitalization. Degrees of symptoms are determined by using the COPD 
Assessment Test (for more information see Appendix C: COPD Assessment Test) and the modified 
Medical Research Council (mMRC) dyspnea scale (for more information see Appendix D the mMRC 
dyspnea scale). The results are then calculated using the combined assessment tool (for more 
information see Appendix E: Table 11 E. 1 Combined Assessment Tool of COPD). 
Symptoms of COPD. Dyspnea was measured with mMRC dyspnea 
scale. Fatigue was measured with the PROMIS CAT fatigue scale. 
Dyspnea. Dyspnea was assessed using the modified Medical Research Council 
(mMRC) dyspnea scale (for more information see Appendix D the mMRC dyspnea scale). 
The mMRC is a simple and valid method of categorizing patients with COPD in terms of their 
disability based on breathlessness. Intraclass correlation coefficient for test-retest reliability at 
a 6 + 5-day interval was 0.82 with 95% CI (0.72-0.88) (Mahler et al., 2009). It was found that 
the mMRC detected changes between stages II & IV and III & IV but not between II & III 
(Mahler et al., 2009). 
Fatigue. Fatigue was measured using the PROMIS® Fatigue CAT instrument. 
The instrument measures fatigue from mild subjective feelings of tiredness to an overwhelming, 
debilitating, and sustained sense of exhaustion (HealthMeasures, 2017). Four items must be 
completed to receive a T score. A higher score indicates more fatigue (HealthMeasures, 2014). 
Reliability of the PROMIS® fatigue short form was .88 across samples in healthy controls, and 
its correlations with scores on the Multidimensional Fatigue Symptom Inventory-Short Form 
and Brief Fatigue Inventory was .60 to .85 (Ameringer et al., 2016). 
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Emotional State 
Depression. Depression was measured using the PROMIS® CAT depression scale. The  
PROMIS® depression scale assesses negative mood, negative views of self, negative social 
cognition, and decreased positive affect and engagement (PROMIS®). The internal reliability 
of all scales for depression had a Cronbach's alpha 0.93 (Kroenke, Yu, Wu, Kean, & Monahan, 
2014). 
Anxiety. Anxiety was measured using the PROMIS® CAT Anxiety Scale The 
PROMIS® Anxiety scale assesses fear, anxious misery, hyperarousal, and somatic complaints 
related to hyperarousal (PROMIS®). The internal reliability on PROMIS® scale of anxiety had 
a Cronbach’s alpha 0.89 (Kroenke et al., 2014).  Stone et al., 2015) examined ecological 
validity on eight PROMIS® tests including anxiety and depression. Daily scores were taken and 
averaged and then compared to seven-day recall and compared to the average levels of 
depression or anxiety. Three types of ecological validity were examined: group differences, 
correspondence between the daily diaries and the 7-day recall and change over time (Stone et 
al., 2015). In the scores from the depression scales and the anxiety scales, all three types of 
ecological validity had correlations greater than 0.85. 
Sleep disturbance 
 Sleep disturbance was measured using the PROMIS® CAT for sleep disturbance test. It 
assesses quality and depth of sleep and its associated restorations; perceived difficulties and 
concerns regarding getting to sleep or staying asleep (PROMIS®). The reliability was reported 
Cronbach's α = 0.96 (Yu et al., 2011). Convergent validity of the Sleep Disturbance measure 
was supported with moderate to high correlations with existing scale the Pittsburgh Sleep 
Quality Study, and the items were reviewed by experts for content (Yu et al., 2011). 
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Functional Performance 
 
Physical Function. Physical Function was measured using PROMIS® physical function 
CAT. This test assesses the ability and the frequency within a specified timeframe in which a 
person carries out self-care activities to more complex actions; the stem is "Are you able to . . ?" 
(HealthMeasures, 2017). The computerized adaptive test of physical function was found to be 
superior to static forms of equal length (Fries, Cella, Rose, Krishnan, & Bruce, 2009). 
PROMIS® Physical Function has been validated in persons with rheumatoid arthritis (Bartlett et 
 
al. 2015), orthopedic trauma (Stuart et al. 2015), heart failure (Flynn, 2015) and a person with 
cancer (Jensen et al., 2015). 
Social Participation. Social participation was measured using PROMIS® ability to 
participate in social roles and activities scale. The participant answers regarding their ability to 
perform roles such as work, family responsibilities, and discretionary social activities on a 5- 
point Likert scale that is anchored never to always. The internal reliability is Cronbach's alpha 
.99. The correlation with the FACIT-Functional Well Being Scale was 0.76. (Cella et al., 2010). 
 
Life Satisfaction 
 
Life satisfaction was measured with the NIH Toolbox® General Life Satisfaction 
Survey. It is a CAT self-report measure that assesses general feelings of one’s life. The CAT 
consists of a Likert scale with items being five or seven item response ranging from strongly 
disagree to strongly agree. The internal reliability is Cronbach's α = 0.91 (Salsman et al., 
2014). 
Feasibility and Acceptability 
We examined feasibility and acceptability with a brief survey that was administered at 
the completion of the exam. There were six items on a Likert scale and two open-ended 
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questions. The six-items included: was adequate instruction given to complete the required 
tasks, the screen was easy to read, the use of the keyboard was easy, whether there was a need 
to take a break, and a rating of the overall impression of the experience (for more information 
see Appendix U: Table 25 U. 1 Feasibility and Acceptability Survey). 
Data Analysis 
The NIH Assessment calculated and reported fully corrected T-scores based on age, 
gender, race/ethnicity and educational attainment for all PROMIS and NIHTB-CB tests. 
Statistical Analysis was performed using SPSS Version 24. Descriptive statistics were 
analyzed for all continuous variables. Cognitive scores of individual participants were 
compared to T-scores to determine the number of individuals that had a deficit of at least one 
standard deviation. Spearman rho Correlation coefficients were calculated for disease severity, 
domain-specific cognition, related factors, functional performance and life satisfaction 
Results 
 
Population Characteristics 
 
Population characteristics are presented in Table 7 (for more information see Table 7 
Sample Characteristics from the Pilot Study (n = 19)). 
Feasibility and Acceptability 
 
On a scale of 0 – 5, adequate instructions were rated 4.6, the ease of reading the tablet 
was 4.7, length of the test too long 3.7, agreement with not needing to take a break was 4.2, 
an overall impression of the experience was 4.3. In open ended declined to complete the 
questioning, 37% would like to see the computerized voice different, 16% said it was 
annoying and 21% felt it used the phrase “good job’ too frequently; 10.5% of participants felt 
that too many pictures were used in the Picture Sequence Memory test. As for format, 42% of 
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the participants suggested that the format should stay the same (for more information see 
Table 8 Responses to Open-ended Questions on Feasibility and Acceptability Survey (N = 
19)).  
Observations from a researcher’s perspective, it was important to sit next to the 
participant to facilitate the testing as there are times both Participant and researcher need to see 
the screen. During the exam one participant saw the Picture Sequence Memory screen and 
declined to complete the test. This participant had completed the tutorial which had only four 
pictures. When she observed the screen with 15 pictures to be placed back in order presented, 
she stated that no one could remember all those pictures and she declined to attempt the task. 
Her data could not be included in the crystallized cognition or total cognitive score. Midway 
through research time frame, an error message appeared on the tablet when opening the 
NIHTB application. The message stated the program needed to be rebooted as there was an 
error in scoring. Scores were adjusted for three of the subjects that completed the pilot. 
 In the following cognitive tests, none of the participants showed 
significant deficits: executive function measured by Dimension Card Sort, language 
measured by Oral Reading, and crystallized and total cognition. Four domains of 
cognition had one person (5.3%) show significant deficit language as measured by 
Picture Vocabulary, working memory, fluid cognition. Two persons (11.1%) 
showed significant deficit in episodic memory. On the Flanker test for executive 
function and attention, four persons (21%) had a significant deficit. Nine persons 
(47.4%) had deficits in processing speed as measured by Pattern Comparison test. 
There were at least four persons in each domain of related factors that exhibited 
deficits. Four persons (21%) of the participants had significantly increased fatigue 
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Table 7 Sample Characteristics from the Pilot Study (n=19) 
 
Variable N Percentage 
Gender 
Female 
Male 
 
12 
7 
 
63.2 
36.8 
Education 
11th grade 
HS 
< 1-year college 
1-year college 
AD 
BA 
PhD 
 
2 
3 
3 
6 
1 
2 
1 
 
10.5 
15.8 
15.8 
31.6 
5.3 
10.5 
5.3 
Smoking status 
former smokers 
current smokers 
 
17 
2 
 
89.5 
10.5 
Oxygen therapy 2 10.5 
Exacerbations per year 
hospitalized in past year with 
exacerbation 
 
2 
 
10.5 
GOLD COPD Stage 
GOLD Stage I (mild) 
GOLD Stage II (moderate) 
GOLD Stage III (severe) 
GOLD Stage IV (very severe) 
0 
9 
6 
4 
0 
47.4 
31.6 
21 
mMRC 
Grade 0 
Grade 1 
Grade 2 
Grade 3 
Grade 4 
 
0 
6 
4 
2 
1 
 
0 
31.6 
21.1 
10.5 
5.3 
 Min/Max Mean(SD) 
Age 57 - 80 68.15 (7.39) 
Comorbid Conditions 0 - 11 2.15 (3.14) 
FEV1 18 -71 46.4 (15.8) 
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Table 8 Responses to Open-Ended Questions on Feasibility and Acceptability Survey (N=19) 
What would you like to see done differently? N 
"Repetitive robot voice is very annoying." 3 
"quit saying 'good job'" 4 
“nothing” 3 
“more time” 1 
"Use less words to remember, just by 2." 1 
Regarding the NIH Picture Sequence Memory Test 
"no one can complete putting all pictures back in 
order” 
“not so many pictures” 
2 
What would you like to stay the same?  
"all good" 2 
"good format." 3 
"Like the shape and colors, the best." 1 
“everything” 2 
“okay” 1 
“no comment” 1 
 
and anxiety with a decrease in ability to participate in social activities. Five persons (26.3%) 
had a significant increase in sleep disturbance. Nine persons (47.4%) had significant increase 
in depressive symptoms. Nine persons (47.4%) had decrease in physical function with eleven 
(57.9%) decrease (for more information see Table 9: Descriptive for Domain-Specific 
Cognition, Functional Performance and Life Satisfaction from PROMIS and the NIHTB-CB). 
Correlations between cognitive domains and related factors 
 
The correlations between cognitive domains and related factors, there was no 
association between disease severity, dyspnea, or anxiety and any of the cognitive domains. 
There was a negative association sleep disturbance and working memory (rs = -.512, 
p < 0.05). Correlations between functional performance and domains of cognition, were the 
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domain of episodic memory and social participation (rs = - .663, p < .001) There were no 
significant correlations with life satisfaction (for more information see Appendix V: Table 26 V. 
1 Correlations of Domain-specific Cognition, Related Factors, Functional Performance, and 
Life Satisfaction – Spearman Rho). 
Discussion 
 
In this pilot study, no aggregate score in any domain of cognitive function reached a level 
of deficit. The domain of processing speed had the greatest number of participants. The use of 
PROMIS® and NIHTB-CB are both feasible and acceptable to use in the persons with COPD. 
The overall format was acceptable to all participants. The instruments were easy to administer. 
The instructions provided were clear. There were no difficulties with instructions or readability 
of the tablet. The most frequent complaint from participants was the computerized voice saying, 
"great job" after every item in the practice tests. 
with decline. However, all the domains of cognition had at least one individual with a deficit 
score of one standard deviation below the T-score. The domain of processing speed 
approached the level of an aggregate score deficit with a mean of 43.6 (14.6) with 47.5%  
(n= 9) of participants having a score that was at least one standard deviation below the T- 
score. The findings of this study are consistent with previous research. 
Another CAT for assessing cognition, the Central Nervous System Vital Sign although 
the domains and tests were slightly different than the NIHTB-CB had similar findings. Over 
half (51.8%) of persons with COPD had (51.8%) had impaired functioning on 1 or more 
cognitive domains (Campman, Ranst, Meijer, & Sitskoorn, 2017). Processing speed had the 
greatest difference from the normative mean performance and the scores fell in the low 
average category indicating a slight deficit and impairment. 
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Table 9 Descriptive Statistics for Domain-Specific Cognition, Functional Performance and Life 
Satisfaction from PROMIS and the NIHTB-CB (n=19) 
 
 Mean (SD) Min/Max At least 
1 SD 
below 
T-Score 
% (N) 
NIHTB-CB 
Flanker Executive Function 
& Attention 
50.3 (8.4) 32 - 63 21 (4) 
Dimension Card Sort 
Executive Function 
57.7 (12.4) 44 - 85 0 
Picture Sequence2 
Episodic Memory 
51.8 (8.7) 37 - 69 11.1 (2) 
Picture vocabulary 
Language 
56.3 (9.4) 39 - 77 5.3 (1) 
Oral Reading 
Language 
64.9 (8.9) 47 - 77 0 
Pattern Comparison 
Processing Speed 
43.6 (14.6) 14 - 73 47.4 (9) 
List Sort 
Working Memory 
56.3 (9.1) 39 - 70 5.3 (1) 
Fluid Cognition2 56.4 (9.7) 40 - 73 5.3 (1) 
Crystallized Cognition2 62 (8.8) 52 - 79 0 
Total Cognition2 61.5 (8.7) 49 - 77 0 
Life Satisfaction 50 (8.4) 40 - 76 5.3 (1) 
PROMIS® CAT Assessments 
Fatigue1 52.7 (7.8) 39 – 69 21 (4) 
Anxiety1 54.8 (6.9) 44 - 67 21 (4) 
Depression1 52.3 (8.0) 38 – 71 47.4 (9) 
Sleep Disturbance1 48.6 (10.4) 28 – 63 26.3 (5) 
Physical Function 40.9 (7.6) 28 – 53 47.3 (9) 
Mobility 39.5 (6.4) 29 – 53 57.9 (11) 
Participate in social 
activities 
47.6 (9.1) 31 – 63 21 (4) 
1One SD above population; an undesirable outcome 
2 N = 18: missing data 
 
(Campman et al., 2017, p.3077). However, several factors need to be considered when 
administering a cognitive battery. First, it is common for persons in the general population to 
obtain one or more low scores (Holdnack et al., 2017; Mistridis et al., 2015). Second, the 
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more tests included in the battery, the higher the probability that an individual will have a low 
score on a test (Holdnack et al., 2017; Mistridis et al., 2015). In the general population, 42.7% 
- 45.9% would meet the criterion of the DSM-5 for mild neurocognitive disorder as defined 
by at least one standard deviation below the mean standard score (Holdnack et al., (2017). 
Thus, using a standardized battery such as the NIHTB-SB which uses seven tests to exam five 
domains of cognition has the potential to eliminate obtaining artificially elevated predications 
of cognitive decline caused by testing procedures. 
When comparing cognitive scores to standardized mean scores, many characteristics 
of the individual must be considered. These factors include a person's level of intellectual 
ability, education level, physical health status, lifetime occupation and past performance of 
cognitive tests (Ardila, Ostrosky-Solis, Rosselli, Gomez, 2000; Apolinario et al., 2013; 
Bento-Torres et al., 2017; Bergman & Almkvist, 2015; Holdnack et al., 2017; Mistridis et 
al, 2015). Many neuropsychological tests especially those that involve language, are 
sensitive to educational levels (Ardila et al., 2000; Bento-Torres et al., 2017). Less 
education early in life is a risk factor for age-related cognitive decline, with a much 
stronger influence than age itself (Bento-Torres et al., 2017). In contrast, our findings did 
not support a difference on tests of language. Of the participants in this study, 63.2% had 
high school education and no more than one year of college. Two tests were given for 
language and between the two tests, only one participant showed deficit. 
In a preliminary estimate of the strength of the relationship among domain-specific 
cognition, functional performance and life satisfaction in persons with mild to severe 
COPD, there was limited evidence to support a relationship. There only significant 
relationship was between social participation and episodic memory. 
There is limited research on sleep disturbances in persons with COPD and domain- 
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specific cognition. A weak correlation was found between COPD and copying ability on the 
MMSE which reflects executive and visuospatial functions (Cleutjens et al., 2016). In 
contrast, there was no a significant relationship between sleep disturbance and executive 
function in our sample. There was a moderate negative correlation between sleep 
disturbance and working memory. The finding supports findings from previous research. 
In persons with COPD, memory scores were significantly worse but there was no significant 
difference in on three tests of executive function (Omachi et al., 2012). 
Limitations of the study include that it was a pilot study with a small sample size. In 
examining, the correlations between cognitive domain and other variables in the model may 
have been limited due to the sample size and large range of scores. 
In conclusion, the PROMIS® and NIHTB-CB assessments are both feasible and 
accessible for performing cognitive testing in the COPD patient population. Processing 
speed seems to be the most frequently occurring deficit. A decline in processing speed may 
be the first decline to occur in the pattern of decline in COPD. Sleep disturbance has a 
negative correlation with working memory. Further work needs to be completed to 
understand the complexity of pattern of domain-specific cognitive decline in persons with 
COPD. 
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CHAPTER V 
 
Discussion 
 
In persons with COPD, the relationship among domain-specific cognition, functional 
performance and life satisfaction is not fully understood. From the systematic review, there is 
strong evidence of decline in domain-specific cognition. Comparisons across studies are 
complicated by no universal categorization of the domains of cognition and a vast array of 
measurements used to assess each domain. In prior reviews, domains were discussed by those 
most frequently assessed. We expanded the knowledge in relationship to domain-specific 
cognitive decline by performing a meta-analysis. Persons with COPD had poorer performance in 
all domains of cognition. A large effect size in the domains of executive function and processing 
speed were found with processing speed having the largest effect size. 
COPD has been related to structural brain changes. A plausible reason for the significant 
decline in executive function and processing speed in persons with COPD can be related to these 
structural changes. The white matter of the frontal cortex is involved in executive function, 
short-term recall and processing speed (Yankner, Lu, & Loerch, 2008). These frontal circuits 
which are associated is particularly sensitive to hypoperfusion and hypoxia (Schilerstrom, 
Horton, & Royall, 2005). Substantial perfusion deficits were found in the frontal lobes of 
persons with COPD and were most marked in oxygen users (Incalzi, 2003). Also, from chronic 
inflammation there are elevated levels of choline which leads to changes in white matter 
(Borson, 2008). These structural changes that occur in COPD lead to deficits in cognitive 
functioning. 
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From the HRS data base, persons with COPD, at time of first reported diagnosis of 
COPD, were found to have a significant decrease in the domains of executive function and 
memory and learning. The difference held true over the 12-year period apart from immediate 
recall at which time there was no longer a difference between the two groups. The slope of 
change did not differ significantly except for immediate recall. The slope of immediate recall 
was steeper in the non-COPD group. The decline was such that after 12 years, the mean 
differences between the two groups were no longer significant. However, the non- COPD group 
continued to have better performance than those with COPD. 
There are three differences to be explained; the difference at baseline between the mean 
scores of the group the similar slopes of decline in executive function and delayed recall and the 
steeper slope in immediate recall in the non-COPD group. The difference at baseline could be 
caused by COPD leading to cognitive changes earlier in life. A few studies have suggested that 
cognitive changes may occur prior to the diagnosis of COPD (Dal Ben and Bricolo, 2012; Dal 
Negro et al., 2014) . One reason that there may not be a difference in the slope of change 
between groups is that 85% of the person in the HRS data had quit smoking. Thus, with the 
cessation of smoking, the rate of decline in lung function slows which may subsequently lead to 
a decline in the consequences of damaged lung function such as cognitive decline. In contrast, in 
the non-COPD group one domain of cognition had a steeper slope, immediate recall. This may in 
part be explained by critical ages in the life course of the brain. One critical age is between the 
ages of 60-90, when brain volume shrinkage occurs with the steepest estimated decline in 
cerebral white matter and hippocampus (Fjell et al., 2013). These areas of the brain are involved 
in executive function, immediate recall and processing speed. 
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Attempting to understand the relationship between domain-specific cognition, functional 
performance and life satisfaction, we examined the potential that the relationship between 
cognitive decline and life satisfaction was mediated by functional performance. In all areas of 
functional performance; mobility, use of large muscles, gross motor and fine motor skills, 
persons with COPD preformed significantly worse than the non-COPD group. However, a 
mediation effect could not be established as there was no significant relationship between any of 
the domains of cognition and life satisfaction in the COPD group. In the non-COPD group, 
delayed recall had a significant relationship with life satisfaction and it was fully mediated by 
functional performance. 
The lack of a significant relationship between domain-specific cognition and life 
satisfaction could be a result that life satisfaction remains relatively stable over time. The focus 
of this research was on cognition; thus, life satisfaction was only examined in the cross-sectional 
analysis in a time when many persons already had been diagnosed with COPD for several years. 
Prior to our analysis, the person with COPD could have used a life management strategy such as 
selection, optimization and compensation(SOC) (Baltes, 1997). SOC is an active process by 
which one chooses and prioritizes goals and tasks, invests resources needed and finally 
compensates using external means to achieve goals (Jopp & Smith, 2006). Optimal use of 
resources through strategies such as SOC may prevent feelings of dissatisfaction (p.262). 
Additionally, we examined functional performance from the activities that are required to 
perform ADLs and IADLs. However, examining function from the perspective of valued life 
activities may be helpful in the future, as valued life activities are more strongly linked to quality 
of life than ADLs and IADLs (Katz et al., 2010). 
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Other factors were identified as having the potential to impact cognitive domains. From 
the psychosocial variables available in the HRS data, we focused on need for cognition, the sense 
of mastery, hopelessness and satisfaction with aging. The sense of mastery was not a significant 
predicator of cognition in either group. The need for cognition and satisfaction with aging were 
weak predictors of cognition in the non-COPD group only. However, hopelessness was a 
predictor of cognition in both groups but was a stronger predictor in the COPD group in 
immediate and delayed recall. In fact, of the variable examined, it was the strongest predicator. 
It becomes apparent just as we cannot isolate and study just one domain of cognition, it is 
equally difficult to separate emotions from the study of cognition. One such emotion is our 
negative or positive perception of self. As people experience life, they develop attitudes and 
predication about aging from information in society and experiences with older person (Levy, 
Slade, & Kasl, 2002). When these attitudes are internalized they become part of one’s self- 
perception of aging. With aging, these self-perceptions can become self-fulfilling prophecies. It 
was found that given the same functional health at baseline, over a span of 20 years, persons with 
a negative self-perception of aging had a greater functional decline that was partially moderator 
by self-control (pP414). Hopelessness may have a strong influence on cognition in persons with 
COPD as they are aware that their disease is manageable but not curable and a weaker predictor 
in the non-COPD group aging occurs out of one’s control. Hopelessness was just examined in 
the cross-sectional portion of the study. A future direction would be to examine it in relationship 
between baseline hopelessness and cognition, functional performance and life satisfaction over 
time. 
The last part of the study was to examine the feasibility and acceptability of using CAT to 
test cognition in persons with COPD. The format was well received by all participants. It is a 
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very feasible and acceptable format for using in the COPD population. We examined aggregate 
data to assess for declines in any of the cognitive domains. In the aggregate data, no domain was 
shown to have a significant level of decline. However, there was at least one person in every 
domain that reached the level of having a deficit. The domain of processing speed showed the 
largest number of persons with deficit, 47.5% of participants which is consistent with other 
findings. 
The NIHTB-CB was used for this pilot study. However, there are other CATs for testing 
cognition available. As there in no universal categories for domain-specific cognition, there 
remains incontinences in labeling domains and tests included. The movement towards 
standardize testing will be helpful in cognitive assessment. But there remains the lack of 
universal categorization of domains of cognition and the best tests for each domain. The use of 
the tablet may be a better format than computer-based testing. However, this was not examined 
in this research. 
From the pilot study, the relationship between domain-specific cognition, functional 
performance and life satisfaction, correlations of the variables were examined. There was no 
correlation between any of the domains of cognition and life satisfaction. In functional 
performance, there was a moderate negative correlation between the ability to participate in 
social roles and episodic memory. Related factors including disease severity, symptoms or 
dyspnea and fatigue and emotional states of depression and anxiety and sleep were examined for 
a relationship with domain-specific cognition. Only sleep disturbance had a significant negative 
correlation with working memory. Sleep disturbances in COPD have been well 
documented. Sleep was found to be correlated to memory (Omachi et al., 2012). 
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In summary, future directions of research include systematic review of executive 
function including clinical relevance. Repeating the longitudinal study including asymptomatic 
smokers or trace the persons COPD and include the years prior to self-reporting diagnosis of 
COPD. Since we could not establish a significant relationship between domains of cognition, 
functional performance and life satisfaction, a future direction would be to examine functional 
performance from a valued life activity or social performance perspective. An important future 
direction of research needs to be to determine clinical significance of the cognitive declines. 
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APPENDIX A 
 
Revised Wilson and Cleary Model for Health-Related Quality of Life 
 
 
 
Figure 19 A. 1 Revised Wilson & Cleary Model for Health-Related Quality of Life 
Retrieved from Google Images: 
https://www.researchgate.net/figure/5685471_fig1_Revised-Wilson- and-Cleary-
Model-for-Health-Related-Quality-Life-Revised-Wilson-and 
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APPENDIX B 
 
GOLD COPD Staging System 
 
Table 10 B. 1 GOLD COPD Staging System 
 
Stage I Mild COPD FEV1/FVC<0.70 FEV1≥ 80% normal 
Stage II Moderate 
COPD 
FEV1/FVC<0.70 FEV1 50-79% 
normal 
Stage III Severe COPD FEV1/FVC<0.70 FEV1 30-49% 
normal 
Stage IV Very Severe 
COPD 
FEV1/FVC<0.70 FEV1 <30% normal, 
or <50% normal with 
chronic respiratory 
failure present* 
*Based on post-bronchodilator FEV1 
Global Strategy for the Diagnosis, Management, and Prevention of 
COPD, Global Initiative for Chronic Obstructive Lung Disease 
(GOLD) 2015. 
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APPENDIX C 
 
COPD Assessment Test 
 
 
(COPD Assessment Test) 
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APPENDIX D 
 
Modified Medical Research Center Dyspnea Scale (mMRC) 
 
Date    
 
Instructions: Choose the one best response. 
 
Please choose the one best response to describe your 
shortness of breath. Grade 0 “I only get short of breath 
with strenuous exercise.” 
Grade 1 “I get short of breath when hurrying on the level or walking up a slight hill.” 
 
Grade 2 “I walk slower than people of the same age on the level 
because of breathlessness or have to stop for breath when 
walking at my own pace on the Level” 
Grade 3 “I stop for breath after walking 100 yards or after a few minutes on the level.” 
 
Grade 4 “I am too breathless to leave the house” or I am breathless while dressing.” 
 
 
 
 
 
(Modified Medical Research Council Dyspnea Scale) 
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APPENDIX E 
 
Combined Assessment Tool of COPD 
 
 Table 11 E. 1 Combined Assessment Tool of COPD 
 
Patient Characteristic Spirometric 
Classification 
Exacerbations 
per year 
CAT mMRC 
 
A 
Low Risk 
Less 
Symptoms 
 
GOLD 1-2 
 
≤ 1 
 
< 10 
 
0-1 
 
B 
Low Risk 
More 
Symptoms 
 
GOLD 1-2 
 
≤ 1 
 
> 10 
 
> 2 
 
C 
High Risk 
Less 
Symptoms 
 
GOLD 3-4 
 
> 2 
 
< 10 
 
0-1 
 
D 
High Risk 
More 
Symptoms 
 
GOLD 3-4 
 
> 2 
 
> 10 
 
> 2 
Global Strategy for the Diagnosis, Management and Prevention of COPD, 
Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2015. 
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APPENDIX F 
 
Search Terms 
 
1. Chronic Obstructive Airway Disease (COAD) 
2. Chronic Obstructive Pulmonary Disease (COPD) 
3. Chronic Bronchitis 
4. Emphysema 
5. 1 or 2 or 3 or 4 
6. Cognition 7. 6 & 7 
8. Cognitive function  
9. 6 & 9 
10. Executive function  
11. 6 & 11 
12. Perception  
13. 6 & 13 
14. Attention  
15. 6 & 15 
16. Memory  
17. 6 & 17 
18. Working memory  
19. 6 & 19 
20. “visual memory”  
21. 6 & 21 
22. “verbal memory”  
23. 6 & 23 
24. “reaction time”  
25. 6 & 25 
26. “processing speed”  
27. 6 & 27 
28. Language  
29. 6 & 29 
30. Visuospatial  
31. 6 & 31 
32. “cognitive dysfunction”  
33. 6 & 33 
34. “cognitive deficit”  
35. 6 & 35 
36. “cognitive domains”  
37. 6 & 38 
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APPENDIX G 
 
Study Selection Tool 
 
Table 12 G. 1 Study Selection Tool 
 
Criteria for Systematic Review Yes* No Comments 
Research Design – 
Descriptive 
Experimental 
Quasi-Experimental 
  EXCLUDE CASE STUDIES AND 
QUALITATIVE STUDIES 
Participants 
Major focus of article COPD/chronic 
bronchitis patients with any of the following 
measures 
FEV1 or FEV1/FVC 
Blood gases 
Diffusion capacity 
PFT 
Lung Volume 
Self- Report 
   
Cognition 
Perception    
Attention    
Learning and Memory 
(declarative and/or 
non-declarative memory)   
Immediate memory    
Delayed Memory    
Episodic Memory    
Working Memory    
Long-term/ 
short-term memory    
Executive Function    
Language    
Speed and Processing    
  **MUST HAVE AT LEAST ONE 
DOMAIN TO BE INCLUDED 
The following section is information: A yes is not necessary for inclusion in the review 
OUTCOME 
Does the article have an outcome(s) 
measure? 
  If yes, list outcome(s). 
*All criteria boxes must be marked yes for inclusion 
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APPENDIX H 
 
Data Extraction Tool 
 
Table 13 H. 1 Data Extraction Tool 
 
1. Date form completed  
2. Name/ID of person extracting 
data 
 
3. Report title  
4. Report ID  
5. Reference details  
6. Report author contact details  
7. Publication type  
8. Study funding source  
Possible conflicts of interest 
(for study authors) 
 
9. Notes: 
Eligibility 
Study 
Characteristics 
Review Inclusion Criteria Yes/No 
Unclear 
Location in 
text 
10. Type of study descriptive ...  
Experimental ...  
Quasi-experimental ...  
Longitudinal ...  
Observational ...  
Cross-sectional ...  
Case-control ...  
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Study 
Characteristics 
Review Inclusion Criteria Yes/No 
Unclear 
Location in 
text 
11. Participants 
 
COPD & Control 
or age referent 
normal 
  
... 
 
12. Domain- 
specific 
Cognition 
  
... 
 
13. Types of 
outcome 
measures 
  
... 
 
14. Decision: ...   
15. Reason for 
exclusion 
 
16. Notes: 
 
DO NOT PROCEED IF STUDY EXCLUDED FROM REVIEW 
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Population and setting 
 
 Description Location in text 
17. Population 
description 
  
18. Setting   
19. Inclusion criteria   
20. Exclusion criteria   
21. Method/s of 
recruitment of 
participants 
  
22. Notes: 
 
Methods 
 Descriptions as stated in report/paper Location in text 
23. Aim of study   
24. Design   
25. Unit of allocation 
 
(by individuals, cluster/ 
groups or body parts) 
  
26. Start date   
27. End date   
28. Duration of 
participation 
 
(from recruitment to 
last follow-up) 
  
29. Notes: 
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Risk of Bias assessment 
 
Domain Risk of bias 
Low/ 
High/Unclear 
Support for 
judgement 
Location in 
text 
30. Random sequence generation 
 
(selection bias) 
 
... 
  
31. Allocation concealment 
 
(selection bias) 
 
... 
  
32. Blinding of participants and 
personnel 
 
(performance bias) 
 
 
... 
Outcome group: 
All/ 
 
33. Blinding of outcome 
assessment 
 
(detection bias) 
 
 
... 
Outcome group: 
All/ 
 
34. Incomplete outcome data 
 
(attrition bias) 
 
... 
  
35. Selective outcome reporting? 
 
(reporting bias) 
 
... 
  
36. Other bias ...   
37. Notes: 
 
Participants 
 Description as stated in report/paper Location in text 
38. Total no. randomised 
 
(or total pop. at start of 
study for NRCTs) 
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 Description as stated in report/paper Location in text 
39. Clusters 
 
(if applicable, no., type, no. 
people per cluster) 
  
40. Baseline imbalances   
41. Withdrawals and 
exclusions 
  
42. Age   
43. Sex   
44. Race/Ethnicity   
45. Severity of illness   
46. Co-morbidities   
47. Other treatment received   
48. Other relevant 
sociodemographic 
  
49. Subgroups measured   
50. Subgroups reported   
51. Notes: 
Results 
Copy and paste the appropriate table for each outcome, including additional tables 
for each time point and subgroup as required. For randomized or non-randomized 
trial - Dichotomous outcome 
 Description as stated in report/paper Location in text 
52. Comparison   
53. Outcome   
54. Subgroup   
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 Description as stated in report/paper Location in text 
55. Time point   
56. Results 
 
Note whether: 
 
... post-intervention 
OR 
 
... change from 
baseline 
 
And whether 
 
... Adjusted OR 
 
...Unadjusted 
Intervention Comparison  
No. 
events 
No. participants No. 
event 
s 
No. 
partic 
ipants 
    
57. Baseline data Intervention Comparison  
No. event No. part. No. 
event 
No. 
part. 
    
58. No. missing 
participants and 
reasons 
   
59. No. participants 
moved from other 
group and reasons 
   
60. Any other results 
reported 
  
61. Unit of analysis   
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 Description as stated in report/paper Location in text 
62.  Statistical 
methods used and 
appropriateness of 
these methods 
 
(e.g. adjustment for 
correlation) 
  
63. Reanalysis 
required? 
 
(if yes, specify why, 
e.g. correlation 
adjustment) 
... 
Yes/No/Unclear 
  
64. Reanalysis 
possible? 
... 
Yes/No/Unclear 
  
65. Reanalyzed results   
66. No 
test: 
 
Other information 
 
 Description as stated in report/paper Location in text 
67. Key conclusions of 
study authors 
  
68. References to other 
relevant studies 
  
69. Correspondence 
required for further 
study information 
 
(what and from 
whom) 
 
70. Further study 
information 
requested 
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(from whom, what 
and when) 
 
71. Correspondence 
received 
 
(from whom, what 
and when) 
 
72. Note 
s: 
 
 
Effective Practice and Organization of Care (EPOC). (2013) 
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APPENDIX I 
 
Sign Checklist 
 
 
S I G N 
Methodology Checklist 4: Case-control studies  
Study identification (Include author, title, year of publication, journal title, pages)  
Guideline topic: Key Question No: Reviewer:  
Before completing this checklist, consider: 
1. Is the paper really a case-control study? If in doubt, check the study design algorithm available 
from SIGN and make sure you have the correct checklist. 
2. Is the paper relevant to key question? Analyze using PICO (Patient or Population Intervention 
Comparison Outcome). IF NO REJECT (give reason below). IF YES complete the checklist. 
 
Reason for rejection: Reason for rejection: 1. Paper not relevant to key question □ 2. Other reason □ 
(please specify): 
 
Section 1: Internal validity  
In a well conducted case control study: Does this study, do 
it? 
 
1.1 The study addresses an appropriate and clearly focused question. 
Yes 
Can’t say 

No 
 
SELECTION OF SUBJECTS  
1.2 The cases and controls are taken from comparable populations. 
Yes 
Can’t say 

No 
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1.3 The same exclusion criteria are used for both cases and controls. 
Yes 
Can’t say 

No 
 
1.4 What percentage of each group (cases and controls) participated in the study? 
Cases: 
Controls: 
 
1.5 Comparison is made between participants and non-participants to establish their 
similarities or differences.i 
Yes 
Can’t say 

No 
 
1.6 Cases are clearly defined and differentiated from controls. 
Yes 
Can’t say 

No 
 
1.7 It is clearly established that controls are non-cases. 
Yes 
Can’t say 

No 
 
ASSESSMENT  
1.8 Measures will have been taken to prevent knowledge of primary exposure 
influencing case ascertainment. 
Yes 
Can’t say 

No 
Does 
not 
apply 

 
1.9 Exposure status is measured in a standard, valid and reliable way. 
Yes 
Can’t say 

No 
 
CONFOUNDING  
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1.10 The main potential confounders are identified and considered in the design 
and analysis.ii 
Yes 
Can’t say 

No 
 
STATISTICAL ANALYSIS 
 
1.11 Confidence intervals are provided. 
Yes  No 
 
SECTION 2: OVERALL ASSESSMENT OF THE STUDY  
2.1 How well was the study done to minimize the risk of bias or confounding? 
High quality (++) 
□ 
Acceptable (+) □ 
Unacceptable – 
reject 0 □ 
 
2.2 Considering clinical considerations, your evaluation of the methodology used, 
and the statistical power of the study, do you think there is clear evidence of 
an association between exposure and outcome? 
Yes 
Can’t say 
No 
2.3 Are the results of this study directly applicable to the patient group targeted by 
this guideline? 
Yes  No 
 
2.4 Notes. Summarize the author’s conclusions. Add any comments on your own assessment of the 
study, and the extent to which it answers your question and mention any areas of uncertainty raised 
above. 
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APPENDIX J 
 
Perception Studies 
 
Table 14 J. 1 Perception Studies 
 
Study Sample Mean Age (SD) Mean (SD) Sign. 
Perceptual Score 
†Prigatano et 
al. (1983) 
100 COPD 
 
25 Controls 
61.5 (7.4) 
 
59.6 (9) 
5.7(7.4) 
 
6.0 (6.6 
NS 
Speech-Sound Perception Test 
†Grant et al., 
(1982) 
51 COPD 
 
51 Controls 
64.4 (8.1) 
 
64.3 (10.5) 
11.2(n.r.) 
 
8 (n.r.) 
p < 
.05 
†Prigatano et 
al. (1983) 
100 COPD 
 
25 Controls 
61.5 (7.4) 
 
59.6 (9) 
7.9 (6.9) 
 
5.9 (5.4) 
NS 
Sensory Exam 
†Grant et al., 
(1982) 
51 COPD 
 
51 Controls 
64.4 (8.1) 
 
64.3 (10.5) 
12.3(n.r.) 
 
6.4 (n.r.) 
p < 
.001 
(n.r.) = not reported 
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APPENDIX K 
 
Attention Studies 
 
Table 15 K. 1 Attention Studies 
 
Study Sample Mean Age (SD) Mean (SD) Sign. 
Bourbon-Test 
Measures sustained selective attention by measuring simple reaction time-consists of 33 lines with 
different dot patterns and patterns of 4 must be selected-scores are based on the mean time in seconds it 
takes to complete each line.  Higher score indicates poorer cognitive performance 
†Vos et al (1995) 39 COPD 65.9 (5) Time in sec (SD)  
 38 Control 64.8 (5)   
   Overall mean line  
   COPD: 14.1 (3) p< 0.05 
   Control: 12.6 (2)  
   
Mean line time on 
 
   lines 0-11  
   COPD: 14.4 (3) p< 0.05 
   Control: 12.7 (2)  
   
Mean line time on 
 
   lines11-22 p< 0.05 
   COPD: 13.9 (3)  
   Control: 12.4 (2)  
   
Mean line time on 
 
   lines 22-33 p< 0.05 
   COPD: 14 (3)  
   Control: 12.7 (2)  
STROOP 
Measures selective attention when the name of the color is printed in a color not denoted by the name, the 
naming process takes extra processing time test is scored in seconds above predicted test duration based 
on gender and education level higher score indicates poorer cognitive performance 
†Liesker et al. (2004) 30 COPD 64.8 (8.2) Stroop Word Card  
 20 Control 65.6 (11.2) COPD:  
   6 (-17-40.5) **  
   Control: NS 
   2.5 (-6-16.5) **  
   
Stroop Color Card 
 
   COPD:  
   3 (-18-31) ** NS 
   Control:  
   -2 (-12-36) **  
   
Stroop Color Word 
 
   Card  
   COPD:  
   28 (-6-164) ** NS 
   Control:  
   21 (-19-68) **  
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†Pereira, et al. (2011) 34 COPD 65.2 (7) *Test 1  
 18 Control 62.7 (4) COPD:  
   22 (12-38) **  
   Control: NS 
   19 (12-32) **  
   
*Test 2 
 
   COPD:  
   28 (6.4) NS 
   Control:  
   25.2 (7.2)  
   *type of Stroop not  
   specified by authors  
Trailmaking Test A 
Consists of numbers 1-25 placed in circles distributed randomly over a sheet of paper 
-using a pencil, the numbers within the circles are connected in ascending order 
-the tested is scored by then number of seconds it takes to complete the test 
-the test is normative data based on age and education 
†Bratek et al. (2013) 12 COPD 
13 Control 
67(n.r.) 
48(n.r.) 
42.8 (n.r) 
30.04 (n.r.) 
Not 
report
ed 
(Bratek et al., 2015) 24 COPD 67(7) 42 (17) p < 0.05 
 18 Control 48 (14) 35 (11)  
   Note: authors used  
   cutoff of > 78 sec as  
   some deficiency  
†Dal Ben & Bricolo 132 71.5 (12.1) Age 40-49 p < 0.015 
(2012) COPD  COPD  
   48.9(23.6)  
   Control  
   72.2 (24.9)  
   
Age 50-59 p <0.006 
   COPD  
   53.8 (26.3)  
   Control  
   73.7 (34.5)  
†Dal Negro, et al. 161 Age ranked:   
(2014) COPD 40-49   
 151 13 COPD 73.2 (15.3)  
 Control 52 Control 48.9 (23.6) p = 0.002 
  50-59   
  24 COPD 96 (55.3)  
  52 Control 53.8 (26.3) p = 0.001 
  60-69   
  56 COPD 99.9 (58.3)  
  39 Control 67.3 (28.7) p = 0.001 
  70-79   
  68 COPD 110.1 (44.3)  
  10 Control 84.6 (23.8) p = 0.004 
†Favalli, et al. (2008) 21 COPD 74.6 (5.4) 92 (24-152) ** p < 0.01 
 20 Control 73.7 (4.5) 48 (26-184) **  
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Hjalmarsen et al. 10 COPD 65.9 (7.3) 66 (24.9) p = 0.02 
(1999) 10 Control 66.1(4.7) 42.2 (13.3)  
Kozora et al. (2005) 19 COPD 64.8(4.9) 42.4 (17) NS 
 LVRS    
*LVRS COPD and 20 COPD 64.3(6.2) 37.6 (14.9)  
Controls at baseline †MT    
were selected for 39 control 64(5.4) 30.9 (10.8)  
analysis     
Kozora, et al. 56 COPD 64.8 (5.9) 40.2 (15.8) Not 
(2010) 54 Control 64.2 (5.8) 32.1 (12.7) reported 
†Liesker, et al. (2004) 30 COPD 64.8 (8.2) 48 (25-173) ** NS 
 20 Control 65.6 (11.2) 40 (22-74) **  
Prigatano, et al. (1983) 100 61.5 (7.4) 46.8 (18.6) NS 
 COPD    
 25 Control 59.6 (9) 44.6 (18.9)  
Seashore Rhythm Test 
Requires the discrimination between like and unlike pairs of musical beats 
Lower score indicates poorer cognitive performance 
†Grant et al., (1982) 51 COPD 64.4 (8.1) 23 (n.r.) Not 
 51 Control 64.3 (10.5) 23.5 (n.r.) reported 
     
†Hjalmarsen et al 10 COPD 65.9 (7.3) 18.6 (4) p = 0.02 
(1999) 10 Control 66.1 (4.7) 23.2 (3.8)  
†Prigatano et al. 100 61.5 (7.4) 23.3 (4.3) NS 
(1983) COPD    
 25 Control 59.6 (9) 24.2 (3.3)  
Digit Vigilance Time 
Measure of sustained visual attention 
Higher score indicates poorer cognitive performance 
†Kozora et al. (2005) 19 COPD 64.8(4.9) 442.3 (90.7) NS 
 LVRS    
 
20 COPD 64.3(6.2) 422.5 (63.0) 
 
 MT    
 
39 control 64(5.4) 407.4 (70.5) 
 
†Kozora et al, (2010) 56 COPD 64.8 (5.9) 435.4 (92.6) NS 
 54 Control 64.2 (5.8) 403.4 (70.6)  
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Barrage 
-must cross all lines that are randomly arranged on page 
Lower score indicates poorer cognitive performance 
†Incalzi, et al. (1993) 36 COPD 69 (10) 132 (71) NS 
 
29 Control 68.9 (7.7) 145 (78) 
 
Attention Network Test 
Computerized testing 
†Klein, et al.   Attention Network  
(2010) 60 COPD 63.2 (9.8) Relative alerting p < 0.01 
 60 Control 63.5(8.3) Relative orienting p < 0.05 
   Relative conflict NS 
Zahlenverbindungstest 
-computerized test of attention 
Lower score indicates poorer cognitive performance 
†(Kotterba et al., 1998) 32 COPD 
10 Control 
57.4(8.2) 
48 (9.9) 
Alertness 
COPD 23.1 (20.2) 
Control 75.5(24.1) 
p < 0.001 
   
Selective attention 
COPD 45.4(33.4) 
Control 77.0 (10.6) 
p < 0.001 
   
Divided attention 
COPD 46.1 (27.8) 
Control 35 (15.1) 
 
NS 
   
Continuous 
attention 
COPD 18.9 (17.2) 
Control 64.4 (24.4) 
 
 
p < 0.001 
   
Vigilance 
COPD 71.5 (20.5) 
Control 74.8 (16.9) 
 
NS 
**reported in median and range 
† Not included in meta-analysis 
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APPENDIX L 
Memory and Learning Studies 
Table 16 L. 1 Memory and Learning Studies 
 
Study Sample Mean Age 
(SD) 
Mean (SD) Sign. 
Span Forward 
-measures short term memory span 
Called digit when numbers are used and verbal is words are used 
Lower number indicated less memory span 
†Cleutjens et al., (2014)   Digit  
 5764 9 (7.6) β=-0.05 (-0.10-.00) ** p =0.47 
 COPD    
 
37,275 56 (8.3) 
  
 Controls    
†Incalzi, et al., (1993) 36 COPD 69 (10) Verbal  
 29 Control 68.9 (7.7) 5.1 (0.9) NS 
   5.7 (0.9)  
Incalzi, et al (1997)   Digit  
 42 COPD 72 (62-76) ** 5.1 (0.9)  
 27 Control 70 (67-72) ** 5.4 (0.9) NS 
Kozora, et al., (1999)   Digit  
 32 COPD 70.3 (4.4) 7.2 (1.4)  
 31 Control 69.9(5.8) 6.7 (1.0) NS 
Kozora et al. (2005)   Digit  
*LVRS COPD pts and 19 COPD 64.8(4.9) 14.7 (3.4) NS 
controls at baseline LVRS    
were selected for     
analysis 20 COPD †MT 64.3(6.2) 14.2 (2.7)  
 
39 control 
   
  64(5.4) 16.1(4.1)  
Kozora et al., (2010)  
56 COPD 
54 Control 
 
64.8 (5.9) 
64.2 (5.8) 
Digit 
14.1 (2.9) 
15.5 (4.2) 
 
NS 
Ortapamuk & Naldoken 
(2006) 
10 non- 
hypoxemic 
COPD 
 
54.8(6.9) 
Digit 
6.9 (1.7) 
 
NS 
 
8 stable 
hypoxemic 
COPD 
 
52.6(5.4) 
 
7.0 (0.9) 
 
 
10 Control 54.1(8.7) 7.1 (5.1) 
 
Pereira, et al.   Digit  
(2011) 34 COPD 65.2 (7) 10.7 (2.8) NS 
 18 Control 62.7 (4) 11.7 (3.8)  
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Zhang, et al. (2013)  
25 COPD 
25 Control 
 
69.2 (8) 
68(8) 
Digit 
7.0 (1.6) 
7.7 (1.4) 
 
NS 
Wechsler Memory Scale 
Lower score indicates poorer cognitive performance 
Dodd et al.,   Verbal  
(2013)   Immediate  
 50 COPD 69 (8) COPD: 8.9 (2.7) p < .001 
 30 Control 65 (8) Control: 11.2 (3.8)  
   Delayed  
   COPD: 11.5 (2.3) p = .007 
   Control: 12.1 (2.7)  
†Grant et al., 
1982 
51 COPD 
51 Controls 
64.4 (8.1) 
64.3(10.5) 
Immediate 
COPD: 20.1 % loss 
Control: 17.2 % loss 
 
NS 
   
Delayed (30 min) 
COPD: 33.3 % loss 
Control: 20.2 % loss 
 
p < .05 
Incalzi, et al. 42 COPD 72 (62-76) Immediate p<0.001 
(1997) 27 Control 70 (67-72) COPD 33.6 (7.3)  
   Control 40.5 (6.8)  
   Delayed  
   COPD 6.2 (2.5) p<0.001 
   Control 8.6 (2.9)  
Kozora et al., 
(1999) 
32 COPD 
31 Control 
70.3 (4.4) 
69.9(5.8) 
Immediate 
COPD 16.0 (3.8) 
Control 19.4(3.1) 
 
NS 
   
Delayed 
COPD 6.7 (1.3) 
Control 7.3 (0.8) 
 
NS 
Ortapamuk & †10 non-hypoxemic  Immediate  
Naldoken COPD 54.8(6.9) Non-hypoxemic  
(2006)   COPD  
 8 stable hypoxemic  33.8 (3.7)  
 COPD 52.6(5.4) Stable hypoxemic NS 
   COPD  
 10 controls  27.1 (5.9)  
   Control  
  54.1(8.7) 35.2 (8.3)  
    
Delayed 
 
   Non-hypoxemic p<0.01 
   COPD between 
   7.8 (2.9) hypo- 
   Stable hypoxemic xemic and 
   COPD controls 
   4.1 (2.7)  
   Control  
   8.6 (3.1)  
†Zhou et 
al (2012) 
 
110 COPD 
 
80.9(1.78) 
Visual 
Immediate 
COPD 16.1 (2.89) 
 
p = 0.018 
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 110 Control 80.8 (1.59) Control 17.0 (2.61) 
 
Delayed 
COPD 5.2 (1.18) 
Control 5.5 (1.29) 
 
 
NS 
Raven’s colored Progressive Matrices 
Immediate Visual Memory & Visual-Spatial Intelligence 
Lower score indicates poorer cognitive performance 
†Favalli, et al. 21 COPD 74.6 (5.4) 41.8 (23.8-53) ** p<0.001 
(2008) 20 Control 73.7 (4.5) 50.5 (32.8-57.3) **  
†Incalzi, et al. 36 COPD 69 (10) 23 (4.8) p<0.001 
(1993) 29 Control 68.9 (7.7) 27 (4.5)  
†(Ortapamuk & 
Naldoken, 
2006) 
†10 non- 
hypoxemic 
COPD 
 
54.8(6.9) 
 
15.4 (5.5) 
 
 
8 stable 
hypoxemic 
COPD 
52.6(5.4) 14.8 (4.5)  
NS 
 
10 controls 54.1(8.7 17.2 (5.1) 
 
Wechsler Adult Intelligence Scale Subtest Block Design 
-recreate red and white blocks measured in speed and accuracy 
Lower scores indicate poorer performance 
†Hjalmarsen et 10 COPD 65.9 (7.3) 21.6 (6.2) p = 0.02 
al. (1999) 10 Control 66.1 (4.7) 28.5 (6.3)  
Wechsler Memory Scale-Revised 
Has 7 subsets that require the performance of a specific variety of tasks and to retell certain details 
Lower score indicates poorer cognitive performance 
†Hjalmarsen et 10 COPD 65.9 (7.3) WMS-R Subset  
al., (1999) 10 Control 66.1 (4.7) Verbal paired  
   associates –  
   immediate p = 0.006 
   COPD 12.5 (4.9)  
   Control 17.9 (2.5)  
   WMS-R Subset  
   Visual  
   Reproduction p = 0.04 
   immediate  
   COPD 24.2 (7.9)  
   Control 33.1 (9.9)  
   WMS-R Subset  
   Verbal paired p = .003 
   associates –delayed  
   COPD 4.4 (2)  
   Control 6.8 (1) p = 0.02 
   WMS-R Subset  
   Visual  
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   Reproduction 
delayed 
COPD 19.6 (8.1) 
Control 28.4 (7.4) 
 
†Kozora et al. 
(2002) 
29 COPD 
21 Control 
66.9 (n.r.) 
65.2 (n.r.) 
Story Retention 
COPD 79.3 (2.9) 
Control 82.4 (2.7) 
 
Visual Retention 
COPD 69.8 (4.9) 
Control 69 (5.7) 
 
Verbal Pairs 
COPD 17.5 (0.7) 
Control 19 (0.7) 
Not 
reported 
†Prigatano et 
al., (1983) 
100 COPD 
25 Control 
61.5 (7.4) 
59.6 (9) 
WMS-R Subset 
Verbal paired 
associates – 
immediate 
COPD 8.0 (1.5) 
Control 8.8 (1.5) 
 
 
 
 
p =.03 
   
WMS-R Subset 
Visual 
Reproduction 
immediate 
COPD 6.7 (3.3) 
Control 9.1 (2.2) 
 
 
 
p = .001 
   
WMS-R Subset 
Verbal paired 
associates –delayed 
COPD 7.5 (1.7) 
Control 8.3 (1.2) 
 
 
p = .04 
    p = .002 
   WMS-R Subset 
Visual 
Reproduction 
delayed 
COPD 5.7 (3.3) 
Control 8.0 (2.9) 
 
†Shim 15 COPD 62(4) WMS-R Not 
et al. (2001)   General memory reported 
   62 (15)  
   100 (15) * Note: data 
    missing 
   Verbal memory from 2 
   66 (14) subjects 
   100 (15) *  
   
Visual memory 
 
   71 (21)  
   100 (15) *  
   
Delayed memory 
 
   67 (13)  
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   100 (15)*  
†Zhang et al 
(2013) 
25 COPD 
25 Control 
69.2 (8) 
68(8) 
WMS-R 
Visual 
Reproduction 
COPD 8.2 (3.4) 
Control 10.3 (3.0) 
 
Figure Memory 
COPD   10.5 (3.0) 
Control 12.4 (1.9) 
 
 
 
P = 
0.031 
 
P = 
0.010 
Corsi Block – Spatial Span 
Involves mimicking a researcher as he taps a sequence of up to 9 blocks 
Lower score indicates poorer cognitive performance 
†Incalzi, et al 36 COPD 69 (10) 4.5 (0.7  
(1993) 29 Control 68.9 (7.7) 5.3 (0.9) NS 
Rey Auditory Verbal Learning Test (RAVLT) 
A list of 15 words are heard and then as many as possible are recalled 
Lower score poorer cognitive performance 
†Favalli et al. 21 COPD 74.6 (5.4) Rey’s immediate p <0.02 
(2008) 20 Control 73.7 (4.5) COPD  
   37.6 (29.2-59) **  
   Control  
   43.5 (33-67) **  
   Rey’s List Delayed  
   COPD p<0.001 
   8.3 (3.1-13.6) **  
   Control  
   10.4 (7.4-15.8) **  
†Incalzi et al., 
(1993) 
36 COPD 
29 Control 
69 (10) 
68.9 (7.7) 
RAVLT short-term 
COPD 33 (7.3) 
Control 41 (7) 
 
p <0.001 
    
RAVLT long-term 
COPD 5.4 (2.5) 
Control 8.7 (3) 
 
p < 0.005 
†Pereira 34 COPD 65.2 (7) RAVLT A1-5 p = 0.03 
et al., 18 Control 62.7 (4) COPD 43.5 (10)  
(2011)   Control 50.5 (10)  
   RAVLT SDFR p =0.002 
   COPD 7.5 (3.3)  
   Control 10.7 (3.6)  
   RAVLT LDFR p = 0.003 
   COPD 8.4 (3.8)  
   Control 11.6 (3.9)  
Wechsler Memory Scale III-logical memory 
Lower score indicates poorer cognitive performance 
†Borson, et al. 
(2008) 
18 COPD: 68.5 (8) COPD non-02 
dependent 
12.6 (2.1) 
 
p = 
0.049 
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 (9 02 
dependent, 9 
without 02) 
 
9 Control 
 
 
68.2 (5.8) 
COPD 02 dependent 
10.7 (3.1) 
Control 
13.7 (2.1) 
*02 
uses 
lower 
than 
both 
groups 
(p=0.5 
-1) 
Priganto et al., 
(1983) 
100 COPD 
25 Control 
61.5 (7.4) 
59.6 (9.0) 
Immediate 
COPD 18.1 (6.4) 
Control 20.9 (5.4) 
 
Delayed 
COPD 14.9 (6.6) 
Control 18.7 (5.8) 
 
p = .04 
 
 
p = .009 
Story Recall 
†Liesker et al., 
(2004) 
30 COPD 
20 Control 
64.8 (8.2) 
 
65.6 (11.2) 
Direct 
COPD  18 (3-20) ** 
Control 18 (3-20) ** 
Delayed 
COPD 18 (0-20) ** 
Control 18 (0-20) 
** 
 
NS 
NS 
Verbal and Non-verbal Learning from the Vienna Test System 
A computer assisted application 
Lower score indicates poorer cognitive performance 
†Incalzi et al. 42 COPD 72 (62-76) 40.5 (16.5)  
(1997)    NS 
 27 Control 70 (67-72) 47.3 (16.6)  
†Klein et al., 60 COPD 63.2 (9.8) Diff corr/false  
(2010) 60 Control 63.5 (8.3) COPD 23.8 (20.3) p < 0.05 
   Control 50 (10)  
   VLT Corr  
   COPD 40.9 (25.6) p < 0.05 
   Control 50 (10)  
   False  
   COPD 35.6 (32.6) p < 0.01 
   Control 50 (10)  
   Diff corr/false  
   COPD 1.9 (27.1)  
   Control 50 (10) NS 
   NVLT Corr  
   COPD 55.7 (25.7)  
   Control 50 (10) p < 0.01 
   False  
   COPD 21.3 (24.6)  
   Control 50 (10) p < 0.01 
Prospective Memory 
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†Cleutjens et al. 
(2014) 
5764 COPD 
 
37275 
Controls 
59(7.6) 
 
56 (8.3) 
β = -0.15 (-0.22 to 0.009) p<0.005 
Visual Spatial Memory 
Lower score indicates poorer cognitive performance 
†Cleutjens et al 
(2014) 
5764 COPD 59 (7.6) Round 1 
β = 0.06 (0.03-0.10) 
 
p<0.05 
 37,275 
Controls 
 
56 (8.3) 
 
Round 2 
β = 0.09 (0.00-0.18) 
 
p=0.047 
†Dodd et al., 50 COPD 69(8) 8.2 (2.8) p<0.001 
(2013) 30 Control 65(8)   
   10(0)  
†Incalzi et al 
(1993) 
36 COPD 
29 Control 
69 (10) 
68.9 (7.7) 
Spatial span forward 
COPD 4.5 (0.7) 
Control 5.3 (0.8 
 
NS 
   
Spatial span reverse 
COPD 3.8 (0.6) 
Control 4.4 (0.7) 
 
p<0.005 
Rey Complex Figure Test 
Measure visuospatial ability and visuospatial memory 
Score is based on three drawing trials: copy, 3-minute immediate recall and 30-minute delayed 
Lower score indicates poorer cognitive performance 
†Dodd, et al. 
(2013) 
50 COPD 
30 Control 
69 (8) 
65 (8) 
Immediate 
COPD 9.4 (4.3) 
Control 11.3 (4.7) 
 
. 
NS 
   
Delayed 
COPD 9.4 (4.4) 
Control 11.4 (4.8) 
 
 
NS 
* standardized norm 
** reported median and range 
† Not included in meta-analysis 
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APPENDIX M 
 
Executive Function Studies 
 
Table 17 M. 1 Executive Function Studies 
 
Study Sample Mean Age 
(SD) 
Mean (SD) Sign. 
Verbal Fluency 
Say as many words possible from a given category 
Lower score indicates poorer cognitive performance 
Incalzi et al., 36 COPD 69 (10) Phonetic  
(1993) 29 Control 68.9 (7.7) COPD 24.2 (9.7) p < 0.005 
   Control 31 (8)  
   Semantic NS 
   COPD 19.8 (5)  
   Control 24 (7)  
†Dodd, et al. (2013)   Delis-Kaplan Verbal  
 50 COPD 69 (8) fluency  
 30 Control 65 (8) COPD 11.1 (3.7) NS 
   Control 12 (3.4)  
†Favalli et al. (2008) 21 COPD 74.6 (5.4) Phonemic  
 20 Control 73.7 (4.5) COPD  
   30.5 (18-47) *** NS 
   Control  
   36.5 (16-53) ***  
   
Semantic 
 
   COPD  
   11.8 (6.7-17.3) *** p < 0.05 
   Control  
   14.7 (9.5-18.5) ***  
Kozora, et al., (1999) 32 COPD 70.3 (4.4) Letter Fluency  
 31 Control 69.9(5.8) COPD 36.4 (11.4) p < 0.001 
   Control 46.3 (13.4)  
   Animal Fluency  
   COPD 19.3 (5.1) NS 
   Control 19.0 (4.3)  
†Kozora et al., (2002)   Note: from Controlled  
   Oral Word Association 
   Test 
   Letter Fluency 
 9 COPD 66.9 31.2 (1.9) 
 21 Control 65.2 41.4 (3.1) 
Kozora et al. 
(2005) 
 
 
*LVRS COPD pts 
and Controls were 
selected at baseline 
for analysis 
19 COPD 
LVRS 
 
20 COPD 
†MT 
 
39 Control 
64.8(4.9) 
 
64.3(6.2) 
 
64(5.4) 
Letter Fluency 
COPD LVRS 
31.6 (10.7) 
COPD †MT 
31.1 (10) 
Control 
40.2 (12.4) 
 
Animal Fluency 
COPD LVRS 
 
NS 
 
 
 
 
 
NS 
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   19.3 (4.3)  
COPD †MT 
19.7 (4.5) 
Control 
19.3 (4.4) 
(at baseline) 
Kozora et al. (2010) 56 COPD 64.8 (5.9) Letter Fluency  
 54 Control 64.2 (5.8) COPD 31.6 (10.5) Not 
   Control 38.9 (12.1) reported 
   Animal Fluency COPD  
   19.2 (4.4)  
   Control 19.2 (4.3)  
Ortapamuk & †10 non- 54.8(6.9) Phonological  
Naldoken (2006) hypoxemic  †non-hypoxemic  
 COPD  COPD 26.8 (8.8) NS 
 
8 stable 
 
stable hypoxemic COPD 
 
 hypoxemic 52.6(5.4) 25.9 (7.8)  
 
10 Control 54.1(8.7) Control 27.8 (9.1) 
 
Pereira, et al. (2011)   Letters FAS Fluency  
 34 COPD 65.2 (7) 21.1(1) p = 0.003 
 18 Control 62.7 (4) 30.2 (12.3  
Span Backwards – Executive Function 
Numbers that are read must be repeated backwards starting with last number 
Lower score indicates poorer cognitive performance 
Incalzi, et al., 36 COPD 69 (10) 3.3 (0.9)  
(1993) 29 Control 68.9 (7.7) 4.1 (0.8) p < 0.05 
Incalzi, et al., 42 COPD 72 (62-76) 3.3 (0.98)  
(1997) 27 Control 70 (67-72) 3.8 (0.8) p < 
    0.001 
Kozora, et al., 32 COPD 70.3 (4.4) 5.4 (1.4)  
(1999) 31 Controls 69.9(5.8) 5.2 (1.4) NS 
Ortapamuk & 
Naldoken 
(2006) 
†10 non- 
hypoxemic 
COPD 
 
54.8(6.9) 
†non-hypoxemic 
COPD 5.1 (1.1) 
 
    NS 
 8 stable 
hypoxemic 
COPD 
52.6(5.4) stable hypoxemic COPD 4.8 
(1.3) 
 
 
10 Control 54.1(8.7) Control 5.3 (0.8) 
 
Zhang et al 25 COPD 69.2 (8) 4.1 (1.9) NS 
(2013) 25 Control 68(8) 4.3 (1.5)  
Trailmaking Test B 
Consists of 25 circles containing letters and numbers which need to be alternately connected in ascending 
order (ex. A 1 B 2) 
-results are recorded in number of seconds taken to complete task 
-a higher score indicates poorer cognitive function 
†Bratek, et al. 12 COPD 67 107.79(n.r.) Not 
(2013) 13 Controls 48 67.37 (n.r.) reported 
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Bratek, et al. 
(2015) 
24 COPD 
18 Controls 
67(7) 
48(14) 
107 (41) 
70 (23) 
 
p < 0.05 
†Dal Ben & 
Bricolo (2012) 
132 COPD 
 
COPD 
Control 
71.5 (12.1) 
 
40-49 
11.8 (53.9) *** 
163.2 (97.5) 
 
***as reported in results 
p < 0.015 
†Dal Negro, et 
al. 
(2014) 
16 COPD 
52 Control 
 
27COPD 
52 Control 
 
25COPD 
39 Control 
 
30 COPD 
10 Control 
40-49 
 
50-59 
 
60-69 
 
70-79 
157.3 (53.9)3) 
111.8 (53.9) 
 
184.2 (101.9) 
134.5 (80.1) 
 
186.7 (100.3) 
164.5 (97.4) 
 
254.6 (197.8) 
336.8 (197.8) 
p = 0.01 
 
p = 0.01 
NS 
NS 
†Favalli, et al. 
(2008) 
21 COPD 
20 Control 
74.6 (5.4) 
73.7 (4.5) 
143 (55-346) *** 
68.5 (11-270) *** 
p < 0.01 
†Grant, et al. 
(1982) 
51 COPD 
51 Control 
64.4 (8.1) 
64.3 (10.5) 
161.8 (not reported) 
119.8 (not reported) 
p < 0.001 
Hjalmarsen, et 
al. (1999) 
10 COPD 
10 Control 
65.9 (7.3) 
66.1 (4.7) 
201.9 (97.2) 
98.1 (29.6) 
p = 0.005 
Kozora, et al. 
(1999) 
32 COPD 
31 Control 
70.3 (4.4) 
69.9(5.8) 
108.8 (49.7) 
93.9 (48) 
NS 
Kozora, et al. 
(2002) 
29 COPD 
21 Control 
66.9(n.r.) 
65.2 (n.r.) 
125.5(15.2) 
72 (4.2) 
Not 
reported 
Kozora et al. 
(2005) 
*LVRS COPD 
pts at baseline 
were selected 
for analysis 
19 COPD 
LVRS 
 
20 COPD 
†MT 
 
39 Control 
64.8(4.9) 
 
64.3(6.2) 
 
64(5.4) 
102.4 (38) 
 
113.9 (69.7) 
 
79.9 (25.5) 
Not 
reported 
Kozora, et al. 
(2010) 
56 COPD 
54 Control 
64.8 (5.9) 
64.2 (5.8) 
107 (49.5) 
80.7 (24.8) 
Not 
reported 
†Liesker, et al. 
(2004) 
30 COPD 
20 Control 
64.8 (8.2) 
65.6 (11.2) 
122 (54-235) *** 
89 (41-163) *** 
p < 0.05 
Prigatano, et 
al. (1983) 
100 COPD 
25 Control 
61.5 (7.4) 
59.6 (9) 
125.1 (62) 
103.8 (35.5) 
p = .03 
†Shim, et al 
(2001) 
15 COPD 62(4) CTT1 
35 (11) ** 
50 (10) ** 
Not 
reported 
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 Standardized 
value =100 
 CTT2 
35 (14) ** 
50 (10) ** 
 
Corsi Block – Reverse Spatial Span 
Incalzi, et al. 
(1993) 
36 COPD 
29 Control 
69 (10) 
68.9 (7.7) 
3.8 (0.6) 
4.4 (0.7) 
p < 0.005 
Copying Designs 
Incalzi, et al., 
(1993) 
36 COPD 
29 controls 
69 (10) 
68.9 (7.7) 
Simple copy 
COPD 6.9 (2.3) 
Control   8.8 (2) 
Copy with landmarks 
COPD  61 (6) 
Control 65 (4) 
 
p < 0.001 
 
p < 0.005 
Ortapamuk & 
Naldoken 
(2006) 
†10 non- 
hypoxemic 
COPD 
 
8 stable 
hypoxemic 
COPD 
 
10 Control 
54.8(6.9) 
 
 
52.6(5.4) 
 
 
54.1(8.7) 
non-hypoxemic COPD 7.0 
(3.6) 
stable hypoxemic COPD 6.9 
(3.0) 
Control 7.2 (2.8) 
 
Copy with landmarks 
non-hypoxemic COPD 60.1 
(8.9) 
stable hypoxemic COPD 
59.6 (7.5) 
Control 61.6 (5.2) 
NS 
 
 
NS 
Standard Progressive Matrices (SPM) 
†Klein et al 
(2010) 
60 COPD 
60 Control 
63.2 (9.8) 
63.5(8.3) 
9.9 (13.2) 
50 (10) 
p < 0.01 
Fluid intelligence 
Problem Solving and reasoning ability 
†Cleutjens et 
al., (2014) 
5764 COPD 
 
37,275 Control 
59 (7.6) 
 
56 (8.3) 
β = -0.05 (-0.11-.003) NS 
WAIS Similarities 
†Hjalmarsen et 
al (1999) 
10 COPD 
10 Control 
65.9 (7.3) 
66.1 (4.7) 
14.8 (4.3) 
15.1 (4.6) 
NS 
†Kozora et al. 
(2005) 
*LVRS COPD 
pts at baseline 
were selected 
for analysis 
19 COPD 
LVRS 
 
20 COPD 
†MT 
 
39 control 
64.8(4.9) 
 
64.3(6.2) 
 
64(5.4) 
16.5 (5.1) 
 
16.6 (6.8) 
 
19.1 (3.7) 
Not 
reported 
†Kozora et al. 
(2010) 
56 COPD 
54 Control 
64.8 (5.9) 
64.2 (5.8) 
16.8 (5.5) 
19.8(3.7) 
Not 
reported 
**reported standardized scores 
***reported median and range 
†not included in meta-analysis 
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APPENDIX N 
 
Language Studies 
 
Table 18 N. 1 Language Studies 
 
Study Sample Mean Age 
(SD) 
Mean (SD) Sign. 
Aphasia Screening Test 
Series of tasks that require one to name objects spell words, identify numbers 
†Grant et al., 1982 51 COPD 64.4 (8.1) 7.8 (n.r.) NS 
 51 Control 64.3 (10.5) 6.6 (n. r.)  
†Prigatano et al. 100 COPD 61.5 (7.4) 7.6 (7.3) P = .0006 
(1983) 25 Controls 59.6 (9) 3.7 (4.1)  
Boston Naming 15 
Measures visual confrontation naming abilities of 15 words 
Lower score indicates poorer cognitive performance 
Kozora, et al., (1999) 32 COPD 70.3 (4.4) 13.9 (1.5)  
 31 Control 69.9(5.8) 13.9 (1.2) NS 
Kozora et al. (2005) 19 COPD 64.8(4.9) 13.7 (1.8)  
 LVRS    
*LVRS COPD pts at    NS 
baseline was 20 COPD †MT 64.3(6.2) 13.4 (2.1)  
selected for analysis     
 39 Control    
  64(5.4) 14.2 (1.1)  
Kozora et al., (2010) 56 COPD 64.8 (5.9) 13.6 (1.8) NS 
 54 controls 64.2 (5.8) 14.4 (2.9)  
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APPENDIX O 
 
Processing Speed Studies 
 
Table 19 O. 1 Processing Speed Studies 
 
Study Sample Mean Age (SD) Results 
Mean (SD) 
Sign. 
Simple Reaction Time 
Higher score indicates poorer cognitive performance 
†Cleutjens et al., 5764 COPD 59 (7.6) β = 4.62 (1.25-8.01)  
(2014)     
 37,275   P =007 
 Control 56 (8.3)   
†Hjalmarsen et 10 COPD 65.9 (7.3) 400.9 (91.8) NS 
al (1999) 10 Control 66.1 (4.7) 329.1(65.6)  
Complex Reaction Time 
Higher score indicates poorer cognitive performance 
†Hjalmarsen et 10 COPD 65.9 (7.3) 543.4 (146.5) p = 0.02 
al (1999) 10 Control 66.1 (4.7) 416.7 (42.6)  
Complex Reaction Time, sequential 
Higher score indicates poorer cognitive performance 
†Hjalmarsen et 10 COPD 65.9 (7.3) 621.1 (132.1) p = 0.03 
al (1999) 10 Control 66.1 (4.7) 507.8 (64.4)  
Overall Reaction Time -Attention Network Test 
Computerized test 
Higher score indicates poorer cognitive performance 
†Klein et al 60 COPD 63.2 (9.8) 649 (113) p < 0.01 
(2010) 60 Control 63.5(8.3) 583 (110)  
Digit Symbol (from WAIS-III) 
Timed test that requires matching 9-digit symbols with their corresponding number 
Lower score indicates poorer cognitive performance 
Borson, et al. 
2008 
18 COPD: 
9 non-oxygen 
dependent 
COPD & 
9 02 
dependent 
 
 
68.5 (8) 
COPD 
non-oxygen dependent 
12.1 (1.5) 
02 dependent 8.4(3.3) 
Control 12.7 (1.5) 
p=0.034 
02 users 
lower 
scores 
than 
both 
other 
groups 
p <0.005 
  68.2 (5.8)  
 9 Control   
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Dodd, et al. 
(2013) 
50 COPD 
30 Control 
69 (8) 
65 (8) 
96 (14) 
111(13) 
p<0.001 
†Favalli et al. 
2008 
21 COPD 
20 Control 
74.6 (5.4) 
73.7 (4.5) 
17 (9-35) ** 
24 (12-45) ** 
 
p<0.001 
Kozora et al. 
(2005) 
*LVRS COPD 
pts was 
selected for 
analysis 
19 COPD 
LVRS 
20 COPD 
†MT 
 
39 control 
64.8(4.9) 
 
64.3(6.2) 
 
64(5.4) 
40.9 (5.2) 
 
44.2 (9.2) 
 
51.4 (10) 
NS 
Kozora et al. 
(2010) 
56 COPD 
54 Control 
64.8 (5.9) 
64.2 (5.8) 
42.6(8.5) 
51.1(10.3) 
NS 
†Liesker et al., 
(2004) 
30 COPD 
20 Control 
64.8 (8.2) 
65.6 11.2) 
34.5 (15-60) ** 
47 (24-75) ** 
p < 0.05 
Prigatano et al., 
(1983) 
100 COPD 
25 Control 
61.5 (7.4) 
59.6 (9) 
6.4 (2.0) 
8.0 (2.5) 
P = .001 
**reported median and range 
†not included in meta-analysis 
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APPENDIX P 
Selected HRS Measures 
Table 20 P. 1 Selected HRS Measures 
 
Questions Response Options 
Demographics  
-Age Enumerated 
-Year of birth  
-Gender  
-Education Level 
Did you get a high school diploma or 
pass a high school equivalency test? 
 
Did you get a college degree? 
 
What is the highest degree you have 
earned 
 
1=Yes, diploma; 3= Yes, equivalency; 
5=no; 8=DK; 9=RF 
 
1=Yes; 5=no; 8=DK; 9=RF 
 
1=less than bachelors; 2=bachelors; 
3=masters 4=law; 5=Ph.D.; 6=MD; 
7=other; 8=DK; 9=RF 
-Household Income Enumerated 
-Net Worth Enumerated 
-Marital Status  
-Smoking history 
-ever smoked 
-smoke now 
-number of packs per day 
-age started smoking 
 
-Comorbities 
-Has your doctor ever told you that you have. . . 
-high blood pressure or hypertension? 
-diabetes? 
-cancer? 
-heart condition? 
-stroke? 
-emotion/psychiatric problems? 
-arthritis? 
 
Cognition 
Immediate Recall 
Respondent is given list of 10 nouns and asked to 
recall as many as possible in any order 
 
Delayed Recall 
After approximately 5 minutes is asked to recall 
the nouns previously presented 
Executive function 
 
Serial 7s Test 
 
Number correct 
 
 
 
Number correct 
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Subtract 7 from 100 and continue subtracting 7 
from each subsequent number for a total of 5 
trials. 
Backwards Count starting from 20 
Count backwards for 10 continuous numbers. 
 
Number correct 
 
Completed on 
1st attempt =1 
2nd attempt =2 
Unable to complete = 0 
 
Sleep 
How often do you have trouble falling asleep? 
How often do you have trouble staying asleep? 
How often do you have trouble with waking up 
too early and not being able to fall asleep again? 
How often do you feel really rested when you 
wake up in the morning? 
 
Would you say most of the time, sometimes, or 
rarely or never? 
 
Recoded to any difficulty =1 
No difficulty = 0 
 
Composite score 
Emotional State 
Depression 
-20 items from CEDS 
 
Anxiety 
Have you ever had an anxiety disorder? 
 
1=yes, 0 = no 
  
Life Satisfaction 
Please think about your life as a whole. 
How satisfied are you with it? 
Are you completely satisfied, very satisfied, somewhat 
satisfied, not very satisfied, or not at all satisfied? 
1. Completely Satisfied 
2. Very Satisfied 
3. Somewhat Satisfied 
4. Not Very Satisfied 
5. Not at All Satisfied 
8. DK (Don't Know); NA (Not Ascertained) 
9. RF (Refused) 
Functional Performance  
Walking several blocks 
Walk one block 
Climbing several flights of stairs 
Climb one flight of stairs 
Walk across the room 
Mobility 
Score range 0-5 
Sitting for about 2 hours 
Getting up from a chair 
Stooping, kneeling or crouching 
Pull or push large object 
Large Muscle groups 
Score range 0-4 
Walking 1 block 
Walk across the room 
Climbing a flight of stairs 
Bathing 
Transfer to bed 
Gross Motor Skills 
Score range 0-5 
Picking up a dime 
Dressing 
Eating 
Fine Motor Skills 
Score range 0-3 
Need for cognition 
1) I like to have the responsibility of handing a 
situation that requires a lot of thinking. 
1=Not at all like me 
2=Somewhat like me 
3=Uncertain 
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2) I really enjoy a task that involves coming up 
with new solutions to problems. 
3) The notion of thinking abstractly is appealing to 
me. 
4) I would rather do something that requires little 
thought than something that is sure to challenge 
my thinking abilities. (-) 
5) I try to anticipate and avoid situations where 
there is likely a chance I will have to think in 
depth about something (-). 
6) I only think as hard as I have to (-). 
4=Somewhat like me 
5=Very much like me. 
 
Cognitive Enjoyment 
(Positive Items 34a_a, b, and c) 
Cognitive Effort 
(Reverse coded Items 34a_d. e. and f). 
Composite Score 
Perceived mastery 
I can do just about anything I really set my mind 
to. 
When I really want to do something, I usually find 
a way to succeed at it. 
Whether or not I am able to get what I want is in 
my own hands. 
What happens to me in the future mostly depends 
on me. 
I can do the things that I want to do. 
 
6-point Likert 
scale  
Scale score 
Hopelessness 
I feel it is impossible for me to reach the goals that 
I would like to strike for. 
The future seems hopelessness to me and I can’t 
believe that things are changing for the better. 
I don’t expect to get what I really want. 
There’s no use in really trying to get something I 
want because I probably won’t get it. 
6-point Likert scale 
1 strongly disagree to 6 strongly agree 
Composite score 
Satisfaction with aging 
The next statements are about the way people feel 
about their age and about the things that happen as 
they get older. Please tell us how much you agree 
or disagree with each statement for you 
personally.) 
1) Things keep getting worse as I get older. 
2) I have as much as pep as I did last year. 
3) The older I get, the more useless I feel. 
4) I am as happy now as I was when I was 
younger. 
5) As I get older, things are better than I thought 
they would be. 
6) So far, I am satisfied with the way that I am 
aging. 
7) The older I get, the more I have had to stop the 
things that I liked. 
8) Getting older has brought with it many things 
that I do not like. 
6-point Likert scale 
 
Create a rating of aging satisfaction by reverse 
coding items Q29b1, b3, b7, and b8 and averaging 
the scores across all 8 items. 
 
Alternatively, separate scores may be obtained for 
positive and negative aging satisfaction. Average 
across items Q29 b2, b4, b5, and b6 to get a rating 
of positive aging satisfaction. 
 
Average across items Q29 b1, b3, b7, and b8 to 
get a rating of negative aging satisfaction 
172  
Appendix Q 
 
Sample Size from HRS Data Set for Longitudinal Study Based on Assessment Point 
 
Table 21 Q. 1 Sample Size from HRS Data Set for Longitudinal Study Based on Assessment Point 
 
Assessment 
point 
 
Sample Size 
Non-COPD 
 
Years 
with COPD 
 
Sample Size 
COPD 
1 3070 1 380 
2 3070 3 332 
3 3070 5 289 
4 3070 7 233 
5 3068 9 172 
6 3070 11 134 
7 3070 13 95 
8 3068 15 56 
9 3066 17 30 
10 3060 19 14 
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APPENDIX R 
 
Regression of Psychosocial Variables on Domains of Cognition Cross-sectional 
Study from 2014 Wave of HRS Data Set 
 
Table 22 R. 1 Regression of Psychosocial Variables on Domains of Cognition Cross-sectional 
Study from 2014 Wave of HRS Data Set 
 
Attention/Executive Function: Serial Seven Subtractions 
Non-COPD 
N =1285 
F(4, 1280) = 10.80, p < 0.01, R2 = 0.03 
 β Coef. t-score p-value 
Need for Cognition -0.398 -2.90 0.004 
Mastery -0.012 -1.20 NS 
Hopelessness -0.047 -3.87 0.000 
Satisfaction With Aging 0.012 1.71 NS 
Constant (Seven) 4.57   
Memory & Learning Immediate Recall 
COPD 
N = 143 
F(4,138) = 4.29, p < 0.01, R2 =0.11 
Need for Cognition -0.055 -1.31 NS 
Mastery 0.0157 0.52 NS 
Hopelessness -0.122 -3.30 0.001 
Satisfaction With Aging -0.02 -1.00 NS 
Constant (Immediate) 7.34   
Memory & Learning Immediate Recall 
Non-COPD 
N = 1285 
F(4,1280) = 15.59, p <0.001, R2 = 0.04 
Need for Cognition -0.24 -1.81 NS 
Mastery -0.015 -1.46 NS 
Hopelessness -0.061 -5.01 0.00 
Satisfaction With Aging 0.019 2.65 <0.001 
Constant (Immediate) 5.9   
Memory & Learning Delayed Recall 
COPD 
N = 143 
F(4,138) = 15.19, p<0.001, R2 = 0.12 
Need for Cognition -0.05 -.99 NS 
Mastery 0.008 0.24 NS 
Hopelessness -0.167 -3.77 0.00 
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Satisfaction With Aging -0.23 -0.98 NS 
Constant (Immediate) 6.9   
Memory & Learning Delayed Recall 
Non-COPD 
N = 1285 
F(4,1280) = 46.74, p<0.001, R2 = 0.04 
Need for Cognition -0.034 -2.17 0.03 
Mastery -0.012 0.335 NS 
Hopelessness -0.071 -4.92 0.00 
Satisfaction With Aging 0.018 2.21 NS 
Constant (Immediate) 5.07   
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APPENDIX S 
Convergent and Discriminant validity of NIHTB-CB Persons Aged 8-85 (Weintraub et al., 2014) 
 
Table 23 S. 1 Convergent and Discriminant Validity of the NIHTB-CB Persons Aged 8-85 
 
Cognitive 
Battery 
Measures 
Convergent 
Test 
Convergent Validity Discriminant Test Discriminant Validity 
  N r  N r 
Flanker/ Wechsler 317 -0.48b Peabody Picture Vocabulary Test 89 0.15a 
Attention, Adult      
Executive Intelligence      
 Scale      
Dimension Delis-Kaplan 317 -0.51a Peabody Picture Vocabulary Test 85 0.14c 
Change Card Executive      
Sort/ Function      
Executive       
Switching       
Picture Brief 350 0.69a Peabody Picture Vocabulary Test 115 -0.08 
Sequence Visuospatial      
Memory/ Memory Test-      
Episodic revised      
Memory       
Vocabulary/Lan 
gauge 
Peabody Picture 
Vocabulary Test 
351 0.78a Brief Visuospatial 
revised 
Memory Test- 111 0.08 
Reading/ 
Language 
Wide Range 
Achievement 
Test 
351 0.93a Brief Visuospatial 
revised 
Memory Test- 115 0.19a 
Pattern Wechsler 349 0.49a Peabody Picture Vocabulary Test 99 0.12c 
Comparison/ Intelligence      
Processing Scale      
Speed       
List Sorting/ 
Working 
Memory 
Wechsler 
Intelligence 
Scale 
350 0.58a Peabody Picture Vocabulary Test 112 0.30a 
a p<0.001 
bp < 0.01 
cp < 0.05 
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APPENDIX T 
 
Reliability NIHTB-CB 
 
Table 24 T. 1 Reliability of NIHTB-CB 
 
Cognitive 
Domain 
NIH toolbox 
measurement(s) 
Reliability 
7-21-day test-retest 
Attention NIH Toolbox Flanker 
Inhibitory Control and 
Attention Test 
r = 0.85 CI (0.74-89). 
Executive 
Function 
NIH Toolbox Flanker 
Inhibitory Control and 
Attention Test 
 
NIH Toolbox Dimensional 
Change Card Sort Test 
 
r = 0.85 with CI (0.74-0.89) 
 
 
r = 0.88 with CI (0.82-0.92) 
Working 
memory 
NIH Toolbox List Sorting 
Working Memory Test 
r = 0.77 CI (0.67-0.84) 
Language NIH Toolbox Picture 
Vocabulary Test 
Oral Reading Recognition 
Test 
r = 0.81 CI (0.73-0.87) 
Processing 
speed 
NIH Toolbox Pattern 
Comparison 
Processing Speed Test 
r = 0.72 CI (0.60-0.81) 
Episodic 
Memory 
NIH Toolbox Picture 
Sequence Memory Test 
r = 0.77 CI (0.67-0.84). 
(NIH Toolbox.org). 
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APPENDIX U 
Feasibility and Acceptability Survey 
Table 25 U .1 Feasibility and Acceptability Survey 
 
 Strongly 
Disagree 
Disagree Neutral Agree Strongly 
Agree 
I received 
adequate 
instruction to 
complete the 
task. 
     
The screen 
was easy to 
read. 
     
Answering 
the questions 
using a 
computer 
keyboard 
was easy. 
     
The test took 
too long. 
     
I needed to 
take breaks 
during the 
test. 
     
My overall 
impression 
of the 
experience 
was 
excellent. 
     
 
If you were asked to take these tests again: 
What would you like to see done differently? 
 
 
What would you like to see stay the same? 
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APPENDIX V 
 
Correlations of Domain-specific Cognitive Function - Spearman’s rho 
 
Table 26 V. 1 Correlations of Domain-specific Cognitive Function, Related Factors, Functional Performance, and Life Satisfaction - 
Spearman's rho 
 
 Attention/ 
Flanker 
Exec 
function 
Dimen. 
Sort 
Episodic 
Memory 
Pict. 
Sequence 
Language 
Pict. 
Vocab.. 
Language 
Oral 
Processing 
Speed 
Pattern 
Recogn. 
Working 
Memory 
List Sort 
Physical 
Function 
-.302 .043 -.185 .235 .119 .350 .082 
Mobility -.337 .170 -.226 .149 -.167 .244 -.020 
Ability 
Social 
Participation 
-.319 -.185 -.512* .404 .106 .437 .047 
Life 
Satisfaction 
-.397 -.154 -.301 .151 .079 -.166 .327 
Related Factors 
Disease 
Severity 
FEV1 
-.291 .064 -.391 .229 .201 .203 -.391 
mMRC .084 .094 -.444 -.319 .062 -.444 -.035 
Fatigue .227 .012 .153 -.378 .141 -.283 -.392 
Anxiety .263 .334 .273 -.375 .035 -.143 -.211 
Depression .397 .069 .179 -.432 -.064 -.128 -.434 
Sleep -.118 .314 -.204 -.290 .150 -.351 -.663** 
*p < 0.05 
**p < 0.00 
 
 
 
 
 
 
